Antifungal components

Abstract

The present invention relates to a fungicidal composition comprising components (A) and (B) as described in claim 1, and to the use of the composition in agriculture or horticulture for controlling or preventing plant infections caused by plant pathogenic microorganisms, preferably fungi.

Description

[Technical Field]

[0001] The present invention relates to novel fungicidal compositions, their use in agriculture or horticulture to control diseases caused by plant pathogens, particularly plant pathogenic fungi, more specifically oomycetes, and methods for controlling diseases on useful plants. [Background technology]

[0002] Although many fungicidal compounds and compositions belonging to various different chemical classifications have been developed / are under development for use as fungicides on useful plant crops, their crop resistance and activity against specific plant pathogens do not always meet the needs of agricultural practices in many respects. Therefore, there remains a need to find novel compounds and compositions with superior biological properties that can be used to control or prevent plant invasion by plant pathogenic fungi. For example, compounds with higher biological activity, a favorable activity spectrum, an increased safety profile, improved physicochemical properties, or increased biodegradability; or compositions with a broader activity spectrum, improved crop resistance, synergistic interactions or enhancing properties; or compositions that exhibit a faster onset of action or have longer-lasting residual activity; or compositions that enable a reduction in the number and / or amount of application of compounds and compositions required for effective control of plant pathogens, thereby enabling beneficial resistance management, reduced environmental impact, and reduced operator exposure.

[0003] Some of these requirements can be met by using a composition containing a mixture of different fungicidal compounds with different mechanisms of action (for example, by combining fungicidal agents with different activity spectra). [Overview of the project] [Means for solving the problem]

[0004] According to the present invention, there is provided a fungicidal composition comprising components (A) and (B) as active ingredients, wherein component (A) has the formula (I):

Chemical formula

[0005] In a preferred embodiment of the present invention, component (A) is formula (I): [ka] (In the formula, Z is O; R 1 C 1-6 Alkyl, C 1-6 Alkoxy-C 1-6 Alkyl, C 3-6 Cycloalkyl, C 1-6 Alkylsulfonyl-C 1-6 Alkyl and C 3-6 Cycloalkyl-C 1-4 Selected from alkyl, where C 1-6 Alkyl, C 1-6 Alkoxy-C 1-6 Alkyl, C 3-6 Cycloalkyl, C 1-6 Alkylsulfonyl-C 1-6 Alkyl and C 3-6 Cycloalkyl-C 1-4 Each alkyl group may be optionally substituted with CN; R 2a H, C1-6 alkyl, C 3-6 cycloalkyl, and C 1-6 alkoxy-C 1-6 alkyl selected therefrom; R 2b is H, CN, C 1-6 alkyl, C 3-6 cycloalkyl, C 1-6 alkoxy-C 1-6 alkyl, amino, and -NHC(O)C 1-6 alkyl selected therefrom; R 2c is H; J is CR 4 ; G is CR 5 ; R 3 is H; R 4 is halogen or CN; R 5 is H, C 1-6 alkyl, C 1-6 alkoxy and halogen selected therefrom; A is CH or N; and R 6 is C 1-6 alkyl, C 1-6 alkoxy, C 3-6 cycloalkyl, C 1-6 alkylamino, C 1-6 alkoxyamino and C 1-6 alkylC 1-6 alkoxyamino selected therefrom); a compound of; or a salt or N-oxide thereof.

[0006] In another preferred embodiment according to the present invention, component (A) is of formula (I):

Chemical formula

[0007] In this invention, N-[(1R)-1-benzyl-3-chloro-1-methyl-buto-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methyl-buto-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoroquinoline-3-carboxamide , N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoroquinoline-3-carboxamide, 8-fluoro-N-[(1R) -1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl] [Tyl-butyl]-8-fluoroquinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-buto-3-enyl)-8-fluoroquinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-buto-3-enyl)-8-fluoroquinoline-3-carboxamide can be prepared by the method described in International Publication No. 2017 / 153380.

[0008] In this invention, N-[(1R)-1-benzyl-3-chloro-1-methyl-buto-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methyl-buto-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoroquinoline-3-carboxamide, N-[(1S )-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoroquinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoroquinoline-3-carboxamide Among the compounds selected from -carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-buto-3-enyl)-8-fluoroquinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-buto-3-enyl)-8-fluoroquinoline-3-carboxamide, the preferred compound is one having the following CAS number 2132414-04-9 (pheneptamidoquin). Compound Z is, more specifically, N-[(1RS)-1-benzyl-1,3-dimethyl-butyl]-8-fluoroquinoline-3-carboxamide containing 80-100% R-enantiomer.

[0009] In the present invention, Streptomyces chrestomyceticus contains a nucleotide sequence having at least 99.8%, preferably at least 99.9%, preferably at least 99.91%, 99.92%, 99.93%, 99.94%, 99.95%, 99.96%, 99.97%, 99.98%, or 99.99% identity with SEQ ID NO: 1. In certain embodiments, Streptomyces chrestomyceticus contains a nucleotide sequence having 100% identity with SEQ ID NO: 1. SEQ ID NO: 1 contains the 16S RNA gene of Streptomyces chrestomyceticus Saigon 413, deposited at the Westerdijk Institute under accession number CBS149411.

[0010] Throughout this specification, the term “composition” means various mixtures or combinations of components (A) and (B) (including the embodiments defined above), such as a single “pre-formulated” form, a composite spray mixture such as a “tank mix” composed of separate formulations of a single active ingredient element, and a combination of a single active ingredient when applied sequentially (i.e., one after the other over a moderately short period of time, such as a few hours or a few days). The order in which components (A) and (B) are applied is not important for carrying out the present invention.

[0011] The term "halogen" refers to fluorine (fluoro or F), chlorine (chloro or Cl), bromine (bromo or Br), or iodine (iod or I), preferably fluoro or chloro.

[0012] The term "amino" refers to the -NH2 group.

[0013] In this specification, the term "alkyl," used alone or as part of a chemical group, preferably refers to a linear or branched hydrocarbon having 1 to 6 carbon atoms, such as methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, s-butyl, t-butyl, pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 1,2-dimethylpropyl, 1,1-dimethylpropyl, 2,2-dimethylpropyl, 1-ethylpropyl, hexyl, 1-methylpentyl, 2-methylpentyl, 3-methylpentyl, 4-methylpentyl, 1,2-dimethylpropyl, 1,3-dimethylbutyl, 1,4-dimethylbutyl, 2,3-dimethylbutyl, 1,1-dimethylbutyl, 2,2-dimethylbutyl, 3,3-dimethylbutyl, 1,1,2-trimethylpropyl, 1,2,2-trimethylpropyl, 1-ethylbutyl, and 2-ethylbutyl. Alkyl alkyl groups having 1 to 4 carbon atoms are preferred, such as methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, s-butyl, or t-butyl.

[0014] The term "cycloalkyl," either alone or as part of a chemical group, preferably refers to a saturated or partially unsaturated monocyclic, bicyclic, or tricyclic hydrocarbon having 3 to 10 carbon atoms, such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, bicyclo[2.2.1]heptyl, bicyclo[2.2.2]octyl, or adamantyl. Cycloalkyls having 3, 4, 5, 6, or 7 carbon atoms are preferred, such as cyclopropyl or cyclobutyl.

[0015] The term "alkoxy" is derived from the formula -OR a It refers to the base of, and in the formula, R ais an alkyl group as generally defined above. Examples of alkoxys include, but are not limited to, methoxy, ethoxy, propoxy, isopropoxy, and tert-butoxy. The term "alkoxyalkyl" refers to an alkyl group (as described above) substituted with the alkoxy group. Examples include methoxymethyl, methoxyethyl, ethoxymethyl, and propoxymethyl.

[0016] The term "alkylamino" is derived from the formula R a It refers to the NH- group, and in the formula, R a This is an alkyl group as generally defined above.

[0017] The term "alkoxyamino" is derived from the formula R a It refers to the NH- group, and in the formula, R a This is an alkoxy group as generally defined above.

[0018] The term "alkylsulfonyl" is derived from the formula -S(O)2R a It refers to the base of, and in the formula, R a This is an alkyl group as generally defined above.

[0019] In the present invention, the weight ratio of component (A) to component (B) is preferably 100:1 to 1:100, 50:1 to 1:50, 20:1 to 1:40, 15:1 to 1:30, 12:1 to 1:25, 10:1 to 1:20, 5:1 to 1:15, 3:1 to 1:10, or 2:1 to 1:5.

[0020] Furthermore, the present invention provides a method for controlling or preventing plant pathogenic diseases, particularly plant pathogenic fungi, of useful plants or their reproductive materials, comprising applying a fungicidal composition according to the present invention to a useful plant, its location, or its reproductive material.

[0021] The benefits provided by certain fungicidal mixed compositions according to the present invention may include, in particular, advantageous levels of biological activity for protecting plants from fungal diseases or superior properties for use as pesticide active ingredients (e.g., high biological activity, advantageous activity spectrum, increased safety profile, improved physicochemical properties, or increased biodegradability).

[0022] In each case, the compound of formula (I) according to the present invention is in the form of a free form, an oxidized form as an N-oxide, or a salt form such as an agriculturally usable salt form. N-oxides are oxidation forms of tertiary amines or nitrogen-containing heteroaromatic compounds. These are described, for example, in the book "Heterocyclic N-oxides" by A. Albini and S. Pietra, CRC Press, Boca Raton 1991.

[0023] substituent R in the compound of formula (I) 1 , R 2a , R 2b , R 2c , R 3 , R 3 , R 4 , R 5 , A and R 6 The preferred bases and values ​​for any combination thereof are as follows: -R 1 C 1-6 Alkyl, C 1-6 Alkoxy-C 1-6 Alkyl and C 1-6 Alkylsulfonyl-C 1-6 Selected from alkyl groups, C 1-6 Alkyl, C 1-6 Alkoxy-C 1-6 Alkyl and C 1-6 Alkylsulfonyl-C 1-6 Each alkyl group may optionally be substituted with CN, preferably selected from CH3, CH2-CH3, CH2-O-CH3, CH2-SO2-CH3, and CH2CN; -R2a H and C 1-6 Selected from alkyl groups, preferably selected from H and CH3; -R 2b H, C 1-6 Alkyl, C 1-6 Alkoxy-C 1-6 Alkyl, amino, and -NHC(O)C 1-6 Selected from alkyl groups, preferably from H, CH3, -CH2OCH3, -NH2, and -NHC(O)CH3; -R 2c is H; -J is N or CR 4 and; -G is CR 5 and; -R 3 is H; -R 4 is a halogen or CN, preferably chloro, fluoro, or CN; -R 5 H, C 1-6 Alkyl, C 1-6 Selected from alkoxys and halogens, preferably selected from H, CH3, -OCH3, and fluoros; -A is CH or N; and -R 6 C 1-6 Alkyl, C 1-6 Alkoxy, C 3-6 Cycloalkyl, C 1-6 Alkylamino, and C 1-6 Selected from alkoxyaminos, preferably selected from cyclopropyl, -OCH3, and -NH-O-CH3, or its salt or N-oxide.

[0024] In the most preferred embodiment of the present invention, the compounds of formula (I) are, in any combination thereof, as follows: -R 1 C 1-6 Alkyl, C 1-6 Alkoxy-C 1-6 Alkyl and C 1-6 Alkylsulfonyl-C1-6 Selected from alkyl groups, C 1-6 Alkyl, C 1-6 Alkoxy-C 1-6 Alkyl and C 1-6 Alkylsulfonyl-C 1-6 Each alkyl group may optionally be substituted with CN, preferably selected from CH3, CH2-CH3, CH2-O-CH3, CH2-SO2-CH3, and CH2CN; -R 2a H and C 1-6 Selected from alkyl groups, preferably selected from H and CH3; -R 2b H, C 1-6 Alkyl, C 1-6 Alkoxy-C 1-6 Alkyl, amino, and -NHC(O)C 1-6 Selected from alkyl groups, preferably from H, CH3, -CH2OCH3, -NH2, and -NHC(O)CH3; -R 2c is H; -J is CR 4 and; -G is CR 5 and; -R 3 is H; -R 4 is a halogen or CN, preferably chloro, fluoro, or CN; -R 5 H, C 1-6 Alkyl, C 1-6 Selected from alkoxys and halogens, preferably selected from H, CH3, -OCH3, and fluoros; -A is CH or N; and -R 6 C 1-6 Alkyl, C 1-6 Alkoxy, C 3-6 Cycloalkyl, C 1-6 Alkylamino, and C 1-6 Selected from alkoxyaminos, preferably selected from cyclopropyl, -OCH3, and -NH-O-CH3, or its salt or N-oxide.

[0025] In another most preferred embodiment of the present invention, the compounds of formula (I) are, in any combination thereof, as follows: -R 1 C 1-6 Alkyl, C 1-6 Alkoxy-C 1-6 Alkyl and C 1-6 Alkylsulfonyl-C 1-6 Selected from alkyl groups, C 1-6 Alkyl, C 1-6 Alkoxy-C 1-6 Alkyl and C 1-6 Alkylsulfonyl-C 1-6 Each alkyl group may optionally be substituted with CN, preferably selected from CH3, CH2-CH3, CH2-O-CH3, CH2-SO2-CH3, and CH2CN; -R 2a H and C 1-6 Selected from alkyl groups, preferably selected from H and CH3; -R 2b H, C 1-6 Alkyl, C 1-6 Alkoxy-C 1-6 Alkyl, amino, and -NHC(O)C 1-6 Selected from alkyl groups, preferably from H, CH3, -CH2OCH3, -NH2, and -NHC(O)CH3; -R 2c is H; -J is N; -G is CR 5 and; -R 3 is H; -R 5 H, C 1-6 Alkyl, C 1-6 Selected from alkoxys and halogens, preferably selected from H, CH3, -OCH3, and fluoros; -A is CH or N; and -R 6 C 1-6Alkyl, C 1-6 Alkoxy, C 3-6 Cycloalkyl, C 1-6 Alkylamino, and C 1-6 Selected from alkoxyaminos, preferably selected from cyclopropyl, -OCH3, and -NH-O-CH3, or its salt or N-oxide.

[0026] Most preferably, component (A) is a compound selected from compound numbers X.01, X.02, X.03, X.04, X.05, X.06, X.07, X.08, X.09, X.10, X.11, X.12, X.13, X.14, X.15, X.16, X.17, X.18, X.19, X.20, X.21, X.22, and X.23 as defined in Table X below. More preferably, component (A) is a compound selected from compound numbers X.01, X.02, X.03, X.04, X.05, X.06, X.21, X.22, and X.23 as shown in Table X below.

[0027] [Table 1-1]

[0028] [Table 1-2]

[0029] [Table 1-3]

[0030] Preferably, component (B) is acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, chlorothalonil, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, florylpicoxamide, fluazinam, fludioxonil, fluopicolide, fluoxapipproline, forpet, mandipropamide, mefentrifluconazole, metalaxyl-M, oxathiapipproline, picarbutrazox, pidflumetofen, sedaxane, streptomyces crestomycetics The compound is selected from the group consisting of chrestomyceticus, zoxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoroquinoline-3-carboxamide, and N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoroquinoline-3-carboxamide.

[0031] More preferably, component (B) is a compound selected from the group consisting of acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, chlorothalonil, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, florylpicoxamide, fluazinam, fludioxonil, fluopicolide, fluoxapipproline, forpet, mandipropamide, mefentrifluconazole, metalaxyl-M, oxathiapipproline, picarbtrazox, pidflumetofen, sedaxane, streptomyces chrestomyceticus, zoxamide, and compound Z (pheneptamidoquin).

[0032] The compound of component (B) is referred to herein above by so-called "ISO common names" or other "common names" or trademark names used in individual cases. The compound of component (B) can be synthesized using procedures that are known, commercially available, and / or known in the art and / or reported in the literature.

[0033] In a preferred composition according to the present invention, component (A) is compound number X.01[methyl N-[5-[6-[(4-fluoro-3-methoxyphenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate] or a salt thereof, or an N-oxide, and component (B) is acetamiprid, acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, Bacillus amyloricephaciens amyloliquefaciens), benzovindiflupir, broflanilide, chlorothalonil, clothianidin, chlorantraniliprole, cis-jasmon, cyantraniliprole, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, etaboxam, fenpicoxamide, florylpicoxamide, fluazinam, fludioxonil, fluindapir, fluopicolide, fluopyram, fluoxapiproline, fluoxythioconazole, fluxamethoxamide, fluxapyroxad, flu Pet, imidacloprid, impulfluxam, ipconazole, ipflufenokine, isocycloseram, isoflucipram, isothianil, mandipropamide, mefentrifluconazole, metalaxyl, metalaxyl-M (mefenoxam), methyltetraprole, oxathiapiproline, penflufen, phosphite (phosphonate), picarbtrazox, prothioconazole, pidflumetofen, pyraclostrobin, quinofumerine, sedaxane, silthiofame, streptomyces crestomycetics Chrestomyceticus), tebuconazole, tetraniliprol, thiabendazole, thiamethoxam, tolprocarb, triticonazole, zoxamide, N-[(1R)-1-benzyl-3-chloro-1-methylbuta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methylbuta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methylpropyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-Trifluoro-1-methylpropyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethylbutyl]-7,8-difluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethylbutyl]-7,8-difluoroquinoline-3-carboxamide, 8-Fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethylbutyl]quinoline-3-carboxamide, 8-Fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethylbutyl]quinoline The compounds are N-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethylbutyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethylbutyl]-8-fluoroquinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methylbuta-3-enyl)-8-fluoroquinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methylbuta-3-enyl)-8-fluoroquinoline-3-carboxamide, with a weight ratio of component (A) to component (B) of 15:1 to 1:30.

[0034] In other preferred compositions according to the present invention, component (A) is compound number X.02[methyl N-[5-[6-[(4-fluoro-3-methoxyphenyl)-methyl-carbamoyl]-8-methyl-imidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate] or a salt thereof, or an N-oxide, and component (B) is acetamiprid, acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, Bacillus amyloricephaciens amyloliquefaciens), benzovindiflupir, broflanilide, chlorothalonil, clothianidin, chlorantraniliprole, cis-jasmon, cyantraniliprole, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, etaboxam, fenpicoxamide, florylpicoxamide, fluazinam, fludioxonil, fluindapir, fluopicolide, fluopyram, fluoxapiproline, fluoxythioconazole, fluxamethoxamide, fluxapyroxad, flu Pet, imidacloprid, impulfluxam, ipconazole, ipflufenokine, isocycloseram, isoflucipram, isothianil, mandipropamide, mefentrifluconazole, metalaxyl, metalaxyl-M (mefenoxam), methyltetraprole, oxathiapiproline, penflufen, phosphite (phosphonate), picarbtrazox, prothioconazole, pidflumetofen, pyraclostrobin, quinofumerine, sedaxane, silthiofame, streptomyces crestomycetics Chrestomyceticus), tebuconazole, tetraniliprol, thiabendazole, thiamethoxam, tolprocarb, triticonazole, zoxamide, N-[(1R)-1-benzyl-3-chloro-1-methyl-buta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methyl-buta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoroquinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3 The compounds are N-((1R)-1-benzyl-1,3-dimethyl-butyl)-8-fluoroquinoline-3-carboxamide, N-((1R)-1-benzyl-1,3-dimethyl-butyl)-8-fluoroquinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-buta-3-enyl)-8-fluoroquinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-buta-3-enyl)-8-fluoroquinoline-3-carboxamide, with a weight ratio of component (A) to component (B) of 15:1 to 1:30.

[0035] In other preferred compositions according to the present invention, component (A) is compound number X.03[methyl N-[5-[6-[(4-fluoro-3-methoxyphenyl)-(methoxymethyl)carbamoyl]-8-methylimidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate] or a salt thereof, or an N-oxide, and component (B) is acetamiprid, acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, Bacillus amyloricephaciens amyloliquefaciens), benzovindiflupir, broflanilide, chlorothalonil, clothianidin, chlorantraniliprole, cis-jasmon, cyantraniliprole, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, etaboxam, fenpicoxamide, florylpicoxamide, fluazinam, fludioxonil, fluindapir, fluopicolide, fluopyram, fluoxapiproline, fluoxythioconazole, fluxamethoxamide, fluxapyroxad, flu Pet, imidacloprid, impulfluxam, ipconazole, ipflufenokine, isocycloseram, isoflucipram, isothianil, mandipropamide, mefentrifluconazole, metalaxyl, metalaxyl-M (mefenoxam), methyltetraprole, oxathiapiproline, penflufen, phosphite (phosphonate), picarbtrazox, prothioconazole, pidflumetofen, pyraclostrobin, quinofumerine, sedaxane, silthiofame, streptomyces crestomycetics Chrestomyceticus), tebuconazole, tetraniliprol, thiabendazole, thiamethoxam, tolprocarb, triticonazole, zoxamide, N-[(1R)-1-benzyl-3-chloro-1-methyl-buta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methyl-buta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoroquinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3 The compounds are N-((1R)-1-benzyl-1,3-dimethyl-butyl)-8-fluoroquinoline-3-carboxamide, N-((1R)-1-benzyl-1,3-dimethyl-butyl)-8-fluoroquinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-buta-3-enyl)-8-fluoroquinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-buta-3-enyl)-8-fluoroquinoline-3-carboxamide, with a weight ratio of component (A) to component (B) of 15:1 to 1:30.

[0036] In other preferred compositions according to the present invention, component (A) is compound number X.04[methyl N-[5-[6-[(4-fluoro-3-methoxyphenyl)-(methoxymethyl)carbamoyl]imidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate] or a salt thereof, or an N-oxide, and component (B) is acetamiprid, acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, Bacillus amyloricephaciens amyloliquefaciens), benzovindiflupir, broflanilide, chlorothalonil, clothianidin, chlorantraniliprole, cis-jasmon, cyantraniliprole, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, etaboxam, fenpicoxamide, florylpicoxamide, fluazinam, fludioxonil, fluindapir, fluopicolide, fluopyram, fluoxapiproline, fluoxythioconazole, fluxamethoxamide, fluxapyroxad, flu Pet, imidacloprid, impulfluxam, ipconazole, ipflufenokine, isocycloseram, isoflucipram, isothianil, mandipropamide, mefentrifluconazole, metalaxyl, metalaxyl-M (mefenoxam), methyltetraprole, oxathiapiproline, penflufen, phosphite (phosphonate), picarbtrazox, prothioconazole, pidflumetofen, pyraclostrobin, quinofumerine, sedaxane, silthiofame, streptomyces crestomycetics Chrestomyceticus), tebuconazole, tetraniliprol, thiabendazole, thiamethoxam, tolprocarb, triticonazole, zoxamide, N-[(1R)-1-benzyl-3-chloro-1-methyl-buta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methyl-buta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoroquinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3 The compounds are N-((1R)-1-benzyl-1,3-dimethyl-butyl)-8-fluoroquinoline-3-carboxamide, N-((1R)-1-benzyl-1,3-dimethyl-butyl)-8-fluoroquinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-buta-3-enyl)-8-fluoroquinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-buta-3-enyl)-8-fluoroquinoline-3-carboxamide, with a weight ratio of component (A) to component (B) of 15:1 to 1:30.

[0037] In other preferred compositions according to the present invention, component (A) is compound number X.05[methyl N-[4-[6-[(4-fluoro-3-methoxyphenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridine-3-yl]phenyl]carbamate] or a salt thereof, or an N-oxide, and component (B) is acetamiprid, acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, Bacillus amyloricephaciens amyloliquefaciens), benzovindiflupir, broflanilide, chlorothalonil, clothianidin, chlorantraniliprole, cis-jasmon, cyantraniliprole, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, etaboxam, fenpicoxamide, florylpicoxamide, fluazinam, fludioxonil, fluindapir, fluopicolide, fluopyram, fluoxapiproline, fluoxythioconazole, fluxamethoxamide, fluxapyroxad, flu Pet, imidacloprid, impulfluxam, ipconazole, ipflufenokine, isocycloseram, isoflucipram, isothianil, mandipropamide, mefentrifluconazole, metalaxyl, metalaxyl-M (mefenoxam), methyltetraprole, oxathiapiproline, penflufen, phosphite (phosphonate), picarbtrazox, prothioconazole, pidflumetofen, pyraclostrobin, quinofumerine, sedaxane, silthiofame, streptomyces crestomycetics Chrestomyceticus), tebuconazole, tetraniliprol, thiabendazole, thiamethoxam, tolprocarb, triticonazole, zoxamide, N-[(1R)-1-benzyl-3-chloro-1-methylbuta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methylbuta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methylpropyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-Trifluoro-1-methylpropyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethylbutyl]-7,8-difluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethylbutyl]-7,8-difluoroquinoline-3-carboxamide, 8-Fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethylbutyl]quinoline-3-carboxamide, 8-Fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethylbutyl]quinoline The compounds are N-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethylbutyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethylbutyl]-8-fluoroquinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methylbuta-3-enyl)-8-fluoroquinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methylbuta-3-enyl)-8-fluoroquinoline-3-carboxamide, with a weight ratio of component (A) to component (B) of 15:1 to 1:30.

[0038] In other preferred compositions according to the present invention, component (A) is compound number X.06[3-[6-(cyclopropanecarbonylamino)-3-pyridyl]-N-(4-fluoro-3-methoxyphenyl)-N-methylimidazo[1,2-a]pyridine-6-carboxamide] or its salt or N-oxide, and component (B) is acetamiprid, acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, Bacillus amyloricephaciens amyloliquefaciens), benzovindiflupir, broflanilide, chlorothalonil, clothianidin, chlorantraniliprole, cis-jasmon, cyantraniliprole, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, etaboxam, fenpicoxamide, florylpicoxamide, fluazinam, fludioxonil, fluindapir, fluopicolide, fluopyram, fluoxapiproline, fluoxythioconazole, fluxamethoxamide, fluxapyroxad, flu Pet, imidacloprid, impulfluxam, ipconazole, ipflufenokine, isocycloseram, isoflucipram, isothianil, mandipropamide, mefentrifluconazole, metalaxyl, metalaxyl-M (mefenoxam), methyltetraprole, oxathiapiproline, penflufen, phosphite (phosphonate), picarbtrazox, prothioconazole, pidflumetofen, pyraclostrobin, quinofumerine, sedaxane, silthiofame, streptomyces crestomycetics Chrestomyceticus), tebuconazole, tetraniliprol, thiabendazole, thiamethoxam, tolprocarb, triticonazole, zoxamide, N-[(1R)-1-benzyl-3-chloro-1-methyl-buta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methyl-buta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoroquinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3 The compounds are N-((1R)-1-benzyl-1,3-dimethyl-butyl)-8-fluoroquinoline-3-carboxamide, N-((1R)-1-benzyl-1,3-dimethyl-butyl)-8-fluoroquinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-buta-3-enyl)-8-fluoroquinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-buta-3-enyl)-8-fluoroquinoline-3-carboxamide, with a weight ratio of component (A) to component (B) of 15:1 to 1:30.

[0039] In other preferred compositions according to the present invention, component (A) is compound number X.07[methyl N-[4-[6-[(4-fluorophenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridine-3-yl]phenyl]carbamate] or a salt thereof, or an N-oxide, and component (B) is acetamiprid, acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, Bacillus amyloricephaciens amyloliquefaciens), benzovindiflupir, broflanilide, chlorothalonil, clothianidin, chlorantraniliprole, cis-jasmon, cyantraniliprole, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, etaboxam, fenpicoxamide, florylpicoxamide, fluazinam, fludioxonil, fluindapir, fluopicolide, fluopyram, fluoxapiproline, fluoxythioconazole, fluxamethoxamide, fluxapyroxad, flu Pet, imidacloprid, impulfluxam, ipconazole, ipflufenokine, isocycloseram, isoflucipram, isothianil, mandipropamide, mefentrifluconazole, metalaxyl, metalaxyl-M (mefenoxam), methyltetraprole, oxathiapiproline, penflufen, phosphite (phosphonate), picarbtrazox, prothioconazole, pidflumetofen, pyraclostrobin, quinofumerine, sedaxane, silthiofame, streptomyces crestomycetics Chrestomyceticus), tebuconazole, tetraniliprol, thiabendazole, thiamethoxam, tolprocarb, triticonazole, zoxamide, N-[(1R)-1-benzyl-3-chloro-1-methylbuta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methylbuta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methylpropyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-Trifluoro-1-methylpropyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethylbutyl]-7,8-difluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethylbutyl]-7,8-difluoroquinoline-3-carboxamide, 8-Fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethylbutyl]quinoline-3-carboxamide, 8-Fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethylbutyl]quinoline The compounds are N-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethylbutyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethylbutyl]-8-fluoroquinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methylbuta-3-enyl)-8-fluoroquinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methylbuta-3-enyl)-8-fluoroquinoline-3-carboxamide, with a weight ratio of component (A) to component (B) of 15:1 to 1:30.

[0040] In other preferred compositions according to the present invention, component (A) is compound number X.08[methyl N-[4-[6-[(4-chlorophenyl)-methyl-carbamoyl]-8-methyl-imidazo[1,2-a]pyridine-3-yl]phenyl]carbamate] or a salt thereof, or an N-oxide, and component (B) is acetamiprid, acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, Bacillus amyloricephaciens amyloliquefaciens), benzovindiflupir, broflanilide, chlorothalonil, clothianidin, chlorantraniliprole, cis-jasmon, cyantraniliprole, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, etaboxam, fenpicoxamide, florylpicoxamide, fluazinam, fludioxonil, fluindapir, fluopicolide, fluopyram, fluoxapiproline, fluoxythioconazole, fluxamethoxamide, fluxapyroxad, flu Pet, imidacloprid, impulfluxam, ipconazole, ipflufenokine, isocycloseram, isoflucipram, isothianil, mandipropamide, mefentrifluconazole, metalaxyl, metalaxyl-M (mefenoxam), methyltetraprole, oxathiapiproline, penflufen, phosphite (phosphonate), picarbtrazox, prothioconazole, pidflumetofen, pyraclostrobin, quinofumerine, sedaxane, silthiofame, streptomyces crestomycetics Chrestomyceticus), tebuconazole, tetraniliprol, thiabendazole, thiamethoxam, tolprocarb, triticonazole, zoxamide, N-[(1R)-1-benzyl-3-chloro-1-methylbuta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methylbuta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methylpropyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-Trifluoro-1-methylpropyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethylbutyl]-7,8-difluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethylbutyl]-7,8-difluoroquinoline-3-carboxamide, 8-Fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethylbutyl]quinoline-3-carboxamide, 8-Fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethylbutyl]quinoline The compounds are N-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethylbutyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethylbutyl]-8-fluoroquinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methylbuta-3-enyl)-8-fluoroquinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methylbuta-3-enyl)-8-fluoroquinoline-3-carboxamide, with a weight ratio of component (A) to component (B) of 15:1 to 1:30.

[0041] In other preferred compositions according to the present invention, component (A) is compound number X.09[methyl N-[5-[6-[(4-fluoro-3-methylphenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridine-3-yl]2-pyridyl]carbamate] or a salt thereof, or an N-oxide, and component (B) is acetamiprid, acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, Bacillus amyloricephaciens amyloliquefaciens), benzovindiflupir, broflanilide, chlorothalonil, clothianidin, chlorantraniliprole, cis-jasmon, cyantraniliprole, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, etaboxam, fenpicoxamide, florylpicoxamide, fluazinam, fludioxonil, fluindapir, fluopicolide, fluopyram, fluoxapiproline, fluoxythioconazole, fluxamethoxamide, fluxapyroxad, flu Pet, imidacloprid, impulfluxam, ipconazole, ipflufenokine, isocycloseram, isoflucipram, isothianil, mandipropamide, mefentrifluconazole, metalaxyl, metalaxyl-M (mefenoxam), methyltetraprole, oxathiapiproline, penflufen, phosphite (phosphonate), picarbtrazox, prothioconazole, pidflumetofen, pyraclostrobin, quinofumerine, sedaxane, silthiofame, streptomyces crestomycetics Chrestomyceticus), tebuconazole, tetraniliprol, thiabendazole, thiamethoxam, tolprocarb, triticonazole, zoxamide, N-[(1R)-1-benzyl-3-chloro-1-methylbuta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methylbuta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methylpropyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-Trifluoro-1-methylpropyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethylbutyl]-7,8-difluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethylbutyl]-7,8-difluoroquinoline-3-carboxamide, 8-Fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethylbutyl]quinoline-3-carboxamide, 8-Fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethylbutyl]quinoline The compounds are N-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethylbutyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethylbutyl]-8-fluoroquinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methylbuta-3-enyl)-8-fluoroquinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methylbuta-3-enyl)-8-fluoroquinoline-3-carboxamide, with a weight ratio of component (A) to component (B) of 15:1 to 1:30.

[0042] In other preferred compositions according to the present invention, component (A) is compound number X.10[methyl N-[5-[6-[(4-cyano-3-methoxyphenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridine-3-yl]2-pyridyl]carbamate] or a salt thereof, or an N-oxide, and component (B) is acetamiprid, acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, Bacillus amyloricephaciens amyloliquefaciens), benzovindiflupir, broflanilide, chlorothalonil, clothianidin, chlorantraniliprole, cis-jasmon, cyantraniliprole, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, etaboxam, fenpicoxamide, florylpicoxamide, fluazinam, fludioxonil, fluindapir, fluopicolide, fluopyram, fluoxapiproline, fluoxythioconazole, fluxamethoxamide, fluxapyroxad, flu Pet, imidacloprid, impulfluxam, ipconazole, ipflufenokine, isocycloseram, isoflucipram, isothianil, mandipropamide, mefentrifluconazole, metalaxyl, metalaxyl-M (mefenoxam), methyltetraprole, oxathiapiproline, penflufen, phosphite (phosphonate), picarbtrazox, prothioconazole, pidflumetofen, pyraclostrobin, quinofumerine, sedaxane, silthiofame, streptomyces crestomycetics Chrestomyceticus), tebuconazole, tetraniliprol, thiabendazole, thiamethoxam, tolprocarb, triticonazole, zoxamide, N-[(1R)-1-benzyl-3-chloro-1-methylbuta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methylbuta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methylpropyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-Trifluoro-1-methylpropyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethylbutyl]-7,8-difluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethylbutyl]-7,8-difluoroquinoline-3-carboxamide, 8-Fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethylbutyl]quinoline-3-carboxamide, 8-Fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethylbutyl]quinoline The compounds are N-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethylbutyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethylbutyl]-8-fluoroquinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methylbuta-3-enyl)-8-fluoroquinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methylbuta-3-enyl)-8-fluoroquinoline-3-carboxamide, with a weight ratio of component (A) to component (B) of 15:1 to 1:30.

[0043] In other preferred compositions according to the present invention, component (A) is compound number X.11[methyl N-[5-[6-[(4-chloro-3-methoxyphenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridine-3-yl]2-pyridyl]carbamate] or a salt thereof, or an N-oxide, and component (B) is acetamiprid, acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, Bacillus amyloricephaciens amyloliquefaciens), benzovindiflupir, broflanilide, chlorothalonil, clothianidin, chlorantraniliprole, cis-jasmon, cyantraniliprole, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, etaboxam, fenpicoxamide, florylpicoxamide, fluazinam, fludioxonil, fluindapir, fluopicolide, fluopyram, fluoxapiproline, fluoxythioconazole, fluxamethoxamide, fluxapyroxad, flu Pet, imidacloprid, impulfluxam, ipconazole, ipflufenokine, isocycloseram, isoflucipram, isothianil, mandipropamide, mefentrifluconazole, metalaxyl, metalaxyl-M (mefenoxam), methyltetraprole, oxathiapiproline, penflufen, phosphite (phosphonate), picarbtrazox, prothioconazole, pidflumetofen, pyraclostrobin, quinofumerine, sedaxane, silthiofame, streptomyces crestomycetics Chrestomyceticus), tebuconazole, tetraniliprol, thiabendazole, thiamethoxam, tolprocarb, triticonazole, zoxamide, N-[(1R)-1-benzyl-3-chloro-1-methylbuta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methylbuta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methylpropyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-Trifluoro-1-methylpropyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethylbutyl]-7,8-difluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethylbutyl]-7,8-difluoroquinoline-3-carboxamide, 8-Fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethylbutyl]quinoline-3-carboxamide, 8-Fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethylbutyl]quinoline The compounds are N-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethylbutyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethylbutyl]-8-fluoroquinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methylbuta-3-enyl)-8-fluoroquinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methylbuta-3-enyl)-8-fluoroquinoline-3-carboxamide, with a weight ratio of component (A) to component (B) of 15:1 to 1:30.

[0044] In other preferred compositions according to the present invention, component (A) is compound number X.12[methyl N-[5-[6-[(4-fluorophenyl)-methyl-carbamoyl]-8-methyl-imidazo[1,2-a]pyridine-3-yl]2-pyridyl]carbamate] or a salt thereof, or an N-oxide, and component (B) is acetamiprid, acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, Bacillus amyloricephaciens amyloliquefaciens), benzovindiflupir, broflanilide, chlorothalonil, clothianidin, chlorantraniliprole, cis-jasmon, cyantraniliprole, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, etaboxam, fenpicoxamide, florylpicoxamide, fluazinam, fludioxonil, fluindapir, fluopicolide, fluopyram, fluoxapiproline, fluoxythioconazole, fluxamethoxamide, fluxapyroxad, flu Pet, imidacloprid, impulfluxam, ipconazole, ipflufenokine, isocycloseram, isoflucipram, isothianil, mandipropamide, mefentrifluconazole, metalaxyl, metalaxyl-M (mefenoxam), methyltetraprole, oxathiapiproline, penflufen, phosphite (phosphonate), picarbtrazox, prothioconazole, pidflumetofen, pyraclostrobin, quinofumerine, sedaxane, silthiofame, streptomyces crestomycetics Chrestomyceticus), tebuconazole, tetraniliprol, thiabendazole, thiamethoxam, tolprocarb, triticonazole, zoxamide, N-[(1R)-1-benzyl-3-chloro-1-methylbuta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methylbuta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methylpropyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-Trifluoro-1-methylpropyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethylbutyl]-7,8-difluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethylbutyl]-7,8-difluoroquinoline-3-carboxamide, 8-Fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethylbutyl]quinoline-3-carboxamide, 8-Fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethylbutyl]quinoline The compounds are N-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethylbutyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethylbutyl]-8-fluoroquinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methylbuta-3-enyl)-8-fluoroquinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methylbuta-3-enyl)-8-fluoroquinoline-3-carboxamide, with a weight ratio of component (A) to component (B) of 15:1 to 1:30.

[0045] In other preferred compositions according to the present invention, component (A) is compound number X.13[methyl N-[5-[6-[(4-fluorophenyl)-methyl-carbamoyl]-7-methyl-imidazo[1,2-a]pyridine-3-yl]2-pyridyl]carbamate] or a salt thereof, or an N-oxide, and component (B) is acetamiprid, acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, Bacillus amyloricephaciens amyloliquefaciens), benzovindiflupir, broflanilide, chlorothalonil, clothianidin, chlorantraniliprole, cis-jasmon, cyantraniliprole, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, etaboxam, fenpicoxamide, florylpicoxamide, fluazinam, fludioxonil, fluindapir, fluopicolide, fluopyram, fluoxapiproline, fluoxythioconazole, fluxamethoxamide, fluxapyroxad, flu Pet, imidacloprid, impulfluxam, ipconazole, ipflufenokine, isocycloseram, isoflucipram, isothianil, mandipropamide, mefentrifluconazole, metalaxyl, metalaxyl-M (mefenoxam), methyltetraprole, oxathiapiproline, penflufen, phosphite (phosphonate), picarbtrazox, prothioconazole, pidflumetofen, pyraclostrobin, quinofumerine, sedaxane, silthiofame, streptomyces crestomycetics Chrestomyceticus), tebuconazole, tetraniliprol, thiabendazole, thiamethoxam, tolprocarb, triticonazole, zoxamide, N-[(1R)-1-benzyl-3-chloro-1-methylbuta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methylbuta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methylpropyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-Trifluoro-1-methylpropyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethylbutyl]-7,8-difluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethylbutyl]-7,8-difluoroquinoline-3-carboxamide, 8-Fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethylbutyl]quinoline-3-carboxamide, 8-Fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethylbutyl]quinoline The compounds are N-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethylbutyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethylbutyl]-8-fluoroquinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methylbuta-3-enyl)-8-fluoroquinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methylbuta-3-enyl)-8-fluoroquinoline-3-carboxamide, with a weight ratio of component (A) to component (B) of 15:1 to 1:30.

[0046] In other preferred compositions according to the present invention, component (A) is compound number X.14[methyl N-[5-[6-[cyanomethyl-(4-fluoro-3-methoxyphenyl)carbamoyl]imidazo[1,2-a]pyridine-3-yl]2-pyridyl]carbamate] or a salt thereof, or an N-oxide, and component (B) is acetamiprid, acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, Bacillus amyloricephaciens amyloliquefaciens), benzovindiflupir, broflanilide, chlorothalonil, clothianidin, chlorantraniliprole, cis-jasmon, cyantraniliprole, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, etaboxam, fenpicoxamide, florylpicoxamide, fluazinam, fludioxonil, fluindapir, fluopicolide, fluopyram, fluoxapiproline, fluoxythioconazole, fluxamethoxamide, fluxapyroxad, flu Pet, imidacloprid, impulfluxam, ipconazole, ipflufenokine, isocycloseram, isoflucipram, isothianil, mandipropamide, mefentrifluconazole, metalaxyl, metalaxyl-M (mefenoxam), methyltetraprole, oxathiapiproline, penflufen, phosphite (phosphonate), picarbtrazox, prothioconazole, pidflumetofen, pyraclostrobin, quinofumerine, sedaxane, silthiofame, streptomyces crestomycetics Chrestomyceticus), tebuconazole, tetraniliprol, thiabendazole, thiamethoxam, tolprocarb, triticonazole, zoxamide, N-[(1R)-1-benzyl-3-chloro-1-methylbuta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methylbuta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methylpropyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-Trifluoro-1-methylpropyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethylbutyl]-7,8-difluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethylbutyl]-7,8-difluoroquinoline-3-carboxamide, 8-Fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethylbutyl]quinoline-3-carboxamide, 8-Fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethylbutyl]quinoline The compounds are N-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethylbutyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethylbutyl]-8-fluoroquinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methylbuta-3-enyl)-8-fluoroquinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methylbuta-3-enyl)-8-fluoroquinoline-3-carboxamide, with a weight ratio of component (A) to component (B) of 15:1 to 1:30.

[0047] In other preferred compositions according to the present invention, component (A) is compound number X.15[methyl N-[5-[6-[(4-chloro-3-methoxyphenyl)-(cyanomethyl)carbamoyl]imidazo[1,2-a]pyridine-3-yl]2-pyridyl]carbamate] or a salt thereof, or an N-oxide, and component (B) is acetamiprid, acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, Bacillus amyloricephaciens amyloliquefaciens), benzovindiflupir, broflanilide, chlorothalonil, clothianidin, chlorantraniliprole, cis-jasmon, cyantraniliprole, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, etaboxam, fenpicoxamide, florylpicoxamide, fluazinam, fludioxonil, fluindapir, fluopicolide, fluopyram, fluoxapiproline, fluoxythioconazole, fluxamethoxamide, fluxapyroxad, flu Pet, imidacloprid, impulfluxam, ipconazole, ipflufenokine, isocycloseram, isoflucipram, isothianil, mandipropamide, mefentrifluconazole, metalaxyl, metalaxyl-M (mefenoxam), methyltetraprole, oxathiapiproline, penflufen, phosphite (phosphonate), picarbtrazox, prothioconazole, pidflumetofen, pyraclostrobin, quinofumerine, sedaxane, silthiofame, streptomyces crestomycetics Chrestomyceticus), tebuconazole, tetraniliprol, thiabendazole, thiamethoxam, tolprocarb, triticonazole, zoxamide, N-[(1R)-1-benzyl-3-chloro-1-methylbuta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methylbuta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methylpropyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-Trifluoro-1-methylpropyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethylbutyl]-7,8-difluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethylbutyl]-7,8-difluoroquinoline-3-carboxamide, 8-Fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethylbutyl]quinoline-3-carboxamide, 8-Fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethylbutyl]quinoline The compounds are N-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethylbutyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethylbutyl]-8-fluoroquinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methylbuta-3-enyl)-8-fluoroquinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methylbuta-3-enyl)-8-fluoroquinoline-3-carboxamide, with a weight ratio of component (A) to component (B) of 15:1 to 1:30.

[0048] In other preferred compositions according to the present invention, component (A) is compound number X.16[methyl N-[5-[6-[(4-fluoro-3-methoxyphenyl)-(methylsulfonylmethyl)carbamoyl]imidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate] or a salt thereof, or an N-oxide, and component (B) is acetamiprid, acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, Bacillus amyloricephaciens amyloliquefaciens), benzovindiflupir, broflanilide, chlorothalonil, clothianidin, chlorantraniliprole, cis-jasmon, cyantraniliprole, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, etaboxam, fenpicoxamide, florylpicoxamide, fluazinam, fludioxonil, fluindapir, fluopicolide, fluopyram, fluoxapiproline, fluoxythioconazole, fluxamethoxamide, fluxapyroxad, flu Pet, imidacloprid, impulfluxam, ipconazole, ipflufenokine, isocycloseram, isoflucipram, isothianil, mandipropamide, mefentrifluconazole, metalaxyl, metalaxyl-M (mefenoxam), methyltetraprole, oxathiapiproline, penflufen, phosphite (phosphonate), picarbtrazox, prothioconazole, pidflumetofen, pyraclostrobin, quinofumerine, sedaxane, silthiofame, streptomyces crestomycetics Chrestomyceticus), tebuconazole, tetraniliprol, thiabendazole, thiamethoxam, tolprocarb, triticonazole, zoxamide, N-[(1R)-1-benzyl-3-chloro-1-methyl-buta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methyl-buta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoroquinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3 The compounds are N-((1R)-1-benzyl-1,3-dimethyl-butyl)-8-fluoroquinoline-3-carboxamide, N-((1R)-1-benzyl-1,3-dimethyl-butyl)-8-fluoroquinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-buta-3-enyl)-8-fluoroquinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-buta-3-enyl)-8-fluoroquinoline-3-carboxamide, with a weight ratio of component (A) to component (B) of 15:1 to 1:30.

[0049] In other preferred compositions according to the present invention, component (A) is compound number X.17[N-(4-fluoro-3-methoxyphenyl)-3-[6-(methoxycarbamoylamino)-3-pyridyl]-N-methylimidazo[1,2-a]pyridine-6-carboxamide] or its salt or N-oxide, and component (B) is acetamiprid, acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, Bacillus amyloricephaciens amyloliquefaciens), benzovindiflupir, broflanilide, chlorothalonil, clothianidin, chlorantraniliprole, cis-jasmon, cyantraniliprole, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, etaboxam, fenpicoxamide, florylpicoxamide, fluazinam, fludioxonil, fluindapir, fluopicolide, fluopyram, fluoxapiproline, fluoxythioconazole, fluxamethoxamide, fluxapyroxad, flu Pet, imidacloprid, impulfluxam, ipconazole, ipflufenokine, isocycloseram, isoflucipram, isothianil, mandipropamide, mefentrifluconazole, metalaxyl, metalaxyl-M (mefenoxam), methyltetraprole, oxathiapiproline, penflufen, phosphite (phosphonate), picarbtrazox, prothioconazole, pidflumetofen, pyraclostrobin, quinofumerine, sedaxane, silthiofame, streptomyces crestomycetics Chrestomyceticus), tebuconazole, tetraniliprol, thiabendazole, thiamethoxam, tolprocarb, triticonazole, zoxamide, N-[(1R)-1-benzyl-3-chloro-1-methyl-buta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methyl-buta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoroquinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quino The compounds are phosphorus-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoroquinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-buta-3-enyl)-8-fluoroquinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-buta-3-enyl)-8-fluoroquinoline-3-carboxamide, with a weight ratio of component (A) to component (B) of 15:1 to 1:30.

[0050] In other preferred compositions according to the present invention, component (A) is compound number X.18[methyl N-[5-[8-acetamido-6-[(4-fluorophenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridine-3-yl]2-pyridyl]carbamate] or a salt thereof, or an N-oxide, and component (B) is acetamiprid, acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, Bacillus amyloricephaciens amyloliquefaciens), benzovindiflupir, broflanilide, chlorothalonil, clothianidin, chlorantraniliprole, cis-jasmon, cyantraniliprole, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, etaboxam, fenpicoxamide, florylpicoxamide, fluazinam, fludioxonil, fluindapir, fluopicolide, fluopyram, fluoxapiproline, fluoxythioconazole, fluxamethoxamide, fluxapyroxad, flu Pet, imidacloprid, impulfluxam, ipconazole, ipflufenokine, isocycloseram, isoflucipram, isothianil, mandipropamide, mefentrifluconazole, metalaxyl, metalaxyl-M (mefenoxam), methyltetraprole, oxathiapiproline, penflufen, phosphite (phosphonate), picarbtrazox, prothioconazole, pidflumetofen, pyraclostrobin, quinofumerine, sedaxane, silthiofame, streptomyces crestomycetics Chrestomyceticus), tebuconazole, tetraniliprol, thiabendazole, thiamethoxam, tolprocarb, triticonazole, zoxamide, N-[(1R)-1-benzyl-3-chloro-1-methylbuta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methylbuta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methylpropyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-Trifluoro-1-methylpropyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethylbutyl]-7,8-difluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethylbutyl]-7,8-difluoroquinoline-3-carboxamide, 8-Fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethylbutyl]quinoline-3-carboxamide, 8-Fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethylbutyl]quinoline The compounds are N-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethylbutyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethylbutyl]-8-fluoroquinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methylbuta-3-enyl)-8-fluoroquinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methylbuta-3-enyl)-8-fluoroquinoline-3-carboxamide, with a weight ratio of component (A) to component (B) of 15:1 to 1:30.

[0051] In other preferred compositions according to the present invention, component (A) is compound number X.19[methyl N-[5-[6-ethyl[(4-fluorophenyl)carbamoyl]imidazo[1,2-a]pyridine-3-yl]2-pyridyl]carbamate] or a salt thereof, or an N-oxide, and component (B) is acetamiprid, acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, Bacillus amyloricephaciens amyloliquefaciens), benzovindiflupir, broflanilide, chlorothalonil, clothianidin, chlorantraniliprole, cis-jasmon, cyantraniliprole, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, etaboxam, fenpicoxamide, florylpicoxamide, fluazinam, fludioxonil, fluindapir, fluopicolide, fluopyram, fluoxapiproline, fluoxythioconazole, fluxamethoxamide, fluxapyroxad, flu Pet, imidacloprid, impulfluxam, ipconazole, ipflufenokine, isocycloseram, isoflucipram, isothianil, mandipropamide, mefentrifluconazole, metalaxyl, metalaxyl-M (mefenoxam), methyltetraprole, oxathiapiproline, penflufen, phosphite (phosphonate), picarbtrazox, prothioconazole, pidflumetofen, pyraclostrobin, quinofumerine, sedaxane, silthiofame, streptomyces crestomycetics Chrestomyceticus), tebuconazole, tetraniliprol, thiabendazole, thiamethoxam, tolprocarb, triticonazole, zoxamide, N-[(1R)-1-benzyl-3-chloro-1-methylbuta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methylbuta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methylpropyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-Trifluoro-1-methylpropyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethylbutyl]-7,8-difluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethylbutyl]-7,8-difluoroquinoline-3-carboxamide, 8-Fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethylbutyl]quinoline-3-carboxamide, 8-Fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethylbutyl]quinoline The compounds are N-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethylbutyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethylbutyl]-8-fluoroquinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methylbuta-3-enyl)-8-fluoroquinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methylbuta-3-enyl)-8-fluoroquinoline-3-carboxamide, with a weight ratio of component (A) to component (B) of 15:1 to 1:30.

[0052] In other preferred compositions according to the present invention, component (A) is compound number X.20[methyl N-[5-[8-acetamido-6-[(4-fluoro-3-methoxyphenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridine-3-yl]2-pyridyl]carbamate] or a salt thereof, or an N-oxide, and component (B) is acetamiprid, acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, Bacillus amyloricephaciens amyloliquefaciens), benzovindiflupir, broflanilide, chlorothalonil, clothianidin, chlorantraniliprole, cis-jasmon, cyantraniliprole, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, etaboxam, fenpicoxamide, florylpicoxamide, fluazinam, fludioxonil, fluindapir, fluopicolide, fluopyram, fluoxapiproline, fluoxythioconazole, fluxamethoxamide, fluxapyroxad, flu Pet, imidacloprid, impulfluxam, ipconazole, ipflufenokine, isocycloseram, isoflucipram, isothianil, mandipropamide, mefentrifluconazole, metalaxyl, metalaxyl-M (mefenoxam), methyltetraprole, oxathiapiproline, penflufen, phosphite (phosphonate), picarbtrazox, prothioconazole, pidflumetofen, pyraclostrobin, quinofumerine, sedaxane, silthiofame, streptomyces crestomycetics Chrestomyceticus), tebuconazole, tetraniliprol, thiabendazole, thiamethoxam, tolprocarb, triticonazole, zoxamide, N-[(1R)-1-benzyl-3-chloro-1-methyl-buta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methyl-buta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoroquinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3 The compounds are N-((1R)-1-benzyl-1,3-dimethyl-butyl)-8-fluoroquinoline-3-carboxamide, N-((1R)-1-benzyl-1,3-dimethyl-butyl)-8-fluoroquinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-buta-3-enyl)-8-fluoroquinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-buta-3-enyl)-8-fluoroquinoline-3-carboxamide, with a weight ratio of component (A) to component (B) of 15:1 to 1:30.

[0053] In other preferred compositions according to the present invention, component (A) is compound number X.21[methyl{N}-[5-[6-[(4-fluoro-3-methoxyphenyl)-methyl-carbamoyl]-8-(methoxymethyl)imidazo[1,2-a]pyridine-3-yl]2-pyridyl]carbamate] or a salt thereof, or an N-oxide, and component (B) is acetamiprid, acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, Bacillus amyloricephaciens amyloliquefaciens), benzovindiflupir, broflanilide, chlorothalonil, clothianidin, chlorantraniliprole, cis-jasmon, cyantraniliprole, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, etaboxam, fenpicoxamide, florylpicoxamide, fluazinam, fludioxonil, fluindapir, fluopicolide, fluopyram, fluoxapiproline, fluoxythioconazole, fluxamethoxamide, fluxapyroxad, flu Pet, imidacloprid, impulfluxam, ipconazole, ipflufenokine, isocycloseram, isoflucipram, isothianil, mandipropamide, mefentrifluconazole, metalaxyl, metalaxyl-M (mefenoxam), methyltetraprole, oxathiapiproline, penflufen, phosphite (phosphonate), picarbtrazox, prothioconazole, pidflumetofen, pyraclostrobin, quinofumerine, sedaxane, silthiofame, streptomyces crestomycetics Chrestomyceticus), tebuconazole, tetraniliprol, thiabendazole, thiamethoxam, tolprocarb, triticonazole, zoxamide, N-[(1R)-1-benzyl-3-chloro-1-methyl-buta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methyl-buta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoroquinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3 The compounds are N-((1R)-1-benzyl-1,3-dimethyl-butyl)-8-fluoroquinoline-3-carboxamide, N-((1R)-1-benzyl-1,3-dimethyl-butyl)-8-fluoroquinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-buta-3-enyl)-8-fluoroquinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-buta-3-enyl)-8-fluoroquinoline-3-carboxamide, with a weight ratio of component (A) to component (B) of 15:1 to 1:30.

[0054] In other preferred compositions according to the present invention, component (A) is compound number X.22[methyl N-[5-[6-[(2-methoxy-4-pyridyl)-methyl-carbamoyl]-8-methyl-imidazo[1,2-a]pyridin-3-yl]2-pyridyl]carbamate] or a salt thereof, or an N-oxide, and component (B) is acetamiprid, acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, Bacillus amyloricephaciens amyloliquefaciens), benzovindiflupir, broflanilide, chlorothalonil, clothianidin, chlorantraniliprole, cis-jasmon, cyantraniliprole, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, etaboxam, fenpicoxamide, florylpicoxamide, fluazinam, fludioxonil, fluindapir, fluopicolide, fluopyram, fluoxapiproline, fluoxythioconazole, fluxamethoxamide, fluxapyroxad, flu Pet, imidacloprid, impulfluxam, ipconazole, ipflufenokine, isocycloseram, isoflucipram, isothianil, mandipropamide, mefentrifluconazole, metalaxyl, metalaxyl-M (mefenoxam), methyltetraprole, oxathiapiproline, penflufen, phosphite (phosphonate), picarbtrazox, prothioconazole, pidflumetofen, pyraclostrobin, quinofumerine, sedaxane, silthiofame, streptomyces crestomycetics Chrestomyceticus), tebuconazole, tetraniliprol, thiabendazole, thiamethoxam, tolprocarb, triticonazole, zoxamide, N-[(1R)-1-benzyl-3-chloro-1-methylbuta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methylbuta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methylpropyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-Trifluoro-1-methylpropyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethylbutyl]-7,8-difluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethylbutyl]-7,8-difluoroquinoline-3-carboxamide, 8-Fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethylbutyl]quinoline-3-carboxamide, 8-Fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethylbutyl]quinoline The compounds are N-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethylbutyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethylbutyl]-8-fluoroquinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methylbuta-3-enyl)-8-fluoroquinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methylbuta-3-enyl)-8-fluoroquinoline-3-carboxamide, with a weight ratio of component (A) to component (B) of 15:1 to 1:30.

[0055] In other preferred compositions according to the present invention, component (A) is compound number X.23[methyl N-[5-[6-[(4-cyano-3-methoxyphenyl)-methyl-carbamoyl]-8-methylimidazo[1,2-a]pyridine-3-yl]2-pyridyl]carbamate] or a salt thereof, or an N-oxide, and component (B) is acetamiprid, acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, Bacillus amyloricephaciens amyloliquefaciens), benzovindiflupir, broflanilide, chlorothalonil, clothianidin, chlorantraniliprole, cis-jasmon, cyantraniliprole, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, etaboxam, fenpicoxamide, florylpicoxamide, fluazinam, fludioxonil, fluindapir, fluopicolide, fluopyram, fluoxapiproline, fluoxythioconazole, fluxamethoxamide, fluxapyroxad, flu Pet, imidacloprid, impulfluxam, ipconazole, ipflufenokine, isocycloseram, isoflucipram, isothianil, mandipropamide, mefentrifluconazole, metalaxyl, metalaxyl-M (mefenoxam), methyltetraprole, oxathiapiproline, penflufen, phosphite (phosphonate), picarbtrazox, prothioconazole, pidflumetofen, pyraclostrobin, quinofumerine, sedaxane, silthiofame, streptomyces crestomycetics Chrestomyceticus), tebuconazole, tetraniliprol, thiabendazole, thiamethoxam, tolprocarb, triticonazole, zoxamide, N-[(1R)-1-benzyl-3-chloro-1-methyl-buta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methyl-buta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoroquinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3 The compounds are N-((1R)-1-benzyl-1,3-dimethyl-butyl)-8-fluoroquinoline-3-carboxamide, N-((1R)-1-benzyl-1,3-dimethyl-butyl)-8-fluoroquinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-buta-3-enyl)-8-fluoroquinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-buta-3-enyl)-8-fluoroquinoline-3-carboxamide, with a weight ratio of component (A) to component (B) of 15:1 to 1:30.

[0056] In a more preferred composition according to the present invention, component (A) is compound number X.01 [methyl N-[5-[6-[(4-fluoro-3-methoxyphenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate] or its salt or N-oxide, and component (B) is acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, chlorothalonil, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, florylpicoxamide, fluazinam, fludioxonil, fluopicolide, fluoxapipproline, forpet, mandipropamide, mefentrifluconazole, metalaxyl-M, oxathiapipproline, picarbtrazox, pidiflumetofen, sedaxane, Streptomyces crestomycetics The compound is selected from the group consisting of chrestomyceticus, zoxamide, and compound Z (pheneptamidequine), and the weight ratio of component (A) to component (B) is 15:1 to 1:30.

[0057] In another more preferred composition according to the present invention, component (A) is compound number X.02 [methyl N-[5-[6-[(4-fluoro-3-methoxyphenyl)-methyl-carbamoyl]-8-methyl-imidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate] or its salt or N-oxide, and component (B) is acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, chlorothalonil, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, florylpicoxamide, fluazinam, fludioxonil, fluopicolide, fluoxapipproline, forpet, mandipropamide, mefentrifluconazole, metalaxyl-M, oxathiapipproline, picarbtrazox, pidiflumetofen, sedaxane, Streptomyces crestomycetics The compound is selected from the group consisting of chrestomyceticus, zoxamide, and compound Z (pheneptamidequine), and the weight ratio of component (A) to component (B) is 15:1 to 1:30.

[0058] In another more preferred composition according to the present invention, component (A) is compound number X.03 [methyl N-[5-[6-[(4-fluoro-3-methoxyphenyl)-(methoxymethyl)carbamoyl]-8-methylimidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate] or its salt or N-oxide, and component (B) is acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, chlorothalonil, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, florylpicoxamide, fluazinam, fludioxonil, fluopicolide, fluoxapipproline, forpet, mandipropamide, mefentrifluconazole, metalaxyl-M, oxathiapipproline, picarbtrazox, pidiflumetofen, sedaxane, Streptomyces crestomycetics The compound is selected from the group consisting of chrestomyceticus, zoxamide, and compound Z (pheneptamidequine), and the weight ratio of component (A) to component (B) is 15:1 to 1:30.

[0059] In another more preferred composition according to the present invention, component (A) is compound number X.04 [methyl N-[5-[6-[(4-fluoro-3-methoxyphenyl)-(methoxymethyl)carbamoyl]imidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate] or its salt or N-oxide, and component (B) is acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, chlorothalonil, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, florylpicoxamide, fluazinam, fludioxonil, fluopicolide, fluoxapipproline, forpet, mandipropamide, mefentrifluconazole, metalaxyl-M, oxathiapipproline, picarbtrazox, pidiflumetofen, sedaxane, Streptomyces crestomycetics The compound is selected from the group consisting of chrestomyceticus, zoxamide, and compound Z (pheneptamidequine), and the weight ratio of component (A) to component (B) is 15:1 to 1:30.

[0060] In another more preferred composition according to the present invention, component (A) is compound number X.05 [methyl N-[4-[6-[(4-fluoro-3-methoxyphenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridine-3-yl]phenyl]carbamate] or its salt or N-oxide, and component (B) is acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, chlorothalonil, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, florylpicoxamide, fluazinam, fludioxonil, fluopicolide, fluoxapipproline, forpet, mandipropamide, mefentrifluconazole, metalaxyl-M, oxathiapipproline, picarbtrazox, pidiflumetofen, sedaxane, Streptomyces crestomycetics The compound is selected from the group consisting of chrestomyceticus, zoxamide, and compound Z (pheneptamidequine), and the weight ratio of component (A) to component (B) is 15:1 to 1:30.

[0061] In other more preferred compositions according to the present invention, component (A) is compound number X.06[3-[6-(cyclopropanecarbonylamino)-3-pyridyl]-N-(4-fluoro-3-methoxyphenyl)-N-methylimidazo[1,2-a]pyridine-6-carboxamide] or its salt or N-oxide, and component (B) is acibenzolar-S-methyl, amethoctrazine, amisulbrom, azoxystrobin, chlorothalonil, shea The compound is selected from the group consisting of zofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, florylpicoxamide, fluazinam, fludioxonil, fluopicolide, fluoxapipproline, forpet, mandipropamide, mefentrifluconazole, metalaxyl-M, oxathiapipproline, picarbutrazox, pidflumetofen, sedaxane, streptomyces chrestomyceticus, zoxamide, and compound Z (pheneptamidoquin), with a weight ratio of component (A) to component (B) of 15:1 to 1:30.

[0062] In another more preferred composition according to the present invention, component (A) is compound number X.07 [methyl N-[4-[6-[(4-fluorophenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridine-3-yl]phenyl]carbamate] or its salt or N-oxide, and component (B) is acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, chlorothalonil, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, florylpicoxamide, fluazinam, fludioxonil, fluopicolide, fluoxapipproline, forpet, mandipropamide, mefentrifluconazole, metalaxyl-M, oxathiapipproline, picarbtrazox, pidiflumetofen, sedaxane, Streptomyces crestomycetics The compound is selected from the group consisting of chrestomyceticus, zoxamide, and compound Z (pheneptamidequine), and the weight ratio of component (A) to component (B) is 15:1 to 1:30.

[0063] In another more preferred composition according to the present invention, component (A) is compound number X.08 [methyl N-[4-[6-[(4-chlorophenyl)-methyl-carbamoyl]-8-methyl-imidazo[1,2-a]pyridine-3-yl]phenyl]carbamate] or its salt or N-oxide, and component (B) is acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, chlorothalonil, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, florylpicoxamide, fluazinam, fludioxonil, fluopicolide, fluoxapipproline, forpet, mandipropamide, mefentrifluconazole, metalaxyl-M, oxathiapipproline, picarbtrazox, pidiflumetofen, sedaxane, Streptomyces crestomycetics The compound is selected from the group consisting of chrestomyceticus, zoxamide, and compound Z (pheneptamidequine), and the weight ratio of component (A) to component (B) is 15:1 to 1:30.

[0064] In another more preferred composition according to the present invention, component (A) is compound number X.09 [methyl N-[5-[6-[(4-fluoro-3-methylphenyl)-methylcarbamoyl]imidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate] or its salt or N-oxide, and component (B) is acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, chlorothalonil, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, florylpicoxamide, fluazinam, fludioxonil, fluopicolide, fluoxapipproline, forpet, mandipropamide, mefentrifluconazole, metalaxyl-M, oxathiapipproline, picarbtrazox, pidflumetofen, sedaxane, Streptomyces crestomycetics The compound is selected from the group consisting of chrestomyceticus, zoxamide, and compound Z (pheneptamidequine), and the weight ratio of component (A) to component (B) is 15:1 to 1:30.

[0065] In another more preferred composition according to the present invention, component (A) is compound number X.10 [methyl N-[5-[6-[(4-cyano-3-methoxyphenyl)-cyanomethyl-carbamoyl]imidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate] or its salt or N-oxide, and component (B) is acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, chlorothalonil, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, florylpicoxamide, fluazinam, fludioxonil, fluopicolide, fluoxapipproline, forpet, mandipropamide, mefentrifluconazole, metalaxyl-M, oxathiapipproline, picarbtrazox, pidiflumetofen, sedaxane, Streptomyces crestomycetics The compound is selected from the group consisting of chrestomyceticus, zoxamide, and compound Z (pheneptamidequine), and the weight ratio of component (A) to component (B) is 15:1 to 1:30.

[0066] In another more preferred composition according to the present invention, component (A) is compound number X.11 [methyl N-[5-[6-[(4-chloro-3-methoxyphenyl)-cyanomethyl-carbamoyl]imidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate] or its salt or N-oxide, and component (B) is acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, chlorothalonil, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, florylpicoxamide, fluazinam, fludioxonil, fluopicolide, fluoxapipproline, forpet, mandipropamide, mefentrifluconazole, metalaxyl-M, oxathiapipproline, picarbtrazox, pidiflumetofen, sedaxane, Streptomyces crestomycetics The compound is selected from the group consisting of chrestomyceticus, zoxamide, and compound Z (pheneptamidequine), and the weight ratio of component (A) to component (B) is 15:1 to 1:30.

[0067] In another more preferred composition according to the present invention, component (A) is compound number X.12 [methyl N-[5-[6-[(4-fluorophenyl)-methyl-carbamoyl]-8-methyl-imidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate] or its salt or N-oxide, and component (B) is acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, chlorothalonil, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, florylpicoxamide, fluazinam, fludioxonil, fluopicolide, fluoxapipproline, forpet, mandipropamide, mefentrifluconazole, metalaxyl-M, oxathiapipproline, picarbtrazox, pidflumetofen, sedaxane, Streptomyces crestomycetics The compound is selected from the group consisting of chrestomyceticus, zoxamide, and compound Z (pheneptamidequine), and the weight ratio of component (A) to component (B) is 15:1 to 1:30.

[0068] In another more preferred composition according to the present invention, component (A) is compound number X.13 [methyl N-[5-[6-[(4-fluorophenyl)-methyl-carbamoyl]-7-methyl-imidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate] or its salt or N-oxide, and component (B) is acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, chlorothalonil, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, florylpicoxamide, fluazinam, fludioxonil, fluopicolide, fluoxapipproline, forpet, mandipropamide, mefentrifluconazole, metalaxyl-M, oxathiapipproline, picarbtrazox, pidiflumetofen, sedaxane, Streptomyces crestomycetics The compound is selected from the group consisting of chrestomyceticus, zoxamide, and compound Z (pheneptamidequine), and the weight ratio of component (A) to component (B) is 15:1 to 1:30.

[0069] In another more preferred composition according to the present invention, component (A) is compound number X.14 [methyl N-[5-[6-[cyanomethyl-(4-fluoro-3-methoxyphenyl)carbamoyl]imidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate] or its salt or N-oxide, and component (B) is acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, chlorothalonil, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, florylpicoxamide, fluazinam, fludioxonil, fluopicolide, fluoxapipproline, forpet, mandipropamide, mefentrifluconazole, metalaxyl-M, oxathiapipproline, picarbtrazox, pidiflumetofen, sedaxane, Streptomyces crestomycetics The compound is selected from the group consisting of chrestomyceticus, zoxamide, and compound Z (pheneptamidequine), and the weight ratio of component (A) to component (B) is 15:1 to 1:30.

[0070] In another more preferred composition according to the present invention, component (A) is compound number X.15 [methyl N-[5-[6-[(4-chloro-3-methoxyphenyl)-(cyanomethyl)carbamoyl]imidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate] or its salt or N-oxide, and component (B) is acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, chlorothalonil, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, florylpicoxamide, fluazinam, fludioxonil, fluopicolide, fluoxapipproline, forpet, mandipropamide, mefentrifluconazole, metalaxyl-M, oxathiapipproline, picarbtrazox, pidiflumetofen, sedaxane, Streptomyces crestomycetics The compound is selected from the group consisting of chrestomyceticus, zoxamide, and compound Z (pheneptamidequine), and the weight ratio of component (A) to component (B) is 15:1 to 1:30.

[0071] In another more preferred composition according to the present invention, component (A) is compound number X.16 [methyl N-[5-[6-[(4-fluoro-3-methoxyphenyl)-(methylsulfonylmethyl)carbamoyl]imidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate] or its salt or N-oxide, and component (B) is acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, chlorothalonil, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, florylpicoxamide, fluazinam, fludioxonil, fluopicolide, fluoxapipproline, forpet, mandipropamide, mefentrifluconazole, metalaxyl-M, oxathiapipproline, picarbtrazox, pidiflumetofen, sedaxane, Streptomyces crestomycetics The compound is selected from the group consisting of chrestomyceticus, zoxamide, and compound Z (pheneptamidequine), and the weight ratio of component (A) to component (B) is 15:1 to 1:30.

[0072] In other more preferred compositions according to the present invention, component (A) is compound number X.17[N-(4-fluoro-3-methoxyphenyl)3-[6-(methoxycarbamoylamino)-3-pyridyl]-N-methylimidazo[1,2-a]pyridine-6-carboxamide] or its salt or N-oxide, and component (B) is acibenzolar-S-methyl, amethoctrazine, amisulbrom, azoxystrobin, chlorothalonil, cyazo The compound is selected from the group consisting of Famide, Cyclobtrifluram, Cymoxanil, Difenoconazole, Phosphosodium Disodium, Florylpicoxamide, Fluazinam, Fludioxonil, Fluopicolide, Fluoxapiproline, Forpet, Mandipropamide, Mefentrifluconazole, Metalaxyl-M, Oxathiapiproline, Picarbutrazox, Pidiflumetofen, Sedaxane, Streptomyces chrestomyceticus, Zoxamide, and compound Z (Feneptamidoquin), with a weight ratio of component (A) to component (B) of 15:1 to 1:30.

[0073] In another more preferred composition according to the present invention, component (A) is compound number X.18 [methyl N-[5-[8-acetamide-6-[(4-fluorophenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate] or its salt or N-oxide, and component (B) is acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, chlorothalonil, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, florylpicoxamide, fluazinam, fludioxonil, fluopicolide, fluoxapipproline, forpet, mandipropamide, mefentrifluconazole, metalaxyl-M, oxathiapipproline, picarbtrazox, pidiflumetofen, sedaxane, Streptomyces crestomycetics The compound is selected from the group consisting of chrestomyceticus, zoxamide, and compound Z (pheneptamidequine), and the weight ratio of component (A) to component (B) is 15:1 to 1:30.

[0074] In another more preferred composition according to the present invention, component (A) is compound number X.19 [methyl N-[5-[6-[ethyl-(4-fluorophenyl)carbamoyl]imidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate] or its salt or N-oxide, and component (B) is acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, chlorothalonil, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, florylpicoxamide, fluazinam, fludioxonil, fluopicolide, fluoxapipproline, forpet, mandipropamide, mefentrifluconazole, metalaxyl-M, oxathiapipproline, picarbtrazox, pidiflumetofen, sedaxane, Streptomyces crestomycetics The compound is selected from the group consisting of chrestomyceticus, zoxamide, and compound Z (pheneptamidequine), and the weight ratio of component (A) to component (B) is 15:1 to 1:30.

[0075] In another more preferred composition according to the present invention, component (A) is compound number X.20 [methyl N-[5-[8-acetamide-6-[(4-fluoro-3-methoxyphenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate] or its salt or N-oxide, and component (B) is acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, chlorothalonil, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, florylpicoxamide, fluazinam, fludioxonil, fluopicolide, fluoxapipproline, forpet, mandipropamide, mefentrifluconazole, metalaxyl-M, oxathiapipproline, picarbtrazox, pidiflumetofen, sedaxane, Streptomyces crestomycetics The compound is selected from the group consisting of chrestomyceticus, zoxamide, and compound Z (pheneptamidequine), and the weight ratio of component (A) to component (B) is 15:1 to 1:30.

[0076] In another more preferred composition according to the present invention, component (A) is compound number X.21 [methyl The component (B) is {N}-[5-[6-[(4-fluoro-3-methoxyphenyl)-methyl-carbamoyl]-8-(methoxymethyl)imidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate] or its salt or N-oxide, and component (B) is acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, chlorothalonil, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, florylpicoxamide, fluazinam, fludioxonil, fluopicolide, fluoxapipproline, forpet, mandipropamide, mefentrifluconazole, metalaxyl-M, oxathiapipproline, picarbtrazox, pidiflumetofen, sedaxane, Streptomyces crestomycetics The compound is selected from the group consisting of chrestomyceticus, zoxamide, and compound Z (pheneptamidequine), and the weight ratio of component (A) to component (B) is 15:1 to 1:30.

[0077] In another more preferred composition according to the present invention, component (A) is compound number X.22 [methyl N-[5-[6-[(2-methoxy-4-pyridyl)-methylcarbamoyl]-8-methylimidazo[1,2-a]pyridin-3-yl]-2-pyridyl]carbamate] or its salt or N-oxide, and component (B) is acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, chlorothalonil, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, florylpicoxamide, fluazinam, fludioxonil, fluopicolide, fluoxapipproline, forpet, mandipropamide, mefentrifluconazole, metalaxyl-M, oxathiapipproline, picarbtrazox, pidiflumetofen, sedaxane, Streptomyces crestomycetics The compound is selected from the group consisting of chrestomyceticus, zoxamide, and compound Z (pheneptamidequine), and the weight ratio of component (A) to component (B) is 15:1 to 1:30.

[0078] In another more preferred composition according to the present invention, component (A) is compound number X.23 [methyl N-[5-[6-[(4-cyano-3-methoxyphenyl)-methyl-carbamoyl]-8-methyl-imidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate] or its salt or N-oxide, and component (B) is acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, chlorothalonil, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, florylpicoxamide, fluazinam, fludioxonil, fluopicolide, fluoxapipproline, forpet, mandipropamide, mefentrifluconazole, metalaxyl-M, oxathiapipproline, picarbtrazox, pidiflumetofen, sedaxane, Streptomyces crestomycetics The compound is selected from the group consisting of chrestomyceticus, zoxamide, and compound Z (pheneptamidequine), and the weight ratio of component (A) to component (B) is 15:1 to 1:30.

[0079] In a more preferred composition according to the present invention, component (A) is compound number X.01[methyl N-[5-[6-[(4-fluoro-3-methoxyphenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate] or a salt thereof, or an N-oxide, and component (B) is acetamiprid, acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, Bacillus amyloricephaciens amyloliquefaciens), benzovindiflupir, broflanilide, chlorothalonil, clothianidin, chlorantraniliprole, cis-jasmon, cyantraniliprole, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, etaboxam, fenpicoxamide, florylpicoxamide, fluazinam, fludioxonil, fluindapir, fluopicolide, fluopyram, fluoxapiproline, fluoxythioconazole, fluxamethoxamide, fluxapyroxad, flu Pet, imidacloprid, impulfluxam, ipconazole, ipflufenokine, isocycloseram, isoflucipram, isothianil, mandipropamide, mefentrifluconazole, metalaxyl, metalaxyl-M (mefenoxam), methyltetraprole, oxathiapiproline, penflufen, phosphite (phosphonate), picarbtrazox, prothioconazole, pidflumetofen, pyraclostrobin, quinofumerine, sedaxane, silthiofame, streptomyces crestomycetics Chrestomyceticus), tebuconazole, tetraniliprol, thiabendazole, thiamethoxam, tolprocarb, triticonazole, zoxamide, N-[(1R)-1-benzyl-3-chloro-1-methyl-buta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methyl-buta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoroquinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide The compounds are N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoroquinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-buta-3-enyl)-8-fluoroquinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-buta-3-enyl)-8-fluoroquinoline-3-carboxamide, with a weight ratio of component (A) to component (B) of 10:1 to 1:10 (or more preferably 5:1 to 1:5).

[0080] In other, even more preferred compositions according to the present invention, component (A) is compound number X.02[methyl N-[5-[6-[(4-fluoro-3-methoxyphenyl)-methyl-carbamoyl]-8-methyl-imidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate] or a salt thereof, or an N-oxide, and component (B) is acetamiprid, acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, Bacillus amyloricephaciens amyloliquefaciens), benzovindiflupir, broflanilide, chlorothalonil, clothianidin, chlorantraniliprole, cis-jasmon, cyantraniliprole, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, etaboxam, fenpicoxamide, florylpicoxamide, fluazinam, fludioxonil, fluindapir, fluopicolide, fluopyram, fluoxapiproline, fluoxythioconazole, fluxamethoxamide, fluxapyroxad, flu Pet, imidacloprid, impulfluxam, ipconazole, ipflufenokine, isocycloseram, isoflucipram, isothianil, mandipropamide, mefentrifluconazole, metalaxyl, metalaxyl-M (mefenoxam), methyltetraprole, oxathiapiproline, penflufen, phosphite (phosphonate), picarbtrazox, prothioconazole, pidflumetofen, pyraclostrobin, quinofumerine, sedaxane, silthiofame, streptomyces crestomycetics Chrestomyceticus), tebuconazole, tetraniliprol, thiabendazole, thiamethoxam, tolprocarb, triticonazole, zoxamide, N-[(1R)-1-benzyl-3-chloro-1-methyl-buta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methyl-buta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoroquinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl The compounds are N-[(1R)-1-benzyl-1,3-dimethyl-butyl]quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoroquinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-buta-3-enyl)-8-fluoroquinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-buta-3-enyl)-8-fluoroquinoline-3-carboxamide, where the weight ratio of component (A) to component (B) is 10:1 to 1:10 (or more preferably 5:1 to 1:5).

[0081] In other, even more preferred compositions according to the present invention, component (A) is compound number X.03[methyl N-[5-[6-[(4-fluoro-3-methoxyphenyl)-(methoxymethyl)carbamoyl]-8-methylimidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate] or a salt thereof, or an N-oxide, and component (B) is acetamiprid, acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, Bacillus amyloricephaciens amyloliquefaciens), benzovindiflupir, broflanilide, chlorothalonil, clothianidin, chlorantraniliprole, cis-jasmon, cyantraniliprole, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, etaboxam, fenpicoxamide, florylpicoxamide, fluazinam, fludioxonil, fluindapir, fluopicolide, fluopyram, fluoxapiproline, fluoxythioconazole, fluxamethoxamide, fluxapyroxad, flu Pet, imidacloprid, impulfluxam, ipconazole, ipflufenokine, isocycloseram, isoflucipram, isothianil, mandipropamide, mefentrifluconazole, metalaxyl, metalaxyl-M (mefenoxam), methyltetraprole, oxathiapiproline, penflufen, phosphite (phosphonate), picarbtrazox, prothioconazole, pidflumetofen, pyraclostrobin, quinofumerine, sedaxane, silthiofame, streptomyces crestomycetics Chrestomyceticus), tebuconazole, tetraniliprol, thiabendazole, thiamethoxam, tolprocarb, triticonazole, zoxamide, N-[(1R)-1-benzyl-3-chloro-1-methyl-buta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methyl-buta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoroquinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl The compounds are N-[(1R)-1-benzyl-1,3-dimethyl-butyl]quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoroquinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-buta-3-enyl)-8-fluoroquinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-buta-3-enyl)-8-fluoroquinoline-3-carboxamide, where the weight ratio of component (A) to component (B) is 10:1 to 1:10 (or more preferably 5:1 to 1:5).

[0082] In other, even more preferred compositions according to the present invention, component (A) is compound number X.04[methyl N-[5-[6-[(4-fluoro-3-methoxyphenyl)-(methoxymethyl)carbamoyl]imidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate] or a salt thereof, or an N-oxide, and component (B) is acetamiprid, acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, Bacillus amyloricephaciens amyloliquefaciens), benzovindiflupir, broflanilide, chlorothalonil, clothianidin, chlorantraniliprole, cis-jasmon, cyantraniliprole, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, etaboxam, fenpicoxamide, florylpicoxamide, fluazinam, fludioxonil, fluindapir, fluopicolide, fluopyram, fluoxapiproline, fluoxythioconazole, fluxamethoxamide, fluxapyroxad, flu Pet, imidacloprid, impulfluxam, ipconazole, ipflufenokine, isocycloseram, isoflucipram, isothianil, mandipropamide, mefentrifluconazole, metalaxyl, metalaxyl-M (mefenoxam), methyltetraprole, oxathiapiproline, penflufen, phosphite (phosphonate), picarbtrazox, prothioconazole, pidflumetofen, pyraclostrobin, quinofumerine, sedaxane, silthiofame, streptomyces crestomycetics Chrestomyceticus), tebuconazole, tetraniliprol, thiabendazole, thiamethoxam, tolprocarb, triticonazole, zoxamide, N-[(1R)-1-benzyl-3-chloro-1-methyl-buta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methyl-buta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoroquinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl The compounds are N-[(1R)-1-benzyl-1,3-dimethyl-butyl]quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoroquinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-buta-3-enyl)-8-fluoroquinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-buta-3-enyl)-8-fluoroquinoline-3-carboxamide, where the weight ratio of component (A) to component (B) is 10:1 to 1:10 (or more preferably 5:1 to 1:5).

[0083] In other, even more preferred compositions according to the present invention, component (A) is compound number X.05[methyl N-[4-[6-[(4-fluoro-3-methoxyphenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridine-3-yl]phenyl]carbamate] or a salt thereof, or an N-oxide, and component (B) is acetamiprid, acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, Bacillus amyloricephaciens amyloliquefaciens), benzovindiflupir, broflanilide, chlorothalonil, clothianidin, chlorantraniliprole, cis-jasmon, cyantraniliprole, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, etaboxam, fenpicoxamide, florylpicoxamide, fluazinam, fludioxonil, fluindapir, fluopicolide, fluopyram, fluoxapiproline, fluoxythioconazole, fluxamethoxamide, fluxapyroxad, flu Pet, imidacloprid, impulfluxam, ipconazole, ipflufenokine, isocycloseram, isoflucipram, isothianil, mandipropamide, mefentrifluconazole, metalaxyl, metalaxyl-M (mefenoxam), methyltetraprole, oxathiapiproline, penflufen, phosphite (phosphonate), picarbtrazox, prothioconazole, pidflumetofen, pyraclostrobin, quinofumerine, sedaxane, silthiofame, streptomyces crestomycetics Chrestomyceticus), tebuconazole, tetraniliprol, thiabendazole, thiamethoxam, tolprocarb, triticonazole, zoxamide, N-[(1R)-1-benzyl-3-chloro-1-methylbuta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methylbuta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methylpropyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-Trifluoro-1-methyl-propyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoroquinoline-3-carboxamide, 8-Fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, 8-Fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide The compounds are N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoroquinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-buta-3-enyl)-8-fluoroquinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-buta-3-enyl)-8-fluoroquinoline-3-carboxamide, with a weight ratio of component (A) to component (B) of 10:1 to 1:10 (or more preferably 5:1 to 1:5).

[0084] In other, even more preferred compositions according to the present invention, component (A) is compound number X.06[3-[6-(cyclopropanecarbonylamino)-3-pyridyl]-N-(4-fluoro-3-methoxyphenyl)-N-methylimidazo[1,2-a]pyridine-6-carboxamide] or a salt thereof, or an N-oxide, and component (B) is acetamiprid, acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, Bacillus amyloricephaciens amyloliquefaciens), benzovindiflupir, broflanilide, chlorothalonil, clothianidin, chlorantraniliprole, cis-jasmon, cyantraniliprole, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, etaboxam, fenpicoxamide, florylpicoxamide, fluazinam, fludioxonil, fluindapir, fluopicolide, fluopyram, fluoxapiproline, fluoxythioconazole, fluxamethoxamide, fluxapyroxad, flu Pet, imidacloprid, impulfluxam, ipconazole, ipflufenokine, isocycloseram, isoflucipram, isothianil, mandipropamide, mefentrifluconazole, metalaxyl, metalaxyl-M (mefenoxam), methyltetraprole, oxathiapiproline, penflufen, phosphite (phosphonate), picarbtrazox, prothioconazole, pidflumetofen, pyraclostrobin, quinofumerine, sedaxane, silthiofame, streptomyces crestomycetics Chrestomyceticus), tebuconazole, tetraniliprol, thiabendazole, thiamethoxam, tolprocarb, triticonazole, zoxamide, N-[(1R)-1-benzyl-3-chloro-1-methyl-buta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methyl-buta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoroquinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3-fluorophenyl The compounds are N-((1R)-1-benzyl-1,3-dimethyl-butyl)-8-fluoroquinoline-3-carboxamide, N-((1R)-1-benzyl-1,3-dimethyl-butyl)-8-fluoroquinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-buta-3-enyl)-8-fluoroquinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-buta-3-enyl)-8-fluoroquinoline-3-carboxamide, with a weight ratio of component (A) to component (B) of 10:1 to 1:10 (or more preferably 5:1 to 1:5).

[0085] In other, even more preferred compositions according to the present invention, component (A) is compound number X.07[methyl N-[4-[6-[(4-fluorophenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridine-3-yl]phenyl]carbamate] or a salt thereof, or an N-oxide, and component (B) is acetamiprid, acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, Bacillus amyloricephaciens amyloliquefaciens), benzovindiflupir, broflanilide, chlorothalonil, clothianidin, chlorantraniliprole, cis-jasmon, cyantraniliprole, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, etaboxam, fenpicoxamide, florylpicoxamide, fluazinam, fludioxonil, fluindapir, fluopicolide, fluopyram, fluoxapiproline, fluoxythioconazole, fluxamethoxamide, fluxapyroxad, flu Pet, imidacloprid, impulfluxam, ipconazole, ipflufenokine, isocycloseram, isoflucipram, isothianil, mandipropamide, mefentrifluconazole, metalaxyl, metalaxyl-M (mefenoxam), methyltetraprole, oxathiapiproline, penflufen, phosphite (phosphonate), picarbtrazox, prothioconazole, pidflumetofen, pyraclostrobin, quinofumerine, sedaxane, silthiofame, streptomyces crestomycetics Chrestomyceticus), tebuconazole, tetraniliprol, thiabendazole, thiamethoxam, tolprocarb, triticonazole, zoxamide, N-[(1R)-1-benzyl-3-chloro-1-methylbuta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methylbuta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methylpropyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-Trifluoro-1-methyl-propyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoroquinoline-3-carboxamide, 8-Fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, 8-Fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide The compounds are N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoroquinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-buta-3-enyl)-8-fluoroquinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-buta-3-enyl)-8-fluoroquinoline-3-carboxamide, with a weight ratio of component (A) to component (B) of 10:1 to 1:10 (or more preferably 5:1 to 1:5).

[0086] In other, even more preferred compositions according to the present invention, component (A) is compound number X.08[methyl N-[4-[6-[(4-chlorophenyl)-methyl-carbamoyl]-8-methyl-imidazo[1,2-a]pyridine-3-yl]phenyl]carbamate] or a salt thereof, or an N-oxide, and component (B) is acetamiprid, acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, Bacillus amyloricephaciens amyloliquefaciens), benzovindiflupir, broflanilide, chlorothalonil, clothianidin, chlorantraniliprole, cis-jasmon, cyantraniliprole, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, etaboxam, fenpicoxamide, florylpicoxamide, fluazinam, fludioxonil, fluindapir, fluopicolide, fluopyram, fluoxapiproline, fluoxythioconazole, fluxamethoxamide, fluxapyroxad, flu Pet, imidacloprid, impulfluxam, ipconazole, ipflufenokine, isocycloseram, isoflucipram, isothianil, mandipropamide, mefentrifluconazole, metalaxyl, metalaxyl-M (mefenoxam), methyltetraprole, oxathiapiproline, penflufen, phosphite (phosphonate), picarbtrazox, prothioconazole, pidflumetofen, pyraclostrobin, quinofumerine, sedaxane, silthiofame, streptomyces crestomycetics Chrestomyceticus), tebuconazole, tetraniliprol, thiabendazole, thiamethoxam, tolprocarb, triticonazole, zoxamide, N-[(1R)-1-benzyl-3-chloro-1-methylbuta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methylbuta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methylpropyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-Trifluoro-1-methyl-propyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoroquinoline-3-carboxamide, 8-Fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, 8-Fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide The compounds are N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoroquinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-buta-3-enyl)-8-fluoroquinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-buta-3-enyl)-8-fluoroquinoline-3-carboxamide, with a weight ratio of component (A) to component (B) of 10:1 to 1:10 (or more preferably 5:1 to 1:5).

[0087] In other, even more preferred compositions according to the present invention, component (A) is compound number X.09[methyl N-[5-[6-[(4-fluoro-3-methylphenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate] or a salt thereof, or an N-oxide, and component (B) is acetamiprid, acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, Bacillus amyloricephaciens amyloliquefaciens), benzovindiflupir, broflanilide, chlorothalonil, clothianidin, chlorantraniliprole, cis-jasmon, cyantraniliprole, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, etaboxam, fenpicoxamide, florylpicoxamide, fluazinam, fludioxonil, fluindapir, fluopicolide, fluopyram, fluoxapiproline, fluoxythioconazole, fluxamethoxamide, fluxapyroxad, flu Pet, imidacloprid, impulfluxam, ipconazole, ipflufenokine, isocycloseram, isoflucipram, isothianil, mandipropamide, mefentrifluconazole, metalaxyl, metalaxyl-M (mefenoxam), methyltetraprole, oxathiapiproline, penflufen, phosphite (phosphonate), picarbtrazox, prothioconazole, pidflumetofen, pyraclostrobin, quinofumerine, sedaxane, silthiofame, streptomyces crestomycetics Chrestomyceticus), tebuconazole, tetraniliprol, thiabendazole, thiamethoxam, tolprocarb, triticonazole, zoxamide, N-[(1R)-1-benzyl-3-chloro-1-methyl-buta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methyl-buta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoroquinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide The compounds are N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoroquinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-buta-3-enyl)-8-fluoroquinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-buta-3-enyl)-8-fluoroquinoline-3-carboxamide, with a weight ratio of component (A) to component (B) of 10:1 to 1:10 (or more preferably 5:1 to 1:5).

[0088] In other, even more preferred compositions according to the present invention, component (A) is compound number X.10[methyl N-[5-[6-[(4-cyano-3-methoxyphenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate] or a salt thereof, or an N-oxide, and component (B) is acetamiprid, acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, Bacillus amyloricephaciens amyloliquefaciens), benzovindiflupir, broflanilide, chlorothalonil, clothianidin, chlorantraniliprole, cis-jasmon, cyantraniliprole, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, etaboxam, fenpicoxamide, florylpicoxamide, fluazinam, fludioxonil, fluindapir, fluopicolide, fluopyram, fluoxapiproline, fluoxythioconazole, fluxamethoxamide, fluxapyroxad, flu Pet, imidacloprid, impulfluxam, ipconazole, ipflufenokine, isocycloseram, isoflucipram, isothianil, mandipropamide, mefentrifluconazole, metalaxyl, metalaxyl-M (mefenoxam), methyltetraprole, oxathiapiproline, penflufen, phosphite (phosphonate), picarbtrazox, prothioconazole, pidflumetofen, pyraclostrobin, quinofumerine, sedaxane, silthiofame, streptomyces crestomycetics Chrestomyceticus), tebuconazole, tetraniliprol, thiabendazole, thiamethoxam, tolprocarb, triticonazole, zoxamide, N-[(1R)-1-benzyl-3-chloro-1-methyl-buta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methyl-buta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoroquinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide The compounds are N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoroquinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-buta-3-enyl)-8-fluoroquinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-buta-3-enyl)-8-fluoroquinoline-3-carboxamide, with a weight ratio of component (A) to component (B) of 10:1 to 1:10 (or more preferably 5:1 to 1:5).

[0089] In other, even more preferred compositions according to the present invention, component (A) is compound number X.11[methyl N-[5-[6-[(4-chloro-3-methoxyphenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate] or a salt thereof, or an N-oxide, and component (B) is acetamiprid, acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, Bacillus amyloricephaciens amyloliquefaciens), benzovindiflupir, broflanilide, chlorothalonil, clothianidin, chlorantraniliprole, cis-jasmon, cyantraniliprole, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, etaboxam, fenpicoxamide, florylpicoxamide, fluazinam, fludioxonil, fluindapir, fluopicolide, fluopyram, fluoxapiproline, fluoxythioconazole, fluxamethoxamide, fluxapyroxad, flu Pet, imidacloprid, impulfluxam, ipconazole, ipflufenokine, isocycloseram, isoflucipram, isothianil, mandipropamide, mefentrifluconazole, metalaxyl, metalaxyl-M (mefenoxam), methyltetraprole, oxathiapiproline, penflufen, phosphite (phosphonate), picarbtrazox, prothioconazole, pidflumetofen, pyraclostrobin, quinofumerine, sedaxane, silthiofame, streptomyces crestomycetics Chrestomyceticus), tebuconazole, tetraniliprol, thiabendazole, thiamethoxam, tolprocarb, triticonazole, zoxamide, N-[(1R)-1-benzyl-3-chloro-1-methyl-buta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methyl-buta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoroquinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide The compounds are N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoroquinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-buta-3-enyl)-8-fluoroquinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-buta-3-enyl)-8-fluoroquinoline-3-carboxamide, with a weight ratio of component (A) to component (B) of 10:1 to 1:10 (or more preferably 5:1 to 1:5).

[0090] In other, even more preferred compositions according to the present invention, component (A) is compound number X.12[methyl N-[5-[6-[(4-fluorophenyl)-methyl-carbamoyl]-8-methyl-imidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate] or a salt thereof, or an N-oxide, and component (B) is acetamiprid, acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, Bacillus amyloricephaciens amyloliquefaciens), benzovindiflupir, broflanilide, chlorothalonil, clothianidin, chlorantraniliprole, cis-jasmon, cyantraniliprole, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, etaboxam, fenpicoxamide, florylpicoxamide, fluazinam, fludioxonil, fluindapir, fluopicolide, fluopyram, fluoxapiproline, fluoxythioconazole, fluxamethoxamide, fluxapyroxad, flu Pet, imidacloprid, impulfluxam, ipconazole, ipflufenokine, isocycloseram, isoflucipram, isothianil, mandipropamide, mefentrifluconazole, metalaxyl, metalaxyl-M (mefenoxam), methyltetraprole, oxathiapiproline, penflufen, phosphite (phosphonate), picarbtrazox, prothioconazole, pidflumetofen, pyraclostrobin, quinofumerine, sedaxane, silthiofame, streptomyces crestomycetics Chrestomyceticus), tebuconazole, tetraniliprol, thiabendazole, thiamethoxam, tolprocarb, triticonazole, zoxamide, N-[(1R)-1-benzyl-3-chloro-1-methyl-buta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methyl-buta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoroquinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide The compounds are N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoroquinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-buta-3-enyl)-8-fluoroquinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-buta-3-enyl)-8-fluoroquinoline-3-carboxamide, with a weight ratio of component (A) to component (B) of 10:1 to 1:10 (or more preferably 5:1 to 1:5).

[0091] In other, even more preferred compositions according to the present invention, component (A) is compound number X.13[methyl N-[5-[6-[(4-fluorophenyl)-methyl-carbamoyl]-7-methyl-imidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate] or a salt thereof, or an N-oxide, and component (B) is acetamiprid, acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, Bacillus amyloricephaciens amyloliquefaciens), benzovindiflupir, broflanilide, chlorothalonil, clothianidin, chlorantraniliprole, cis-jasmon, cyantraniliprole, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, etaboxam, fenpicoxamide, florylpicoxamide, fluazinam, fludioxonil, fluindapir, fluopicolide, fluopyram, fluoxapiproline, fluoxythioconazole, fluxamethoxamide, fluxapyroxad, flu Pet, imidacloprid, impulfluxam, ipconazole, ipflufenokine, isocycloseram, isoflucipram, isothianil, mandipropamide, mefentrifluconazole, metalaxyl, metalaxyl-M (mefenoxam), methyltetraprole, oxathiapiproline, penflufen, phosphite (phosphonate), picarbtrazox, prothioconazole, pidflumetofen, pyraclostrobin, quinofumerine, sedaxane, silthiofame, streptomyces crestomycetics Chrestomyceticus), tebuconazole, tetraniliprol, thiabendazole, thiamethoxam, tolprocarb, triticonazole, zoxamide, N-[(1R)-1-benzyl-3-chloro-1-methyl-buta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methyl-buta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoroquinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide The compounds are N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoroquinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-buta-3-enyl)-8-fluoroquinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-buta-3-enyl)-8-fluoroquinoline-3-carboxamide, with a weight ratio of component (A) to component (B) of 10:1 to 1:10 (or more preferably 5:1 to 1:5).

[0092] In other, even more preferred compositions according to the present invention, component (A) is compound number X.14[methyl N-[5-[6-[cyanomethyl-(4-fluoro-3-methoxyphenyl)carbamoyl]imidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate] or a salt thereof, or an N-oxide, and component (B) is acetamiprid, acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, Bacillus amyloricephaciens amyloliquefaciens), benzovindiflupir, broflanilide, chlorothalonil, clothianidin, chlorantraniliprole, cis-jasmon, cyantraniliprole, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, etaboxam, fenpicoxamide, florylpicoxamide, fluazinam, fludioxonil, fluindapir, fluopicolide, fluopyram, fluoxapiproline, fluoxythioconazole, fluxamethoxamide, fluxapyroxad, flu Pet, imidacloprid, impulfluxam, ipconazole, ipflufenokine, isocycloseram, isoflucipram, isothianil, mandipropamide, mefentrifluconazole, metalaxyl, metalaxyl-M (mefenoxam), methyltetraprole, oxathiapiproline, penflufen, phosphite (phosphonate), picarbtrazox, prothioconazole, pidflumetofen, pyraclostrobin, quinofumerine, sedaxane, silthiofame, streptomyces crestomycetics Chrestomyceticus), tebuconazole, tetraniliprol, thiabendazole, thiamethoxam, tolprocarb, triticonazole, zoxamide, N-[(1R)-1-benzyl-3-chloro-1-methyl-buta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methyl-buta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoroquinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl The compounds are N-[(1R)-1-benzyl-1,3-dimethyl-butyl]quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoroquinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-buta-3-enyl)-8-fluoroquinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-buta-3-enyl)-8-fluoroquinoline-3-carboxamide, where the weight ratio of component (A) to component (B) is 10:1 to 1:10 (or more preferably 5:1 to 1:5).

[0093] In other, even more preferred compositions according to the present invention, component (A) is compound number X.15[methyl N-[5-[6-[(4-chloro-3-methoxyphenyl)-(cyanomethyl)-carbamoyl]imidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate] or a salt thereof, or an N-oxide, and component (B) is acetamiprid, acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, Bacillus amyloricephaciens amyloliquefaciens), benzovindiflupir, broflanilide, chlorothalonil, clothianidin, chlorantraniliprole, cis-jasmon, cyantraniliprole, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, etaboxam, fenpicoxamide, florylpicoxamide, fluazinam, fludioxonil, fluindapir, fluopicolide, fluopyram, fluoxapiproline, fluoxythioconazole, fluxamethoxamide, fluxapyroxad, flu Pet, imidacloprid, impulfluxam, ipconazole, ipflufenokine, isocycloseram, isoflucipram, isothianil, mandipropamide, mefentrifluconazole, metalaxyl, metalaxyl-M (mefenoxam), methyltetraprole, oxathiapiproline, penflufen, phosphite (phosphonate), picarbtrazox, prothioconazole, pidflumetofen, pyraclostrobin, quinofumerine, sedaxane, silthiofame, streptomyces crestomycetics Chrestomyceticus), tebuconazole, tetraniliprol, thiabendazole, thiamethoxam, tolprocarb, triticonazole, zoxamide, N-[(1R)-1-benzyl-3-chloro-1-methyl-buta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methyl-buta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoroquinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl The compounds are N-[(1R)-1-benzyl-1,3-dimethyl-butyl]quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoroquinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-buta-3-enyl)-8-fluoroquinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-buta-3-enyl)-8-fluoroquinoline-3-carboxamide, where the weight ratio of component (A) to component (B) is 10:1 to 1:10 (or more preferably 5:1 to 1:5).

[0094] In other, even more preferred compositions according to the present invention, component (A) is compound number X.16[methyl N-[5-[6-[(4-fluoro-3-methoxyphenyl)-(methylsulfonylmethyl)carbamoyl]imidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate] or a salt thereof, or an N-oxide, and component (B) is acetamiprid, acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, Bacillus amyloricephaciens amyloliquefaciens), benzovindiflupir, broflanilide, chlorothalonil, clothianidin, chlorantraniliprole, cis-jasmon, cyantraniliprole, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, etaboxam, fenpicoxamide, florylpicoxamide, fluazinam, fludioxonil, fluindapir, fluopicolide, fluopyram, fluoxapiproline, fluoxythioconazole, fluxamethoxamide, fluxapyroxad, flu Pet, imidacloprid, impulfluxam, ipconazole, ipflufenokine, isocycloseram, isoflucipram, isothianil, mandipropamide, mefentrifluconazole, metalaxyl, metalaxyl-M (mefenoxam), methyltetraprole, oxathiapiproline, penflufen, phosphite (phosphonate), picarbtrazox, prothioconazole, pidflumetofen, pyraclostrobin, quinofumerine, sedaxane, silthiofame, streptomyces crestomycetics Chrestomyceticus), tebuconazole, tetraniliprol, thiabendazole, thiamethoxam, tolprocarb, triticonazole, zoxamide, N-[(1R)-1-benzyl-3-chloro-1-methyl-buta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methyl-buta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoroquinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl The compounds are N-[(1R)-1-benzyl-1,3-dimethyl-butyl]quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoroquinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-buta-3-enyl)-8-fluoroquinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-buta-3-enyl)-8-fluoroquinoline-3-carboxamide, where the weight ratio of component (A) to component (B) is 10:1 to 1:10 (or more preferably 5:1 to 1:5).

[0095] In other, even more preferred compositions according to the present invention, component (A) is compound number X.17[N-(4-fluoro-3-methoxyphenyl)-3-[6-(methoxycarbamoylamino)-3-pyridyl]-N-methylimidazo[1,2-a]pyridine-6-carboxamide] or a salt thereof, or an N-oxide, and component (B) is acetamiprid, acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, Bacillus amyloricephaciens amyloliquefaciens), benzovindiflupir, broflanilide, chlorothalonil, clothianidin, chlorantraniliprole, cis-jasmon, cyantraniliprole, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, etaboxam, fenpicoxamide, florylpicoxamide, fluazinam, fludioxonil, fluindapir, fluopicolide, fluopyram, fluoxapiproline, fluoxythioconazole, fluxamethoxamide, fluxapyroxad, flu Pet, imidacloprid, impulfluxam, ipconazole, ipflufenokine, isocycloseram, isoflucipram, isothianil, mandipropamide, mefentrifluconazole, metalaxyl, metalaxyl-M (mefenoxam), methyltetraprole, oxathiapiproline, penflufen, phosphite (phosphonate), picarbtrazox, prothioconazole, pidflumetofen, pyraclostrobin, quinofumerine, sedaxane, silthiofame, streptomyces crestomycetics Chrestomyceticus), tebuconazole, tetraniliprol, thiabendazole, thiamethoxam, tolprocarb, triticonazole, zoxamide, N-[(1R)-1-benzyl-3-chloro-1-methyl-buta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methyl-buta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoroquinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl The compounds are N-[(1R)-1-benzyl-1,3-dimethyl-butyl]quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoroquinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-buta-3-enyl)-8-fluoroquinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-buta-3-enyl)-8-fluoroquinoline-3-carboxamide, where the weight ratio of component (A) to component (B) is 10:1 to 1:10 (or more preferably 5:1 to 1:5).

[0096] In other, even more preferred compositions according to the present invention, component (A) is compound number X.18[methyl N-[5-[8-acetamido-6-[(4-fluorophenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate] or a salt thereof, or an N-oxide, and component (B) is acetamiprid, acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, Bacillus amyloricephaciens amyloliquefaciens), benzovindiflupir, broflanilide, chlorothalonil, clothianidin, chlorantraniliprole, cis-jasmon, cyantraniliprole, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, etaboxam, fenpicoxamide, florylpicoxamide, fluazinam, fludioxonil, fluindapir, fluopicolide, fluopyram, fluoxapiproline, fluoxythioconazole, fluxamethoxamide, fluxapyroxad, flu Pet, imidacloprid, impulfluxam, ipconazole, ipflufenokine, isocycloseram, isoflucipram, isothianil, mandipropamide, mefentrifluconazole, metalaxyl, metalaxyl-M (mefenoxam), methyltetraprole, oxathiapiproline, penflufen, phosphite (phosphonate), picarbtrazox, prothioconazole, pidflumetofen, pyraclostrobin, quinofumerine, sedaxane, silthiofame, streptomyces crestomycetics Chrestomyceticus), tebuconazole, tetraniliprol, thiabendazole, thiamethoxam, tolprocarb, triticonazole, zoxamide, N-[(1R)-1-benzyl-3-chloro-1-methyl-buta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methyl-buta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoroquinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl The compounds are N-[(1R)-1-benzyl-1,3-dimethyl-butyl]quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoroquinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-buta-3-enyl)-8-fluoroquinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-buta-3-enyl)-8-fluoroquinoline-3-carboxamide, where the weight ratio of component (A) to component (B) is 10:1 to 1:10 (or more preferably 5:1 to 1:5).

[0097] In other, even more preferred compositions according to the present invention, component (A) is compound number X.19[methyl N-[5-[6-[ethyl-(4-fluorophenyl)carbamoyl]imidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate] or a salt thereof, or an N-oxide, and component (B) is acetamiprid, acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, Bacillus amyloricephaciens amyloliquefaciens), benzovindiflupir, broflanilide, chlorothalonil, clothianidin, chlorantraniliprole, cis-jasmon, cyantraniliprole, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, etaboxam, fenpicoxamide, florylpicoxamide, fluazinam, fludioxonil, fluindapir, fluopicolide, fluopyram, fluoxapiproline, fluoxythioconazole, fluxamethoxamide, fluxapyroxad, flu Pet, imidacloprid, impulfluxam, ipconazole, ipflufenokine, isocycloseram, isoflucipram, isothianil, mandipropamide, mefentrifluconazole, metalaxyl, metalaxyl-M (mefenoxam), methyltetraprole, oxathiapiproline, penflufen, phosphite (phosphonate), picarbtrazox, prothioconazole, pidflumetofen, pyraclostrobin, quinofumerine, sedaxane, silthiofame, streptomyces crestomycetics Chrestomyceticus), tebuconazole, tetraniliprol, thiabendazole, thiamethoxam, tolprocarb, triticonazole, zoxamide, N-[(1R)-1-benzyl-3-chloro-1-methylbuta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methylbuta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methylpropyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-Trifluoro-1-methyl-propyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoroquinoline-3-carboxamide, 8-Fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, 8-Fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide The compounds are N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoroquinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-buta-3-enyl)-8-fluoroquinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-buta-3-enyl)-8-fluoroquinoline-3-carboxamide, with a weight ratio of component (A) to component (B) of 10:1 to 1:10 (or more preferably 5:1 to 1:5).

[0098] In other, even more preferred compositions according to the present invention, component (A) is compound number X.20[methyl N-[5-[8-acetamido-6-[(4-fluoro-3-methoxyphenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate] or a salt thereof, or an N-oxide, and component (B) is acetamiprid, acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, Bacillus amyloricephaciens amyloliquefaciens), benzovindiflupir, broflanilide, chlorothalonil, clothianidin, chlorantraniliprole, cis-jasmon, cyantraniliprole, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, etaboxam, fenpicoxamide, florylpicoxamide, fluazinam, fludioxonil, fluindapir, fluopicolide, fluopyram, fluoxapiproline, fluoxythioconazole, fluxamethoxamide, fluxapyroxad, flu Pet, imidacloprid, impulfluxam, ipconazole, ipflufenokine, isocycloseram, isoflucipram, isothianil, mandipropamide, mefentrifluconazole, metalaxyl, metalaxyl-M (mefenoxam), methyltetraprole, oxathiapiproline, penflufen, phosphite (phosphonate), picarbtrazox, prothioconazole, pidflumetofen, pyraclostrobin, quinofumerine, sedaxane, silthiofame, streptomyces crestomycetics Chrestomyceticus), tebuconazole, tetraniliprol, thiabendazole, thiamethoxam, tolprocarb, triticonazole, zoxamide, N-[(1R)-1-benzyl-3-chloro-1-methyl-buta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methyl-buta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoroquinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl The compounds are N-[(1R)-1-benzyl-1,3-dimethyl-butyl]quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoroquinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-buta-3-enyl)-8-fluoroquinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-buta-3-enyl)-8-fluoroquinoline-3-carboxamide, where the weight ratio of component (A) to component (B) is 10:1 to 1:10 (or more preferably 5:1 to 1:5).

[0099] In other, even more preferred compositions according to the present invention, component (A) is compound number X.21[methyl{N}-[5-[6-[(4-fluoro-3-methoxyphenyl)-methyl-carbamoyl]-8-(methoxymethyl)imidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate] or a salt thereof, or an N-oxide, and component (B) is acetamiprid, acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, Bacillus amyloricephaciens amyloliquefaciens), benzovindiflupir, broflanilide, chlorothalonil, clothianidin, chlorantraniliprole, cis-jasmon, cyantraniliprole, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, etaboxam, fenpicoxamide, florylpicoxamide, fluazinam, fludioxonil, fluindapir, fluopicolide, fluopyram, fluoxapiproline, fluoxythioconazole, fluxamethoxamide, fluxapyroxad, flu Pet, imidacloprid, impulfluxam, ipconazole, ipflufenokine, isocycloseram, isoflucipram, isothianil, mandipropamide, mefentrifluconazole, metalaxyl, metalaxyl-M (mefenoxam), methyltetraprole, oxathiapiproline, penflufen, phosphite (phosphonate), picarbtrazox, prothioconazole, pidflumetofen, pyraclostrobin, quinofumerine, sedaxane, silthiofame, streptomyces crestomycetics Chrestomyceticus), tebuconazole, tetraniliprol, thiabendazole, thiamethoxam, tolprocarb, triticonazole, zoxamide, N-[(1R)-1-benzyl-3-chloro-1-methyl-buta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methyl-buta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoroquinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl The compounds are N-[(1R)-1-benzyl-1,3-dimethyl-butyl]quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoroquinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-buta-3-enyl)-8-fluoroquinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-buta-3-enyl)-8-fluoroquinoline-3-carboxamide, where the weight ratio of component (A) to component (B) is 10:1 to 1:10 (or more preferably 5:1 to 1:5).

[0100] In other, even more preferred compositions according to the present invention, component (A) is compound number X.22[methyl N-[5-[6-[(2-methoxy-4-pyridyl)-methyl-carbamoyl]-8-methyl-imidazo[1,2-a]pyridin-3-yl]-2-pyridyl]carbamate] or a salt thereof, or an N-oxide, and component (B) is acetamiprid, acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, Bacillus amyloricephaciens amyloliquefaciens), benzovindiflupir, broflanilide, chlorothalonil, clothianidin, chlorantraniliprole, cis-jasmon, cyantraniliprole, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, etaboxam, fenpicoxamide, florylpicoxamide, fluazinam, fludioxonil, fluindapir, fluopicolide, fluopyram, fluoxapiproline, fluoxythioconazole, fluxamethoxamide, fluxapyroxad, flu Pet, imidacloprid, impulfluxam, ipconazole, ipflufenokine, isocycloseram, isoflucipram, isothianil, mandipropamide, mefentrifluconazole, metalaxyl, metalaxyl-M (mefenoxam), methyltetraprole, oxathiapiproline, penflufen, phosphite (phosphonate), picarbtrazox, prothioconazole, pidflumetofen, pyraclostrobin, quinofumerine, sedaxane, silthiofame, streptomyces crestomycetics Chrestomyceticus), tebuconazole, tetraniliprol, thiabendazole, thiamethoxam, tolprocarb, triticonazole, zoxamide, N-[(1R)-1-benzyl-3-chloro-1-methyl-buta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methyl-buta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoroquinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl The compounds are N-[(1R)-1-benzyl-1,3-dimethyl-butyl]quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoroquinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-buta-3-enyl)-8-fluoroquinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-buta-3-enyl)-8-fluoroquinoline-3-carboxamide, where the weight ratio of component (A) to component (B) is 10:1 to 1:10 (or more preferably 5:1 to 1:5).

[0101] In other, even more preferred compositions according to the present invention, component (A) is compound number X.23[methyl N-[5-[6-[4-cyano-3-methoxyphenyl)-methyl-carbamoyl]-8-methylimidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate] or a salt thereof, or an N-oxide, and component (B) is acetamiprid, acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, Bacillus amyloricephaciens amyloliquefaciens), benzovindiflupir, broflanilide, chlorothalonil, clothianidin, chlorantraniliprole, cis-jasmon, cyantraniliprole, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, etaboxam, fenpicoxamide, florylpicoxamide, fluazinam, fludioxonil, fluindapir, fluopicolide, fluopyram, fluoxapiproline, fluoxythioconazole, fluxamethoxamide, fluxapyroxad, flu Pet, imidacloprid, impulfluxam, ipconazole, ipflufenokine, isocycloseram, isoflucipram, isothianil, mandipropamide, mefentrifluconazole, metalaxyl, metalaxyl-M (mefenoxam), methyltetraprole, oxathiapiproline, penflufen, phosphite (phosphonate), picarbtrazox, prothioconazole, pidflumetofen, pyraclostrobin, quinofumerine, sedaxane, silthiofame, streptomyces crestomycetics Chrestomyceticus), tebuconazole, tetraniliprol, thiabendazole, thiamethoxam, tolprocarb, triticonazole, zoxamide, N-[(1R)-1-benzyl-3-chloro-1-methyl-buta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methyl-buta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoroquinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl The compounds are N-[(1R)-1-benzyl-1,3-dimethyl-butyl]quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoroquinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-buta-3-enyl)-8-fluoroquinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-buta-3-enyl)-8-fluoroquinoline-3-carboxamide, where the weight ratio of component (A) to component (B) is 10:1 to 1:10 (or more preferably 5:1 to 1:5).

[0102] In the most preferred composition according to the present invention, component (A) is compound number X.01 [methyl N-[5-[6-[(4-fluoro-3-methoxyphenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate] or its salt or N-oxide, and component (B) is acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, chlorothalonil, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, florylpicoxamide, fluazinam, fludioxonil, fluopicolide, fluoxapipproline, forpet, mandipropamide, mefentrifluconazole, metalaxyl-M, oxathiapipproline, picarbtrazox, pidiflumetofen, sedaxane, Streptomyces crestomycetics The compound is selected from the group consisting of chrestomyceticus, zoxamide, and compound Z (pheneptamidoquin), and the weight ratio of component (A) to component (B) is 10:1 to 1:10 (or more preferably 5:1 to 1:5).

[0103] In another most preferred composition according to the present invention, component (A) is compound number X.02 methyl N-[5-[6-[(4-fluoro-3-methoxyphenyl)-methyl-carbamoyl]-8-methylimidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate. or its salt or N-oxide, and component (B) is acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, chlorothalonil, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, florylpicoxamide, fluazinam, fludioxonil, fluopicolide, fluoxapipproline, forpet, mandipropamide, mefentrifluconazole, metalaxyl-M, oxathiapipproline, picarbutrazox, pidiflumetofen, sedaxane, streptomyces crestomycetics The compound is selected from the group consisting of chrestomyceticus, zoxamide, and compound Z (pheneptamidoquin), and the weight ratio of component (A) to component (B) is 10:1 to 1:10 (or more preferably 5:1 to 1:5).

[0104] In another most preferred composition according to the present invention, component (A) is compound number X.03 [methyl N-[5-[6-[(4-fluoro-3-methoxyphenyl)-(methoxymethyl)carbamoyl]-8-methyl-imidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate] or its salt or N-oxide, and component (B) is acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, chlorothalonil, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, florylpicoxamide, fluazinam, fludioxonil, fluopicolide, fluoxapipproline, forpet, mandipropamide, mefentrifluconazole, metalaxyl-M, oxathiapipproline, picarbtrazox, pidiflumetofen, sedaxane, Streptomyces crestomycetics The compound is selected from the group consisting of chrestomyceticus, zoxamide, and compound Z (pheneptamidoquin), and the weight ratio of component (A) to component (B) is 10:1 to 1:10 (or more preferably 5:1 to 1:5).

[0105] In another most preferred composition according to the present invention, component (A) is compound number X.04 [methyl N-[5-[6-[(4-fluoro-3-methoxyphenyl)-(methoxymethyl)carbamoyl]imidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate] or its salt or N-oxide, and component (B) is acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, chlorothalonil, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, florylpicoxamide, fluazinam, fludioxonil, fluopicolide, fluoxapipproline, forpet, mandipropamide, mefentrifluconazole, metalaxyl-M, oxathiapipproline, picarbtrazox, pidiflumetofen, sedaxane, Streptomyces crestomycetics The compound is selected from the group consisting of chrestomyceticus, zoxamide, and compound Z (pheneptamidoquin), and the weight ratio of component (A) to component (B) is 10:1 to 1:10 (or more preferably 5:1 to 1:5).

[0106] In another most preferred composition according to the present invention, component (A) is compound number X.05 [methyl N-[4-[6-[(4-fluoro-3-methoxyphenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridine-3-yl]phenyl]carbamate] or its salt or N-oxide, and component (B) is acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, chlorothalonil, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, florylpicoxamide, fluazinam, fludioxonil, fluopicolide, fluoxapipproline, forpet, mandipropamide, mefentrifluconazole, metalaxyl-M, oxathiapipproline, picarbtrazox, pidiflumetofen, sedaxane, Streptomyces crestomycetics The compound is selected from the group consisting of chrestomyceticus, zoxamide, and compound Z (pheneptamidoquin), and the weight ratio of component (A) to component (B) is 10:1 to 1:10 (or more preferably 5:1 to 1:5).

[0107] In another most preferred composition according to the present invention, component (A) is compound number X.06[3-[6-(cyclopropanecarbonylamino)-3-pyridyl]-N-(4-fluoro-3-methoxyphenyl)-N-methylimidazo[1,2-a]pyridine-6-carboxamide] or its salt or N-oxide, and component (B) is acibenzolar-S-methyl, amethoctrazine, amisulbrom, azoxystrobin, chlorothalonil, shea The compound is selected from the group consisting of zofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, florylpicoxamide, fluazinam, fludioxonil, fluopicolide, fluoxapipproline, forpet, mandipropamide, mefentrifluconazole, metalaxyl-M, oxathiapipproline, picarbutrazox, pidflumetofen, sedaxane, streptomyces chrestomyceticus, zoxamide, and compound Z (pheneptamidoquin), and the weight ratio of component (A) to component (B) is 10:1 to 1:10 (or more preferably 5:1 to 1:5).

[0108] In another most preferred composition according to the present invention, component (A) is compound number X.07 [methyl N-[4-[6-[(4-fluorophenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridine-3-yl]phenyl]carbamate] or its salt or N-oxide, and component (B) is acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, chlorothalonil, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, florylpicoxamide, fluazinam, fludioxonil, fluopicolide, fluoxapipproline, forpet, mandipropamide, mefentrifluconazole, metalaxyl-M, oxathiapipproline, picarbtrazox, pidiflumetofen, sedaxane, Streptomyces crestomycetics The compound is selected from the group consisting of chrestomyceticus, zoxamide, and compound Z (pheneptamidoquin), and the weight ratio of component (A) to component (B) is 10:1 to 1:10 (or more preferably 5:1 to 1:5).

[0109] In another most preferred composition according to the present invention, component (A) is compound number X.08 [methyl N-[4-[6-[(4-chlorophenyl)-methyl-carbamoyl]-8-methyl-imidazo[1,2-a]pyridine-3-yl]phenyl]carbamate] or its salt or N-oxide, and component (B) is acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, chlorothalonil, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, florylpicoxamide, fluazinam, fludioxonil, fluopicolide, fluoxapipproline, forpet, mandipropamide, mefentrifluconazole, metalaxyl-M, oxathiapipproline, picarbtrazox, pidiflumetofen, sedaxane, Streptomyces crestomycetics The compound is selected from the group consisting of chrestomyceticus, zoxamide, and compound Z (pheneptamidoquin), and the weight ratio of component (A) to component (B) is 10:1 to 1:10 (or more preferably 5:1 to 1:5).

[0110] In another most preferred composition according to the present invention, component (A) is compound number X.09 [methyl N-[5-[6-[(4-fluoro-3-methylphenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate] or its salt or N-oxide, and component (B) is acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, chlorothalonil, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, florylpicoxamide, fluazinam, fludioxonil, fluopicolide, fluoxapipproline, forpet, mandipropamide, mefentrifluconazole, metalaxyl-M, oxathiapipproline, picarbtrazox, pidiflumetofen, sedaxane, Streptomyces crestomycetics The compound is selected from the group consisting of chrestomyceticus, zoxamide, and compound Z (pheneptamidoquin), and the weight ratio of component (A) to component (B) is 10:1 to 1:10 (or more preferably 5:1 to 1:5).

[0111] In another most preferred composition according to the present invention, component (A) is compound number X.10 [methyl N-[5-[6-[(4-cyano-3-methoxyphenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate] or its salt or N-oxide, and component (B) is acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, chlorothalonil, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, florylpicoxamide, fluazinam, fludioxonil, fluopicolide, fluoxapipproline, forpet, mandipropamide, mefentrifluconazole, metalaxyl-M, oxathiapipproline, picarbtrazox, pidiflumetofen, sedaxane, Streptomyces crestomycetics The compound is selected from the group consisting of chrestomyceticus, zoxamide, and compound Z (pheneptamidoquin), and the weight ratio of component (A) to component (B) is 10:1 to 1:10 (or more preferably 5:1 to 1:5).

[0112] In another most preferred composition according to the present invention, component (A) is compound number X.11 [methyl N-[5-[6-[(4-chloro-3-methoxyphenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate] or its salt or N-oxide, and component (B) is acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, chlorothalonil, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, florylpicoxamide, fluazinam, fludioxonil, fluopicolide, fluoxapipproline, forpet, mandipropamide, mefentrifluconazole, metalaxyl-M, oxathiapipproline, picarbtrazox, pidiflumetofen, sedaxane, Streptomyces crestomycetics The compound is selected from the group consisting of chrestomyceticus, zoxamide, and compound Z (pheneptamidoquin), and the weight ratio of component (A) to component (B) is 10:1 to 1:10 (or more preferably 5:1 to 1:5).

[0113] In another most preferred composition according to the present invention, component (A) is compound number X.12 [methyl N-[5-[6-[(4-fluorophenyl)-methyl-carbamoyl]-8-methyl-imidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate] or its salt or N-oxide, and component (B) is acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, chlorothalonil, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, florylpicoxamide, fluazinam, fludioxonil, fluopicolide, fluoxapipproline, forpet, mandipropamide, mefentrifluconazole, metalaxyl-M, oxathiapipproline, picarbtrazox, pidiflumetofen, sedaxane, Streptomyces crestomycetics The compound is selected from the group consisting of chrestomyceticus, zoxamide, and compound Z (pheneptamidoquin), and the weight ratio of component (A) to component (B) is 10:1 to 1:10 (or more preferably 5:1 to 1:5).

[0114] In another most preferred composition according to the present invention, component (A) is compound number X.13 [methyl N-[5-[6-[(4-fluorophenyl)-methyl-carbamoyl]-7-methyl-imidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate] or its salt or N-oxide, and component (B) is acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, chlorothalonil, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, florylpicoxamide, fluazinam, fludioxonil, fluopicolide, fluoxapipproline, forpet, mandipropamide, mefentrifluconazole, metalaxyl-M, oxathiapipproline, picarbtrazox, pidiflumetofen, sedaxane, Streptomyces crestomycetics The compound is selected from the group consisting of chrestomyceticus, zoxamide, and compound Z (pheneptamidoquin), and the weight ratio of component (A) to component (B) is 10:1 to 1:10 (or more preferably 5:1 to 1:5).

[0115] In another most preferred composition according to the present invention, component (A) is compound number X.14 [methyl N-[5-[6-[cyanomethyl-(4-fluoro-3-methoxyphenyl)carbamoyl]imidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate] or its salt or N-oxide, and component (B) is acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, chlorothalonil, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, florylpicoxamide, fluazinam, fludioxonil, fluopicolide, fluoxapipproline, forpet, mandipropamide, mefentrifluconazole, metalaxyl-M, oxathiapipproline, picarbtrazox, pidiflumetofen, sedaxane, Streptomyces crestomycetics The compound is selected from the group consisting of chrestomyceticus, zoxamide, and compound Z (pheneptamidoquin), and the weight ratio of component (A) to component (B) is 10:1 to 1:10 (or more preferably 5:1 to 1:5).

[0116] In another most preferred composition according to the present invention, component (A) is compound number X.15 [methyl N-[5-[6-[(4-chloro-3-methoxyphenyl)-(cyanomethyl)carbamoyl]imidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate] or its salt or N-oxide, and component (B) is acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, chlorothalonil, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, florylpicoxamide, fluazinam, fludioxonil, fluopicolide, fluoxapipproline, forpet, mandipropamide, mefentrifluconazole, metalaxyl-M, oxathiapipproline, picarbtrazox, pidiflumetofen, sedaxane, Streptomyces crestomycetics The compound is selected from the group consisting of chrestomyceticus, zoxamide, and compound Z (pheneptamidoquin), and the weight ratio of component (A) to component (B) is 10:1 to 1:10 (or more preferably 5:1 to 1:5).

[0117] In another most preferred composition according to the present invention, component (A) is compound number X.16 [methyl N-[5-[6-[(4-fluoro-3-methoxyphenyl)-(methylsulfonylmethyl)carbamoyl]imidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate] or its salt or N-oxide, and component (B) is acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, chlorothalonil, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, florylpicoxamide, fluazinam, fludioxonil, fluopicolide, fluoxapipproline, forpet, mandipropamide, mefentrifluconazole, metalaxyl-M, oxathiapipproline, picarbtrazox, pidiflumetofen, sedaxane, Streptomyces crestomycetics The compound is selected from the group consisting of chrestomyceticus, zoxamide, and compound Z (pheneptamidoquin), and the weight ratio of component (A) to component (B) is 10:1 to 1:10 (or more preferably 5:1 to 1:5).

[0118] In another most preferred composition according to the present invention, component (A) is compound number X.17[N-(4-fluoro-3-methoxyphenyl)-3-[6-(methoxycarbamoylamino)-3-pyridyl]-N-methylimidazo[1,2-a]pyridine-6-carboxamide] or its salt or N-oxide, and component (B) is acibenzolar-S-methyl, amethoctrazine, amisulbrom, azoxystrobin, chlorothalonil, cyazo The compound is selected from the group consisting of Famide, Cyclobtrifluram, Cymoxanil, Difenoconazole, Phosphosphenate disodium, Florylpicoxamide, Fluazinam, Fludioxonil, Fluopicolide, Fluoxapiproline, Forpet, Mandipropamide, Mefentrifluconazole, Metalaxyl-M, Oxathiapiproline, Picarbutrazox, Pidiflumetofen, Sedaxane, Streptomyces chrestomyceticus, Zoxamide, and compound Z (Feneptamidoquin), and the weight ratio of component (A) to component (B) is 10:1 to 1:10 (or more preferably 5:1 to 1:5).

[0119] In another most preferred composition according to the present invention, component (A) is compound number X.18 [methyl N-[5-[8-acetamide-6-[(4-fluorophenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate] or its salt or N-oxide, and component (B) is acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, chlorothalonil, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, florylpicoxamide, fluazinam, fludioxonil, fluopicolide, fluoxapipproline, forpet, mandipropamide, mefentrifluconazole, metalaxyl-M, oxathiapipproline, picarbtrazox, pidiflumetofen, sedaxane, Streptomyces crestomycetics The compound is selected from the group consisting of chrestomyceticus, zoxamide, and compound Z (pheneptamidoquin), and the weight ratio of component (A) to component (B) is 10:1 to 1:10 (or more preferably 5:1 to 1:5).

[0120] In another most preferred composition according to the present invention, component (A) is compound number X.19 [methyl N-[5-[6-[ethyl-(4-fluorophenyl)carbamoyl]imidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate] or its salt or N-oxide, and component (B) is acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, chlorothalonil, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, florylpicoxamide, fluazinam, fludioxonil, fluopicolide, fluoxapipproline, forpet, mandipropamide, mefentrifluconazole, metalaxyl-M, oxathiapipproline, picarbtrazox, pidiflumetofen, sedaxane, Streptomyces crestomycetics The compound is selected from the group consisting of chrestomyceticus, zoxamide, and compound Z (pheneptamidoquin), and the weight ratio of component (A) to component (B) is 10:1 to 1:10 (or more preferably 5:1 to 1:5).

[0121] In another most preferred composition according to the present invention, component (A) is compound number X.20 [methyl N-[5-[8-acetamide-6-[(4-fluoro-3-methoxyphenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate] or its salt or N-oxide, and component (B) is acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, chlorothalonil, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, florylpicoxamide, fluazinam, fludioxonil, fluopicolide, fluoxapipproline, forpet, mandipropamide, mefentrifluconazole, metalaxyl-M, oxathiapipproline, picarbtrazox, pidiflumetofen, sedaxane, Streptomyces crestomycetics The compound is selected from the group consisting of chrestomyceticus, zoxamide, and compound Z (pheneptamidoquin), and the weight ratio of component (A) to component (B) is 10:1 to 1:10 (or more preferably 5:1 to 1:5).

[0122] In another most preferred composition according to the present invention, component (A) is compound number X.21 [methyl The component (B) is {N}-[5-[6-[(4-fluoro-3-methoxyphenyl)-methyl-carbamoyl]-8-(methoxymethyl)imidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate] or its salt or N-oxide, and component (B) is acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, chlorothalonil, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, florylpicoxamide, fluazinam, fludioxonil, fluopicolide, fluoxapipproline, forpet, mandipropamide, mefentrifluconazole, metalaxyl-M, oxathiapipproline, picarbtrazox, pidiflumetofen, sedaxane, Streptomyces crestomycetics The compound is selected from the group consisting of chrestomyceticus, zoxamide, and compound Z (pheneptamidoquin), and the weight ratio of component (A) to component (B) is 10:1 to 1:10 (or more preferably 5:1 to 1:5).

[0123] In another most preferred composition according to the present invention, component (A) is compound number X.22 [methyl N-[5-[6-[(2-methoxy-4-pyridyl)-methyl-carbamoyl]-8-methyl-imidazo[1,2-a]pyridin-3-yl]-2-pyridyl]carbamate] or its salt or N-oxide, and component (B) is acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, chlorothalonil, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, florylpicoxamide, fluazinam, fludioxonil, fluopicolide, fluoxapipproline, forpet, mandipropamide, mefentrifluconazole, metalaxyl-M, oxathiapipproline, picarbtrazox, pidiflumetofen, sedaxane, Streptomyces crestomycetics The compound is selected from the group consisting of chrestomyceticus, zoxamide, and compound Z (pheneptamidoquin), and the weight ratio of component (A) to component (B) is 10:1 to 1:10 (or more preferably 5:1 to 1:5).

[0124] In another most preferred composition according to the present invention, component (A) is compound number X.23 [methyl N-[5-[6-[(4-cyano-3-methoxyphenyl)-methyl-carbamoyl]-8-methylimidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate] or its salt or N-oxide, and component (B) is acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, chlorothalonil, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, florylpicoxamide, fluazinam, fludioxonil, fluopicolide, fluoxapipproline, forpet, mandipropamide, mefentrifluconazole, metalaxyl-M, oxathiapipproline, picarbtrazox, pidiflumetofen, sedaxane, Streptomyces crestomycetics The compound is selected from the group consisting of chrestomyceticus, zoxamide, and compound Z (pheneptamidoquin), and the weight ratio of component (A) to component (B) is 10:1 to 1:10 (or more preferably 5:1 to 1:5).

[0125] In any of the preferred compositions according to the present invention, the composition differs from component (B) in that it contains acetamiprid, acibenzoral-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, Bacillus amyloliquefaciens, benzovindiflupir, broflanilide, chlorothalonil, clothianidin, chlorantraniliprole, cis-jasmon, cyantraniliprole, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, etaboxam, fenpicoxamide, florylpicoxamide, fluazinam, fludioxonil, fluindapir, fluopicolid, fluopyram, fluoxapiproline, fluoxythioconazole, fluxamethoxamide, fluxapyroxad, and flu Pet, imidacloprid, impulfluxam, ipconazole, ipflufenokine, isocycloseram, isoflucipram, isothianil, mandipropamide, mefentrifluconazole, metalaxyl, metalaxyl-M (mefenoxam), methyltetraprole, oxathiapiproline, penflufen, phosphite (phosphonate), picarbtrazox, prothioconazole, pidflumetofen, pyraclostrobin, quinofumerine, sedaxane, silthiofame, streptomyces crestomycetics Chrestomyceticus), tebuconazole, tetraniliprole, thiabendazole, thiamethoxam, tolprocarb, triticonazole, zoxamide, N-[(1R)-1-benzyl-3-chloro-1-methyl-buta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methyl-buta-3-enyl]-8- Fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoroquinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3- It may contain a further active ingredient (C), which is dimethyl-butyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoroquinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-buta-3-enyl)-8-fluoroquinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methyl-buta-3-enyl)-8-fluoroquinoline-3-carboxamide.

[0126] The compositions according to the present invention may be used in the agricultural sector and related fields of use against living organisms for the control of plant pests or against putrefactive microorganisms or organisms potentially harmful to humans. The compositions may also be used to suppress or eliminate pests that appear on plants or parts of plants (fruits, flowers, leaves, stems, tubers, roots) of different crops of useful plants, while simultaneously protecting those parts of the plant that will grow later from, for example, plant pathogenic microorganisms.

[0127] The composition may also be used as a fungicide. As used herein, the term “fungicide” means a compound that controls, modifies, or prevents the growth of fungi. The term “fungicidal effective amount” means the amount of such compound or combination of such compounds that can produce an effect against the growth of fungi. Controlling or modifying effects include all deviations from natural occurrence, such as bactericidal or delayed growth, while prevention includes the formation of a barrier or other defense in a plant to prevent fungal infection. The composition according to the present invention may contain a fungicidal effective amount of component A and / or component B.

[0128] As used herein, the term “field” means a field in which plants are growing or on which seeds of cultivated plants are sown or in which seeds will be sown in the soil. This includes soil, seeds and seedlings, and established vegetation.

[0129] The term "plant" refers to all physical parts of a plant, including seeds, seedlings, saplings, roots, tubers, stems, stalks, leaves, and fruits.

[0130] For protection from fungal infections and from plant pathogenic fungi occurring in the soil, the compositions according to the present invention can also be used as dressings for treating plant propagation material. The propagation material can be treated with the compositions according to the present invention before planting; for example, seeds can be dressed before sowing. The compositions according to the present invention can also be applied to grain (coated) either by impregnating the seeds in a liquid formulation or by coating the seeds with a solid formulation. The compositions can also be applied to the planting site when the propagation material is planted, for example, in the sowing furrow during sowing. The present invention also relates to such methods for treating plant propagation material and to plant propagation material treated in this manner.

[0131] The term “plant propagation material” is understood to refer to the reproductive parts of plants, such as seeds, and vegetative parts, such as cuttings or tubers, that can be used for propagation, such as potatoes. Examples include plant seeds (in the strict sense), roots, fruits, tubers, bulbs, rhizomes, and parts. Germinated plants and seedlings that are transplanted after germination or after emerging from the soil may also be included. These seedlings may be protected before transplantation by complete or partial treatment by immersion. Preferably, “plant propagation material” is understood to mean seeds.

[0132] The pesticides referred to herein by their common names are known, for example, from "The Pesticide Manual", 19th Ed., British Crop Protection Council 2021.

[0133] Furthermore, the compositions according to the invention can be used, for example, for the protection of industrial materials including wood and wood-related industrial products, food storage, and hygiene management in order to control fungi in related fields.

[0134] Furthermore, the present invention can also be used to protect abiotic materials, such as grinding materials, wall materials, and paints, from fungal attack.

[0135] The compositions of the present invention are effective against harmful microorganisms, particularly phytopathogenic fungi and bacteria, such as microorganisms that cause phytopathogenic diseases.

[0136] The compositions of the present invention can be used to control plant diseases caused by a wide range of fungal plant pathogens of the Basidiomycete, Ascomycete, Oomycete, and / or Deuteromycete, Blastocladiomycete, Chytridiomycete, Glomeromycete, and / or Mucoromycete classifications, preferably Oomycete.

[0137] The compositions of the present invention are effective in controlling a wide spectrum of plant diseases, such as leaf pathogens of ornamental crops, lawns, vegetables, field crops, cereals, and fruit crops.

[0138] These pathogens can include the following: Phytophthora diseases, including those caused by Oomycete, Phytophthora capsici, Phytophthora infestans, Phytophthora sojae, Phytophthora fragariae, Phytophthora nicotianae, Phytophthora cinnamomi, Phytophthora citricola, Phytophthora citrophthora, and Phytophthora erythroseptica; Pythium aphanidermatum Pythium diseases, such as those caused by Pythium aphanidermatum, Pythium arrhenomanes, Pythium graminicola, Pythium irregulare, Pythium sylvaticum, and Pythium ultimum; Peronospora destructor, Peronospora parasitica, Plasmopara viticola, Plasmopara halstedii, Pseudoperonospora cubensis, and Albugo candida. Diseases caused by Peronosporales, such as candida, Sclerophthora macrospora, and Bremia lactucae;And also other species such as Aphanomyces cochlioides, Labyrinthula zosterae, Peronosclerospora sorghi, and Sclerospora graminicola; Ascomycetes, for example lesions, spots, blasts or canker and / or rot, for example, Pleosporales, Stemphylium solani, Stagonospora tainanensis, Spirocaea oleaginea, Setosphaeria turcica, Pyrenochaeta lycoperisici, Pleospora herbarum, Phoma destructiva, Phaeosphaeria herpotrichoides, Phaeocryptocus gayumannii Ophiosphaerella graminicola, Ophiobolus graminis, Leptosphaeria maculans, Hendersonia creberrima, Helminthosporium triticirepentis, Setosphaeria turcica, Drecslera glycines, Didymella glycines, Cycloconium oleagineum, Corynespora cassiicola, Cochliobolus sativus Pyrenophora sativus, Bipolaris cactiora, Venturia inaequalis, Pyrenophora teres, Pyrenophora tritichirepentis*Trici-repentis*, *Alternaria alternata*, *Alternaria brassicicola*, *Alternaria solani*, and *Alternaria tomatophila*, *Capnodiales*, such as *Septoria tritici*, *Septoria nodorum*, *Septoria glycines*, *Cercospora arachidicola*, *Cercospora sojina*, *Cercospora zeae-maydis*, and *Cercosporella capsurae*. (Capsellae) and Cercosorella herpotrichoides, Cladosporium carpophilum, Cladosporium effusum, Passalora fulva, Cladosporium oxysporum, Dothistroma septosporum, Isariopsis clavispora, Mycosphaerella fijiensis, Mycosphaerella graminicola, Mycovelosiella coepkei Pseudocercosporella koepkeii, Phaeoisariopsis bataticola, Pseudocercosporella vitis, Pseudocercosporella herpotrichoidesherpotrichoides), Ramularia beticola, Ramularia colol-cygni, Magnaporthales (e.g., Gaeumannomyces graminis, Magnaporthe grisea, Pyricularia oryzae), Diaporthales (e.g., Anisogramma anomala, Apiognonia errabunda, Cytospora platani, Diaporthe phaseolorum, Discula destructiva Destructiva), Gnomonia fructicola, Greeneria uvicola, Melanconium juglandinum, Phomopsis viticola, Sirococcus clavigignenti-juglandacearum, Tubakia dryina, Dicarpella spp., Valsa ceratosperma, and others such as Actinothyrium graminis, Ascochyta pisi, Aspergillus flavus, Aspergillus fumigatus, Aspergillus nidulans, Asperisporium caricae, Blumerella jaapii, Candida spp., Capnodium ramosum, Cephaloascus spp., Cephalosporium gramineum, Ceratocystis paradoxa, Chaetomium spp., Hymenoscyphus pseudoalbidus, Coccidioides spp.), Cylindrosporium padi, Diplocarpon malae, Drepanopeziza campestris, Elsinoe ampelina, Epicoccum nigrum, Epidermophyton spp., Eutypa lata, Geotrichum candidum, Gibellina cerealis, Gloeocercospora sorghi, Gloeodes pomigena, Gloeosporium perenans permannans; Gloeotinia temulenta, Griphospaeria corticola, Kabatierella lini, Leptographium microsporum, Leptosphaerulinia crasiascacrassiasca), Lophodermium seditiosum, Marssonina graminicola, Microdochium nivale, Monilinia fructicola, Monographella albescens, Monosporascus cannonballus, Naemacyclus spp., Ophiostoma novo-ulmi, Paracoccidioides brasiliensis, Penicillium expansum, Pestalotia rhododendri rhododendri), Petrielidium spp., Pezicula spp., Phialophora gregata, Phyllachora pomigena, Phymatotrichum omnivora, Physalospora abdita, Plectosporium tabacinum, Polyscytalum pustulans, Pseudopeziza medicaginis, Pyrenopeziza brassicae, Ramulispora sorghi), Rhabdocline pseudotsugae, Rhynchosporium secalis, Sacrocladium oryzae, Scedosporium spp., Schizothyrium pomipomi), Sclerotinia sclerotiorum, Sclerotinia minor; Sclerotium spp., Typhula ishikariensis, Seimatosporium mariae, Lepteutypa cupressi, Septocyta ruborum, Sphaceloma perseae, Sporonema phacidioides, Stigmina palmivora, Tapesia yallundae, Taphrina blata Powdery mildew caused by plants such as bullata, Thielviopsis basicola, Trichoseptoria fructigena, and Zygophiala jamaicensis; powdery mildew caused by plants such as Erysiphales, such as Blumeria graminis, Erysiphe polygoni, Uncinula necator, Sphaerotheca fuligena, Podosphaera leucotricha, Podospaera macularis Golovinomyces cichoracearum, and Leveillula taurica. taurica), Microsphaera diffusa, Oidiopsis gossypii, Phyllactinia guttata, and Oidium arachidisCaused by aricidis); fungi, e.g., Botryosphaeriales, e.g., Dothiorella aromatica, Diplodia seriata, Guignardia bidwellii, Botrytis cinerea, Botryotinia allii, Botryotinia fabae, Fusicoccum amygdali, Lasiodiplodia theobromae, Macrophoma theicola, Macrophomina phaseolina, Phyllosticta cucurbitaserum Anthracnose caused by cucurbitacearum; for example, Glommerelales, for example Colletotrichum gloeosporioides, Colletotrichum lagenarium, Colletotrichum gossypii, Glomerella cingulata, and Colletotrichum graminicola; damping-off and canker, for example Hypocreales, for example Acremonium strictum, Claviceps purpurea, Fusarium Fusarium culmorum, Fusarium graminearum, Fusarium virguliforme, Fusarium oxysporumCaused by Fusarium oxysporum, Fusarium subglutinans, Fusarium oxysporum f.sp. cubens, Gerlachia nivale, Gibberella fujikuroi, Gibberella zeae, Gliocladium spp., Myrothecium verrucaria, Nectria ramulariae, Trichoderma viride, Trichothecium roseum, and Verticillium theobromae; Basidiomycetes, including the following: smut fungi such as those caused by the order Ustilaginales, such as Ustilaginoidea virens, Ustilago nuda, Ustilago tritici, and Ustilago zeae; and Puccinia arachidis, Puccinia cacabata, and Puccinia graminis. Puccinia graminis), Puccinia recondita, Puccinia sorghi, Puccinia hordei, Puccinia striiformis f.sp. Hordei, Puccinia striiformis f.sp. cecalisPucciniales, such as Secalis, Pucciniastrum coryli, or Cronartium ribicola, Gymnosporangium juniperi-viginianae, Melampsora medusae, Phakopsora pachyrhizi, Phragmidium mucronatum, Physopella ampelosidis, Tranzschelia discolor, and Uromyces viciae-fabee. Caused by species of the order Uredinales, such as viciae-fabae; as well as species of the genera Cryptococcus, Exobasidium vexans, Marasmiellus inoderma, and Mycena.), Sphacelotheca reiliana, Typhula ishikariensis, Urocystis agropyri, Itersonilia perplexans, Corticium invisum, Laetisaria fuciformis, Waitea circinata, Rhizoctonia solani (rice sheath blight fungus), Thanetephorus cucurmeris (sugar beet root rot fungus), Entyloma dahliae, Entylomella microspora, Neovossia molliniae Basidiomycetes are fungi that cause other rot and disease, such as those caused by *Tilletia moliniae* and *Tilletia caries*. Blastocladiomycetes, for example, Physoderma maydis; Mucoromycete, e.g., Choanephora cucurbitarum; Mucor spp.; Rhizopus arrhizus; Furthermore, diseases caused by other species and genera related to those listed above.

[0139] In addition to its bactericidal activity, the composition of the present invention may also have activity against bacteria such as Erwinia amylovora, Erwinia caratovora, Xanthomonas campestris, Pseudomonas syringae, and Streptomyces scabies, as well as other related species and certain protozoa.

[0140] Within the scope of the present invention, target crops and / or useful plants to be protected are typically berry plants, e.g., blackberries, blueberries, cranberries, raspberries and strawberries; cereals, e.g., barley, corn, millet, oats, rice, rye, sorghum, rye and wheat; fiber plants, e.g., cotton, flax, hemp, jute and sisal; crops, e.g., sugar and fodder beets, coffee, hops, mustard, rapeseed (canola), poppies, sugarcane, sunflowers, tea and tobacco; fruit trees, e.g., apples, apricots, avocados, bananas, cherries, citrus fruits, nectarines, peaches, pears and plums; grasses, e.g., Bermuda grass, bluegrass, bentgrass, centipede grass, fescue, ryegrass, St. Augustine grass and zoysia grass Herbs, such as basil, borage, chives, coriander, lavender, lavender, mint, oregano, parsley, rosemary, sage, and thyme; legumes, such as kidney beans, lentils, peas, and soybeans; nuts, such as almonds, cashews, peanuts, hazelnuts, peanuts, pecans, pistachios, and walnuts; palms, such as oil palms; ornamental plants, such as flowers, shrubs, and trees; other trees, such as cocoa, coconuts, olives, and rubber trees; vegetables, such as asparagus, eggplant, broccoli, cabbage, carrots, cucumbers, garlic, lettuce, mallow, melon, okra, onions, peppers, potatoes, pumpkins, rhubarb, spinach, and tomatoes; and climbing plants, such as grapes and other perennial and annual crops.

[0141] Useful plants and / or target crops according to the present invention include conventional varieties such as insect-resistant (e.g., Bt. and VIP varieties), disease-resistant, herbicide-resistant (e.g., glyphosate- and glufosinate-resistant maize varieties, commercially available under trade names RoundupReady® and LibertyLink®), and nematode-resistant varieties, as well as genetically enhanced or genetically modified varieties. Examples of suitably genetically enhanced or genetically modified varieties include the Stoneville 5599BR cotton and Stoneville 4892BR cotton varieties.

[0142] The terms “useful plants” and / or “target crops” should be understood to also include useful plants that have been given resistance to herbicides such as bromoxynil or certain classifications of herbicides (e.g., HPPD inhibitors, ALS inhibitors such as primisulfuron, prosulfuron and trifloxysulfuron, EPSPS (5-enol-pyrovir-shikimate-3-phosphate-synthase) inhibitors, GS (glutamine synthetase) inhibitors, or PPO (protoporphyrinogen-oxidase) inhibitors) by conventional crossbreeding or genetic engineering methods. An example of a crop that has been given resistance to imidazolinones, such as imazamox, by conventional breeding methods (mutation) is Clearfield® summer rapeseed (canola). Examples of crops in which resistance to herbicides or certain classes of herbicides has been induced through genetic engineering include glyphosate- and glufosinate-resistant maize varieties marketed under trade names RoundupReady®, Herculex I®, and LibertyLink®.

[0143] The terms “useful plants” and / or “target crops” should be understood to include those that are naturally resistant to or conferred resistance to harmful insects. This includes plants transformed by the use of recombinant DNA technology, for example, to be able to synthesize one or more selectively acting toxins, such as those known from toxin-producing bacteria. Examples of toxins that can be expressed include δ-endotoxin, vegetative insecticidal protein (Vip), insecticidal proteins from nematode-symbiotic bacteria, and toxins produced by scorpions, arachnids, wasps, and fungi. An example of a crop modified to express Bacillus thuringiensis toxin is Bt maize KnockOut® (Syngenta Seeds). An example of a crop containing two or more genes encoding insecticide resistance and therefore expressing two or more toxins is VipCot® (Syngenta Seeds). Crops or their seed materials can also be resistant to multiple types of pests (so-called superimposed transgenic events when produced by genetic modification). For example, a plant can have the ability to express insecticidal proteins and be simultaneously resistant to herbicides, such as Herculex I® (registered trademark) (Dow AgroSciences, Pioneer Hi-Bred International).

[0144] The terms “useful plants” and / or “target crops” should be understood to also include useful plants transformed using recombinant DNA technology to enable the synthesis of selectively acting antipathogenic substances, such as so-called “infection-specific proteins” (PRPs, see, e.g., European Patent Application Publication No. 0392225). Examples of such antipathogenic substances and transgenic plants capable of synthesizing such antipathogenic substances are known, for example, from European Patent Application Publication No. 0392225, International Publication No. 95 / 33818 and European Patent Application Publication No. 0353191. Methods for producing such transgenic plants are generally known to those skilled in the art and are described, for example, in the aforementioned publications.

[0145] Toxins that can be expressed by transgenic plants include, for example, insecticidal proteins from Bacillus cereus or Bacillus popilliae; or insecticidal proteins from Bacillus thuringiensis such as δ-endotoxins like Cry1Ab, Cry1Ac, Cry1F, Cry1Fa2, Cry2Ab, Cry3A, Cry3Bb1 or Cry9C; or vegetative insecticidal proteins (Vip) such as Vip1, Vip2, Vip3 or Vip3A; or species of the genus Photorhabdus, such as Photorhabdus luminescens or Xenorhabdus nematophilus, for example Photorhabdus spp. or Xenorhabdus Insecticidal proteins of nematode-symbiotic bacteria (spp.); toxins produced by animals such as scorpion toxin, spider toxin, large wasp (wasp) toxin and other insect-specific neurotoxins; toxins produced by fungi such as Streptomycete toxin, plant lectins such as pea lectin, barley lectin or snowdrop lectin; aglutinin; proteinase inhibitors such as trypsin inhibitors, serine protease inhibitors, patain, cystatin, and papain inhibitors; lysine, Examples include ribosome-inactivating proteins (RIPs) such as corn-RIP, abrin, rufin, saporin, or briodin; steroid metabolic enzymes such as 3-hydroxysteroid xidase, ecdysteroid-UDP-glycosyl-transferase, cholesterol oxidase, ecdysone inhibitors, and HMG-COA-reductase; ion channel blockers such as sodium or calcium blockers; juvenile hormone esterase, diuretic hormone receptor, stilbene synthase, bibenzyl synthase, chitinase, and glucanase.

[0146] Furthermore, it should be understood that in connection with the present invention, there are d-endotoxins, such as Cry1Ab, Cry1Ac, Cry1F, Cry1Fa2, Cry2Ab, Cry3A, Cry3Bb1, or Cry9C, or plant-derived insecticidal proteins (Vip), such as Vip1, Vip2, Vip3, or Vip3A, as well as explicitly hybrid toxins, cleavage toxins, and modified toxins. Hybrid toxins are generated by recombinant synthesis through novel combinations of different domains of these proteins (see, for example, International Publication No. 02 / 15701). Cleavage toxins, such as cleavage Cry1Ab, are known. In the case of modified toxins, one or more amino acids of a naturally occurring toxin are substituted. In such amino acid substitutions, preferably, a protease recognition sequence that does not naturally exist is inserted into the toxin. For example, in the case of Cry3A055, a cathepsin-G recognition sequence is inserted into the Cry3A toxin (see International Publication No. 03 / 018810).

[0147] Further examples of such toxins or transgenic plants capable of synthesizing such toxins are disclosed, for example, in European Patent Publication No. 0374753, International Publication No. 93 / 07278, International Publication No. 95 / 34656, European Patent Publication No. 0427529, European Patent Publication No. 451878, and International Publication No. 03 / 052073.

[0148] The processes for preparing such transgenic plants are generally known to those skilled in the art and are described, for example, in the publications mentioned above. CryI-type deoxyribonucleic acids and their preparations are known, for example, from International Publication No. 95 / 34656, European Patent Application Publication No. 0367474, European Patent Application Publication No. 0401979, and International Publication No. 90 / 13651.

[0149] The toxins contained in transgenic plants confer resistance to harmful insects. Such insects can exist in any of the insect taxa, but are typically found in beetles (Coleoptera), diptera, and butterflies (Lepidoptera).

[0150] Transgenic plants containing one or more genes encoding insecticide resistance and expressing one or more toxins are known, and some are commercially available. Examples of such plants include: YieldGard® (maize variety expressing Cry1Ab toxin); YieldGard Rootworm® (maize variety expressing Cry3Bb1 toxin); YieldGard Plus® (maize variety expressing Cry1Ab and Cry3Bb1 toxins); Starlink® (maize variety expressing Cry9C toxin); Herculex I® (maize variety expressing Cry1Fa2 toxin and phosphinothricin N-acetyltransferase (PAT), an enzyme that provides resistance to glufosinate ammonium herbicide); NuCOTN 33B® (cotton variety expressing Cry1Ac toxin); Bollgard I® (cotton variety expressing Cry1Ac toxin); Bollgard Examples include II (registered trademark) (cotton varieties expressing Cry1Ac and Cry2Ab toxins); VipCot (registered trademark) (cotton varieties expressing Vip3A and Cry1Ab toxins); NewLeaf (registered trademark) (potato varieties expressing Cry3A toxin); NatureGard (registered trademark), Agrisure (registered trademark), GT Advantage (GA21 glyphosate resistance trait), Agrisure (registered trademark) CB Advantage (Bt11 corn borer larva (CB) resistance trait), and Protecta (registered trademark).

[0151] Further examples of such transgenic crops include: 1. Bt11 maize, manufactured by Syngenta Seeds SAS, Chemin de l'Hobit 27, F-31, 790 St. Sauveur, France, registration number C / FR / 96 / 05 / 10. Genetically modified maize (Zea mays) conferred resistance to attacks by the European corn borer (Ostrinia nubilalis and Sesamia nonagrioides) through transgenic expression of the cleavage-type Cry1Ab toxin. Bt11 maize has also acquired resistance to the herbicide glufosinate ammonium by transgenic expression of the enzyme PAT. 2. Bt176 maize, manufactured by Syngenta Seeds SAS, Chemin de l'Hobit 27, F-31 790 St. Sauveur, France, registration number C / FR / 96 / 05 / 10. Genetically modified maize (Zea mays) conferred resistance to attacks by the European corn borer (Ostrinia nubilalis and Sesamia nonagrioides) through transgenic expression of Cry1Ab toxin. Bt176 maize has also acquired resistance to the herbicide glufosinate ammonium through transgenic expression of the enzyme PAT. 3. Syngenta Seeds SAS, Chemin de l'Hobit 27, F-31 790 St. Sauveur, France, MIR604 maize, registration number C / FR / 96 / 05 / 10. Maize conferred insect resistance by transgenic expression of modified Cry3A toxin. This toxin is Cry3A055, modified by insertion of a cathepsin-G-protease recognition sequence. The preparation of such transgenic maize plants is described in International Publication No. 03 / 018810. 4. MON 863 maize, registered number C / DE / 02 / 9, produced by Monsanto Europe S.A., 270 - 272 Avenue de Tervuren, B - 1150 Brussels, Belgium. MON 863 expresses the Cry3Bb1 toxin and has resistance to specific Coleoptera insects. 5. IPC 531 cotton, registered number C / ES / 96 / 02, from Monsanto Europe S.A., 270 - 272 Avenue de Tervuren, B - 1150 Brussels, Belgium. 6. Pioneer Overseas Corporation, Avenue Tedesco, 7 B - 1160 Brussels, Belgium produced maize 1507, registered number C / NL / 00 / 10. Genetically modified maize for the expression of the protein Cry1F to acquire resistance to specific Lepidoptera insects and the expression of the PAT protein to acquire resistance to the herbicide glufosinate ammonium. 7. NK603×MON810 maize, registered number C / GB / 02 / M3 / 03, produced by Monsanto Europe S.A., 270 - 272 Avenue de Tervuren, B - 1150 Brussels, Belgium. This consists of a hybrid maize variety obtained by conventionally breeding the genetically modified varieties NK603 and MON 810. NK603×MON 810 maize recombinantly expresses the protein CP4 EPSPS obtained from Agrobacterium sp. strain CP4, which confers resistance to the herbicide Roundup (registered trademark) (containing glyphosate), and also the Cry1Ab toxin obtained from Bacillus thuringiensis subsp. kurstaki, which provides resistance to specific Lepidoptera, including the European corn borer.

[0152] The compounds of formula (I) used in the present invention can be prepared as shown in the following schemes 1 to 19, and unless otherwise specified, the definitions of each variable are as defined in the present invention.

[0153] The compound of formula (I) is mixed with the compound of formula (II) where X is chloro(Cl), bromo(Br), or iodine(I) in the presence of a base such as Cs2CO3, K2CO3, or NaOtBu, and in the presence of a suitable palladium catalyst such as tetrakistriphenylphosphine palladium, palladium chloride, [1,1-bis(diphenylphosphine)ferrocene]dichloropalladium(II), palladium acetate, or bis(diphenylphosphine)palladium(II) chloride, in a suitable solvent such as dimethylformamide, dioxane, tetrahydrofuran, ethanol, or water, and R 7 Either they are hydrogen, C1-C6 alkyl, or two R 7 This can be prepared by Suzuki cross-coupling a compound of formula (III) that can combine to form a C3-C8 cycloalkyl group. This transformation is shown in Scheme 1. [ka] Scheme 1

[0154] Compounds of formula (II), where X is Cl, Br, or I, can be prepared by reacting a compound of formula (IV), where X is Cl, Br, or I, with a compound of formula (V) and a coupling agent, such as N,N'-dicyclohexylcarbodiimide, bis(2-oxo-3-oxazolidinyl)phosphinate chloride, 2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate, 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride, propylphosphonic anhydride, or cyanuryl chloride, and optionally a base such as triethylamine, ethyldiisopropylamine, or N-methylmorpholine, in a suitable solvent such as ethyl acetate, dimethylformamide, tetrahydrofuran, or dichloromethane. This conversion is shown in Scheme 2. [ka] Scheme 2

[0155] Compounds of formula (IV) where X is Cl, Br, or I are commercially available, or where X is Cl, Br, or I, and R 8 Compound (VI) of formula (VI), in which C1-C6 alkyl is present, can be prepared by saponifying it in a suitable solvent such as methanol, ethanol, or water with a base such as NaOH or LiOH at a retention time (RT) to reflux temperature. This transformation is shown in Scheme 3. [ka] Scheme 3

[0156] Instead, the compound of formula (II) where X is Cl, Br or I, in a suitable solvent such as tetrahydrofuran or toluene, in the presence of (CH3)3Al or bis(trimethylaluminum)-1,4-diazabicyclo[2.2.2]octane adduct, where X is Cl, Br or I, and R 8 These compounds can be directly prepared by reacting a compound of formula (VI), in which the parent molecule is C1-C6 alkyl, with a compound of formula (V). These conversions are described in the literature (see, for example, Weinreb, S. et al. Tetrahedron Lett. 1977, 48, 4171; Woodward, S. et al. Tetrahedron Letters 2006, 47, 5767; Woodward S. et al. in Org. Process Res. Dev. 2015, 19, 831). This conversion is shown in Scheme 4. [ka] Scheme 4

[0157] X is Cl, Br, or I, and R 8 Compounds of formula (VI) in which are C1-C6 alkyl are commercially available, or can be prepared in a suitable solvent such as dichloromethane, chloroform, tetrahydrofuran, or acetonitrile. 8It can be prepared by reacting a compound of formula (VII) in which is C1-C6 alkyl with a halogenating agent such as N-chlorosuccinimide, N-bromosuccinimide, N-iodosuccinimide, or bromine. This transformation is shown in Scheme 5. [ka] Scheme 5

[0158] R 8 Compounds of formula (VII) in which X is a C1-C6 alkyl group are commercially available, or alternatively, in the presence of a catalyst such as bis(diphenylphosphino)ferrocene]dichloropalladium(II) and optionally a base such as triethylamine, compounds of formula (VIII) in which X is Cl, Br or I, and carbon monoxide and R 8 Alcohol R is a C1-C6 alkyl group. 8 It can be prepared by reaction with OH. This transformation is shown in Scheme 6. [ka] Scheme 6

[0159] The compound of formula (VIII) is commercially available, or in a solvent such as water, ethanol, acetone, or acetonitrile, it is mixed with the compound of formula (IX) where X is Cl, Br, or I, and the compound of formula (X) where X is Cl, Br, or I, or where X is Cl, Br, or I, and R 9 Either they are C1-C6 alkyl groups independently of each other, or two R 9 It can be prepared by reacting the corresponding acetal of formula (XI), which together can form a C3-C8 cycloalkyl group. The reaction outcome can be improved by using a base such as sodium bicarbonate or potassium carbonate, or by using an acid such as p-toluenesulfonic acid or hydrogen bromide. Furthermore, this conversion is R 8 From the compound of formula (XII) in which is C1-C6 alkyl, R 8This can be used to prepare compounds of formula (VII) where is a C1-C6 alkyl group, and to prepare compounds of formula (XIII) from compounds of formula (XIV). These transformations are shown in Scheme 7. [ka] Scheme 7

[0160] Compounds of formula (IX) where X is Cl, Br, or I, R 8 Compounds of formula (XII) and (XIV), where the group is C1-C6 alkyl, are prepared by known methods or are commercially available.

[0161] Alternatively, the compound of formula (I) can be prepared by reacting the compound of formula (XV) with the compound of formula (V) and a coupling agent, such as N,N'-dicyclohexylcarbodiimide, bis(2-oxo-3-oxazolidinyl)phosphinate chloride, 2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate, 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride, propylphosphonic anhydride, or cyanuryl chloride, and optionally a base such as triethylamine, ethyldiisopropylamine, or N-methylmorpholine, in a suitable solvent such as ethyl acetate, dimethylformamide, tetrahydrofuran, or dichloromethane. This conversion is shown in Scheme 8. [ka] Scheme 8

[0162] The compound of formula (XV) is R 8 Compounds of formula (XVI), in which the parent molecule is C1-C6 alkyl, can be prepared by saponifying them in a suitable solvent such as methanol, ethanol, or water at room temperature to reflux using a base such as NaOH or LiOH. This transformation is shown in Scheme 9. [ka] Scheme 9

[0163] R 8 Compounds of formula (XVI) in which are C1-C6 alkyl are prepared in the presence of a base such as Cs2CO3, K2CO3 or NaOtBu and in the presence of a suitable palladium catalyst such as tetrakistriphenylphosphine palladium, palladium chloride, [1,1-bis(diphenylphosphine)ferrocene]dichloropalladium(II), palladium acetate or bis(diphenylphosphine)palladium(II) chloride, in a suitable solvent such as dimethylformamide, dioxane, tetrahydrofuran, ethanol or water, where X is Cl, Br or I, and R 8 A compound of formula (VI) in which is C1-C6 alkyl, and R 7 Either they are hydrogen, C1-C6 alkyl, or two R 7 This can be prepared by Suzuki cross-coupling a compound of formula (III) with a compound of formula (III) that can combine to form a C3-C8 cycloalkyl group. Furthermore, this conversion can be used to prepare a compound of formula (XV) from a compound of formula (IV). These conversions are shown in Scheme 10. [ka] Scheme 10

[0164] Alternatively, the compound of formula (II), where X is Cl, Br, or I, can be prepared by reacting the compound of formula (XVII) with a halogenating agent such as N-chlorosuccinimide, N-bromosuccinimide, N-iodosuccinimide, or bromine in a suitable solvent such as dichloromethane, chloroform, tetrahydrofuran, or acetonitrile. This conversion is shown in Scheme 11. [ka] Scheme 11

[0165] The compound of formula (XVII) can be prepared by reacting the compound of formula (XIII) with the compound of formula (V) and a coupling agent, such as N,N'-dicyclohexylcarbodiimide, bis(2-oxo-3-oxazolidinyl)phosphinate chloride, 2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate, 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride, propylphosphonic anhydride, or cyanuryl chloride, and optionally a base such as triethylamine, ethyldiisopropylamine, or N-methylmorpholine, in a suitable solvent such as ethyl acetate, dimethylformamide, tetrahydrofuran, or dichloromethane. This conversion is shown in Scheme 12. [ka] Scheme 12

[0166] Alternatively, the compound of formula (XVII) can be synthesized by reacting the compound of formula (VIII), where X is Cl, Br, or I, with the amine of formula (V) and carbon monoxide in the presence of a catalyst such as [1,1-bis(diphenylphosphino)ferrocene]dichloropalladium(II) and optionally a base such as triethylamine or sodium carbonate. This transformation is described in Scheme 13. [ka] Scheme 13

[0167] Alternatively, the compound of formula (II) can be prepared by reacting the compound of formula (XVIII) with the compound of formula (XIX) (wherein Y is Cl, Br, I, OSO2CF3, OSO2C6H4CH3, or OSO2CH3) in the presence of a base such as Cs2CO3, K2CO3, or NaOtBu. This transformation is shown in Scheme 14. [ka] Scheme 14

[0168] Compounds of formula (XVIII), where X is Cl, Br, or I, can be prepared by reacting a compound of formula (IV), where X is Cl, Br, or I, with a compound of formula (XX) and a coupling agent, such as N,N'-dicyclohexylcarbodiimide, bis(2-oxo-3-oxazolidinyl)phosphinate chloride, 2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate, 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride, propylphosphonic anhydride, or cyanuryl chloride, and optionally a base such as triethylamine, ethyldiisopropylamine, or N-methylmorpholine, in a suitable solvent such as ethyl acetate, dimethylformamide, tetrahydrofuran, or dichloromethane. This conversion is shown in Scheme 15. [ka] Scheme 15

[0169] Alternatively, the compound of formula (I) can be synthesized by reacting the compound of formula (XXI), where X is Cl, Br, or I, with the amine of formula (V) and carbon monoxide in the presence of a catalyst such as [1,1-bis(diphenylphosphino)ferrocene]dichloropalladium(II) and optionally a base such as triethylamine or sodium carbonate. This transformation is described in Scheme 16. [ka] Scheme 16

[0170] Compounds of formula (XXI) where X is Cl, Br, or I are obtained from compounds of formula (XXII) where any of X is independently Cl, Br, or I, in a suitable solvent such as dimethylformamide, dioxane, tetrahydrofuran, ethanol, or water, in the presence of a base, such as Cs2CO3, K2CO3, or NaOtBu, and a suitable palladium catalyst, such as tetrakistriphenylphosphine palladium, [1,1-bis(diphenylphosphine)ferrocene]dichloropalladium(II), bis(diphenylphosphine)palladium(II) chloride, palladium dichloride, or palladium acetate, from R 7 Hydrogen and C are independent of each other. 1-6 Alkyl or two R 7 together become C 3-8 These compounds can be prepared by Suzuki cross-coupling with compounds of formula (III) that can form cycloalkyl groups. Compounds of formula (XXII), where any of X is independently Cl, Br, or I, can be prepared by halogenation of compounds of formula (VII), where X is Cl, Br, or I, using halogenating reagents such as N-chlorosuccinimide, N-bromosuccinimide, N-iodosuccinimide, or bromine in a suitable solvent such as dichloromethane, chloroform, tetrahydrofuran, or acetonitrile. These transformations are shown in Scheme 17. [ka] Scheme 17

[0171] Alternatively, the compound of formula (I) can be prepared by reacting the compound of formula (XXIII) with the compound of formula (XXIV) where Y is OH, and a coupling agent, such as N,N'-dicyclohexylcarbodiimide, bis(2-oxo-3-oxazolidinyl)phosphinate chloride, 2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate, 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride, propylphosphonic anhydride, or cyanuryl chloride, and optionally a base such as triethylamine, ethyldiisopropylamine, or N-methylmorpholine, in a suitable solvent such as ethyl acetate, dimethylformamide, tetrahydrofuran, or dichloromethane. This conversion can also be carried out by reacting the compound of formula (XXIII) with the compound of formula (XXIV) where Y is Cl, and optionally with a base such as triethylamine, ethyldiisopropylamine, or pyridine, in a suitable solvent such as ethyl acetate, pyridine, or tetrahydrofuran. This conversion is shown in Scheme 18. [ka] Scheme 18

[0172] The compound of formula (XXIII) is mixed with the compound of formula (II) where X is Cl, Br, or I in the presence of a base such as Cs2CO3, K2CO3, or NaOtBu, and in the presence of a suitable palladium catalyst such as tetrakistriphenylphosphine palladium, palladium chloride, [1,1-bis(diphenylphosphine)ferrocene]dichloropalladium(II), palladium acetate, or bis(diphenylphosphine)palladium(II) chloride, in a suitable solvent such as dimethylformamide, dioxane, tetrahydrofuran, ethanol, or water, and R 7 Either they are hydrogen, C1-C6 alkyl, or two R 7 This can be prepared by Suzuki cross-coupling with a compound of formula (XXV) that can combine to form a C3-C8 cycloalkyl group. This transformation is shown in scheme 19. [ka] Scheme 19

[0173] Compounds of formula (V) and (XX) are prepared by known methods or are commercially available.

[0174] R 7 Either they are hydrogen, C1-C6 alkyl, or two R 7 Compounds of formula (III) that can combine to form a C3-C8 cycloalkyl group are prepared by known methods or are commercially available.

[0175] Those skilled in the art will understand that the above amide coupling reactions between an acid, an amine, and a coupling agent can also be carried out using the corresponding acid chlorides and amines. The conversion of an acid to its corresponding acid chloride is well known to those skilled in the art.

[0176] Alternatively, the compounds of formula (I) according to the present invention can be obtained by transformations using standard synthetic techniques known to those skilled in the art. Non-exclusive examples include oxidation reactions, reduction reactions, hydrolysis reactions, coupling reactions, aromatic nucleophilic or electrophilic substitution reactions, nucleophilic substitution reactions, nucleophilic addition reactions, olefination reactions, oxime formation, alkylation, and halogenation reactions.

[0177] Depending on the appropriate reaction conditions and selection of starting materials for each case, for example, only one substituent may be substituted with another substituent according to the present invention in a single reaction step, or multiple substituents may be substituted with other substituents according to the present invention in the same reaction step.

[0178] The present invention also provides intermediates useful for the preparation of compounds of formula (I) according to the present invention.

[0179] The following intermediates form further embodiments of the present invention. Formula (XXI) [ka] (wherein A is CH or N; R 2a , R 2b and R 2c H, hydroxy, halogen, CN, C 1-6 Alkyl, C 3-6 Cycloalkyl, C 1-6 Alkoxy-C 1-6 Alkyl, C 3-6 Cycloalkyl-C 1-4 Alkyl, C 1-6 Alkyl sulfanyl, C 1-6 Alkyl sulfinyl, C 1-6 Alkyl sulfonyl, C 1-6 Alkoxy, amino, and NHC(O)C 1-6 Selected independently of alkyl; preferably, R 2a , R 2b and R 2c These are independently H, halogen, CN, and C 1-4 Alkyl and C 1-4 Selected from alkoxy; more preferably, R 2a H, C 1-6 Alkyl, C 3-6 Cycloalkyl and C 1-6 Alkoxy-C 1-6 Selected from alkyl, R 2b H, CN, C 1-6 Alkyl, C 3-6 Cycloalkyl, C 1-6 Alkoxy-C 1-6 Alkyl, amino, and -NHC(O)C 1-6 Selected from alkyl, R 2c is H; R 6 C 1-6 Alkyl, C 1-6 Alkoxy, C 3-6 Cycloalkyl, C 3-6 Cycloalkyl-C 1-6 Alkyl, C 1-6 Alkoxy C 1-6 Alkyl, C 1-6 Alkylamino, diC 1-6 Alkylamino, C 1-6 Alkoxyaminos and C1-6 Alkyl C 1-6 Selected from alkoxyaminos, where each of the groups may be optionally substituted with 1 to 3 substituents independently selected from halogens and CN; preferably, R 6 C 1-4 Alkyl, C 1-4 Alkoxy, C 3-6 Cycloalkyl and C 3-6 Cycloalkyl-C 1-3 Selected from alkyl groups, each of the groups may be optionally substituted with 1 to 3 substituents independently selected from halogens; preferably, R 6 C 1-6 Alkyl, C 1-6 Alkoxy, C 3-6 Cycloalkyl, C 1-6 Alkylamino, C 1-6 Alkoxyaminos and C 1-6 Alkyl C 1-6 Selected from alkoxyaminos; and X is chloro(Cl), bromo(Br), or iodine(I). Compounds of the same; or salts or N-oxides thereof.

[0180] The compositions according to the present invention may be used in an unmodified form, or preferably in combination with adjuvants conventionally used in the pharmaceutical field. For this purpose, they may be appropriately incorporated in known forms into emulsifiable concentrates, coating pastes, ready-to-spray or dilutable solutions or suspensions, diluted emulsions, wettable powders, soluble powders, granules, as well as encapsulations in polymeric substances. As with the type of composition, the application method, such as spraying, misting, powdering, granulation, coating, or pouring, is selected according to the intended purpose and the circumstances at hand. The compositions may also contain further adjuvants such as stabilizers, defoamers, viscosity modifiers, binders, or tackifiers, as well as fertilizers, micronutrient donors, or other formulations for obtaining special effects.

[0181] Suitable carriers and / or auxiliary materials, for example, carriers and auxiliary materials for agricultural use, may be solids or liquids and are substances useful in compounding techniques, such as natural or recycled inorganic substances, solvents, dispersants, wetting agents, tackifiers, thickeners, binders, or fertilizers. Such carriers are described, for example, in International Publication No. 97 / 33890.

[0182] A suspension concentrate is an aqueous formulation in which finely ground solid particles of an active compound are suspended. Such formulations contain anti-settling agents and dispersants, and may further contain wetting agents, defoaming agents, and crystal growth inhibitors to enhance activity. When used, these concentrates are diluted with water and typically applied as a spray to the area to be treated. The amount of the active ingredient may range from 0.5% to 95% of the concentrate.

[0183] Wettable powders are in the form of finely ground particles that disperse easily in water or other liquid carriers. The particles contain the active ingredient held within a solid matrix. Typical solid matrices include Fuller's earth, kaolin clay, silica, and other easily humicable organic or inorganic solids. Wettable powders typically contain 5% to 95% of the active ingredient and small amounts of wetting agents, dispersants, or emulsifiers.

[0184] Emulsifying concentrates are homogeneous liquid compositions that are dispersible in water or other liquids and may consist entirely of the active compound together with a liquid or solid emulsifier, or may also contain a liquid carrier such as xylene, heavy aromatic naphtha, isophorone, and other non-volatile organic solvents. When in use, these concentrates are dispersed in water or other liquids and typically applied as a spray to the area to be treated. The amount of the active ingredient may range from 0.5% to 95% of the concentrate.

[0185] Granular formulations include both extruded materials and relatively coarse particles and are typically applied undiluted to the area requiring treatment. Typical carriers for granular formulations include sand, fuller's soil, attapulgite clay, bentonite clay, montmorillonite clay, vermiculite, perlite, calcium carbonate, brick, pumice, pyrophyllite, kaolin, dolomite, plaster, wood flour, crushed corn cob, crushed peanut shells, sugar, sodium chloride, sodium sulfate, sodium silicate, sodium borate, magnesia, mica, iron oxide, zinc oxide, titanium oxide, antimony oxide, cryolite, gypsum, diatomaceous earth, calcium sulfate, and other organic or inorganic materials that can absorb or coat active compounds. Granular formulations typically contain 5% to 25% active ingredients, which may include surfactants such as heavy aromatic naphtha, kerosene and other petroleum fractions, or vegetable oils; and / or stickers such as dextrin, glue or synthetic resins.

[0186] Powder for dispersal is a free-flowing mixture of an active ingredient and finely ground solids such as talc, clay, powder, and other organic and inorganic solids that act as a dispersant and carrier.

[0187] Microcapsules are typically droplets or granules of an active ingredient encapsulated in an inert, porous shell that allows the enclosed material to be released into the surroundings at a controlled rate. The diameter of the encapsulated droplets is typically 1 to 50 microns. The encapsulated liquid typically constitutes 50 to 95% of the capsule's mass and may include a solvent in addition to the active compound. The encapsulated granules are generally porous granules having a porous membrane that seals the pore openings of the granules, retaining the active species in liquid form within the granular pores. The diameter of the granules is typically in the range of 1 millimeter to 1 centimeter, preferably in the range of 1 to 2 millimeters. The granules are formed by extrusion, agglomeration, or prilling, or they may be naturally occurring. Examples of such materials include vermiculite, sintered clay, kaolin, attapulgite clay, sawdust, and granular carbon. Shell or membrane materials include natural and synthetic rubber, cellulosic materials, styrene-butadiene copolymers, polyacrylonitrile, polyacrylates, polyesters, polyamides, polyureas, polyurethanes, and starch xanthetes.

[0188] Other useful formulations for agricultural applications include simple solutions of components A and B in a solvent that completely dissolves them at the desired concentration, such as acetone, alkylated naphthalene, xylene, and other organic solvents. Pressurized sprayers may also be used, in which the active ingredients are dispersed in a finely pulverized form as a result of evaporation of a low-boiling point dispersible solvent carrier.

[0189] Suitable agricultural additives and / or carriers useful for formulating the above-described composition of the present invention are well known to those skilled in the art.

[0190] Examples of liquid carriers that can be used include water, toluene, xylene, petroleum naphtha, crop oil, acetone, methyl ethyl ketone, cyclohexanone, acetic anhydride, acetonitrile, acetophenone, amyl acetate, 2-butanone, chlorobenzene, cyclohexane, cyclohexanol, alkyl acetate, diacetone alcohol, 1,2-dichloropropane, diethanolamine, p-diethylbenzene, diethylene glycol, diethylene glycol abietate, diethylene glycol butyl ether, diethylene glycol ethyl ether, diethylene glycol methyl ether, N,N-dimethylformamide, dimethyl sulfoxide, 1,4-dioxane, dipropylene glycol, dipropylene glycol methyl ether, dipropylene glycol dibenzoate, diproxitol, alkylpyrrolidinone, ethyl acetate, 2-ethylhexanol, ethylene carbonate, 1,1,1-Trichloroethane, 2-Heptanone, α-Pinene, d-Limonene, Ethylene Glycol, Ethylene Glycol Butyl Ether, Ethylene Glycol Methyl Ether, γ-Butyrolactone, Glycerol, Glycerol Diacetate, Glycerol Monoacetate, Glycerol Triacetate, Hexadecane, Hexylene Glycol, Isoamyl Acetate, Isobornyl Acetate, Isooctane, Isophorone, Isopropylbenzene, Isopropyl Myristate, Lactic Acid, Laurylamine, Mesityl Oxide, Methoxypropanol, Methyl Isoamyl Ketone, Methyl Isobutyl Ketone, Methyl Laurate, Methyl Octanoate, Methyl Oleate, Methylene Chloride, m-Xylene, n-Hexane, n-Octylamine, Octadecane Examples include acids, octylamine acetate, oleic acid, oleylamine, o-xylene, phenol, polyethylene glycol (PEG400), propionic acid, propylene glycol, propylene glycol monomethyl ether, p-xylene, toluene, triethyl phosphate, triethylene glycol, xylene sulfonic acid, paraffin, mineral oil, trichloroethylene, perchloroethylene, ethyl acetate, amyl acetate, butyl acetate, methanol, ethanol, isopropanol and amyl alcohol, tetrahydrofurfuryl alcohol, hexanol, octanol and other high molecular weight alcohols, ethylene glycol, propylene glycol, glycerin and N-methyl-2-pyrrolidinone. Generally, water is used as a carrier for diluting the concentrate.

[0191] Suitable solid carriers include, for example, talc, titanium dioxide, pyrophyllite clay, silica, attapulgite clay, kieselgool, chalk, diatomaceous earth, lime, calcium carbonate, bentonite clay, fuller's earth, cottonseed husks, wheat flour, soybean flour, pumice, wood flour, walnut husk powder, and lignin.

[0192] A wide range of surfactants are advantageously used in both the liquid and solid compositions, particularly those designed to be diluted with a carrier before application. When these agents are used, they typically constitute 0.1% to 15% by mass of the formulation. They may be anionic, cationic, nonionic, or polymeric in nature and may be used as emulsifiers, wetting agents, suspending agents, or for other purposes. Typical surfactants include alkyl sulfates such as diethanolammonium lauryl sulfate; alkylaryl sulfonates, such as calcium dodecylbenzenesulfonate; alkylphenol-alkylene oxide addition products, such as nonylphenol-C.sub.18 ethoxylate; alcohol-alkylene oxide addition products such as tridecyl alcohol-C.sub.16 ethoxylate; soaps such as sodium stearate; dialkyl esters of alkylnaphthalene sulfonate salts such as sodium dibutylnaphthalene sulfonate and sulfosuccinate salts such as sodium di(2-ethylhexyl)sulfosuccinate; sorbitol esters such as sorbitol oleate; quaternary amines such as lauryltrimethylammonium chloride; polyethylene glycol esters of fatty acids such as polyethylene glycol stearate; block copolymers of ethylene oxide and propylene oxide; and salts of mono and dialkyl phosphate esters.

[0193] Other additives commonly used in agricultural compositions include crystallization inhibitors, viscosity modifiers, suspending agents, spray droplet regulators, pigments, antioxidants, foaming agents, defoaming agents, light-shielding agents, compatibilizers, defoaming agents, metal ion chelating agents, neutralizing agents and buffering agents, corrosion inhibitors, dyes, odorants, spreading agents, penetration aids, micronutrients, mitigating agents, lubricants and fixing agents.

[0194] Compositions of the present invention, including all embodiments disclosed above and their preferred examples, can also be mixed with one or more additional pesticides, such as further fungicides, insecticides, anthelmintics, fungicides, mite control agents, plant growth regulators, sterilizers, information chemicals, insecticides, attractants, pheromones, feeding stimulants, or other bioactive compounds, to form multi-component pesticides that provide an even broader spectrum of agricultural protection.

[0195] Examples of additional active ingredients, component (C), are as follows, where the term "TX" represents a compound according to the definition of component (A) of the present invention, selected from compound numbers X.01, X.02, X.03, X.04, X.05, X.06, X.07, X.08, X.09, X.10, X.11, X.12, X.13, X.14, X.15, X.16, X.17, X.18, X.19, X.20, X.21, X.22, or X.23 as defined in Table X above or Table T1 below: (7E,9Z)-Dodeca-7,9-diene-1-ylacetate+TX, (9Z,11E)-Tetradeca-9,11-diene-1-ylacetate+TX, (9Z,12E)-Tetradeca-9,12-diene-1-ylacetate+TX, (E)-6-methylhepta-2-en-4-ol+TX, (E)-Deca-5-en-1-ylacetate and (E)-Deca-5-en-1-ol+TX, (E)-Trideca-4-en-1-ylacetate+TX, (E,Z)-Tetradeca-4,10-diene-1-ylacetate+TX Luacetate + TX, (Z)-Dodeca-7-en-1-Illacetate + TX, (Z)-Hexadeca-11-en-1-Illacetate + TX, (Z)-Hexadeca-11-enal + TX, (Z)-Hexadeca-13-en-11-in-1-Illacetate + TX, (Z)-Icosa-13-en-10-on + TX, (Z)-Tetradeca-7-en-1-al + TX, (Z)-Tetradeca-9-en-1-all + TX, (Z)-Tetradeca-9-en-1-Illacetate + TX, 1,2-Dibromo-3 -Chloropropane + TX, 1,2-Dichloropropane + TX, 1,2-Dichloropropane and 1,3-Dichloropropene + TX, 1,3-Dichloropropene + TX, 14-Methyloctadeca-1-ene + TX, 1-H-Pyridine-2-Thione + TX, 2-(Octylthio)ethanol + TX, 2-Chlorophenyl N-methylcarbamate (CPMC) + TX, 3-(4-Chlorophenyl)-5-Methylrhodanine) + TX, 3,4-Dichlorotetrahydrothiophene 1,1-Dioxide + TX, 4-(Quinoxaline-2-ylamino)benzenesulfonamide + TX, 4-methylnonan-5-ol and 4-methylnonan-5-one + TX, 5-methyl-6-thioxo-1,3,5-thiadiadinane-3-ylacetic acid + TX, 6-isopentenylaminopurine + TX, 8-hydroxyquinoline sulfate + TX, abamectin + TX, acequinosyl + TX, acetamiprid + TX, acetoprol + TX, acrinatrin + TX, acylnonapyl + TX, Adoxophyes orana GV + TX, afidopiropen + TX, afoxolaner + TX, Agrobacterium radiobacter + TX,AKD-3088+TX, Aranicarb+TX, Aldicarb+TX, Aldoxicarb+TX, Arethrin+TX, Alpha-Cypermethrin+TX, Alphamethrin+TX, Alpha-Multistriatin+TX, Amblyseius spp.+TX, Amidoflumet+TX, Amino Acids+TX, Aminocarb+TX, Anagrapha falcifera NPV+TX, Anagrus atomus+TX, Aphelinus abdominalis+TX, Aphidius colemani+TX, Aphidoletes aphidimiza+TX, Apholate+TX, Autographa californica NPV+TX, AZ 60541+TX, Azadirachtin+TX, Azocyclotin+TX, Bacillus aizawai+TX, Bacillus chitinosporus AQ746 (NRRL accession number B-21 618)+TX, Bacillus firmus+TX, Bacillus kurstaki+TX, Bacillus mycoides AQ726 (NRRL accession number B-21664)+TX, Bacillus pumilus (NRRL accession number B-30087)+TX, Bacillus pumilus AQ717 (NRRL accession number B-21662)+TX, Bacillus genus sp.)AQ175 (ATCC accession number 55608)+TX, Bacillus sp. AQ177 (ATCC accession number 55609)+TX, Bacillus sp. AQ178 (ATCC accession number 53522)+TX, Bacillus sphaericus Neide+TX,Bacillus subtilis AQ153 (ATCC accession number 55614) + TX, Bacillus subtilis AQ30002 (NRRL accession number B-50421) + TX, Bacillus subtilis AQ30004 (NRRL accession number B-50455) + TX, Bacillus subtilis AQ713 (NRRL accession number B-21661) + TX, Bacillus subtilis AQ743 (NRRL accession number B-21665) + TX, Bacillus subtilis (unspecified) + TX, Bacillus thuringiensis (Bacillus Bacillus thuringiensis)AQ52 (NRRL accession number B-21619) + TX, Bacillus thuringiensis BD#32 (NRRL accession number B-21530) + TX, Bacillus thuringiensis Berliner + TX, Bacillus thuringiensis subspecies Aizawai + TX, Bacillus thuringiensis subspecies Israelensis + TX, Bacillus thuringiensis subspecies Japonensis + TX, Bacillus thuringiensis subspecies Kurstaki + TX, Bacillus thuringiensis Bacillus thuringiensis subspecies Tenebrionis + TX, Bacillus thuringiensis subspecies kurstaki BMP 123 + TX, Beauveria bassiana + TX, Beauveria brongniartii + TX, Bencrothias + TX,Benomyl+TX, Bensultap+TX, Benzoximate+TX, Benzopyrimoxane+TX, Betasilfluthrin+TX, Beta-cypermethrin+TX, Betoxazine+TX, Bifenazate+TX, Bifenthrin+TX, Binapacril+TX, Biorethrin+TX, Biorethmetrin+TX, Bis(tributyltin)oxide+TX, Bisadil+TX, Bistriflurone+TX, Bisulfurfen+TX, Brevicomin+TX, Broflanilide+TX, Broflutrinate+TX, Bromoacetamide+TX, Bromophos-ethyl+TX , Bronopol+TX, Busulfan+TX, Butocarboxim+TX, Butopyronoxyl+TX, Butoxy(polypropylene glycol)+TX, Butylpyridaben+TX, Kazsaphos+TX, Calcium arsenate+TX, Carbaryl+TX, Carbofuran+TX, Carbon disulfide+TX, Carbosulfan+TX, Cartap+TX, CAS No.: 1594624-87-9+TX, CAS No.: 1922957-47-8+TX, CAS No.: 1255091-74-7+TX, CAS No.: 1365070-72-9+TX, CAS No.: 14456 83-71-5+TX, CAS number: 1445684-82-1+TX, CAS number: 1594626-19-3+TX, CAS number: 1594637-65-6+TX, CAS number: 1632218-00-8+TX, CAS number: 1808115-49-2+TX, CA S number: 1922957-46-7+TX, CAS number: 1922957-48-9+TX, CAS number: 1956329-03-5+TX, CAS number: 1990457-52-7+TX, CAS number: 1990457-55-0+TX, CAS number: 1990457-57 -2+TX, CAS number: 1990457-66-3+TX, CAS number: 1990457-77-6+TX, CAS number: 1990457-85-6+TX, CAS number: 2032403-97-5+TX, CAS number: 2044701-44-0+TX, CAS number: 20 95470-94-1+TX, CAS number:2128706-04-5+TX, CAS number:2128706-05-6+TX, CAS number:2133042-31-4+TX, CAS number:2133042-44-9+TX, CAS number:2171099-09-3+TX,CAS number: 2220132-55-6+TX, CAS number: 2396747-83-2+TX, CAS number: 2408220-91-5+TX, CAS number: 2408220-94-8+TX, CAS number: 2415706-16-8+TX, Piperfuranilide (CAS number: 2615135-05-0)+TX, CAS number: 2719848-60-7+TX, CAS number: RNA (Leptinotarsa ​​decemlineata-specific recombinant double-strand interference GS2)+TX, Chlorantraniliprole+TX, Chlordan + TX, Chlorfenapir + TX, Chloropicrin + TX, Chloroprallethrin + TX, Chlorpyrifos + TX, Chromafenozide + TX, Chrysoperla carnea + TX, Clempyrin + TX, Chloetocarb + TX, Clothianidin + TX, Chodrelua + TX, Chodremon + TX, Copper acetoarsenite + TX, Copper dioctanoate + TX, Copper hydroxide + TX, Copper sulfate + TX, Cresol + TX, Culfomate + TX, Cryptolaemus montrouzieri + TX, Cuelua + TX, Cyanophenphos + TX, Cyantraniprol + TX, Sibutrin + TX, Cyclaniliprol + TX, Cyclobtriflurum + TX, Cycloprotrin + TX, Cycloxapride + TX, Cydia pomonera Pomonella GV+TX, cyenopyrafen+TX, citepyrafen+TX, cyflumetofen+TX, cyfluthrin+TX, cyhalodimide+TX, cyclohalothrin+TX, cypermethrin+TX, cyphenothrin+TX, cyprofuranilide+TX, cyromazine+TX, cytokinin+TX, Dacnusa sibirica Diglyphus sibirica + TX, Dazomet + TX, DBCP + TX, DCIP + TX, Deltamethrin + TX, Diafenthiuron + TX, Dialiphos + TX, Diamidaphos + TX, Dibrom + TX, Dibutyl adipate + TX, Dibutyl phthalate + TX, Dibutyl succinate + TX, Diclofenthion + TX, Diclofenthion + TX, Dichlorophene + TX, Dicliphos + TX, Dichloromesothiaz + TX, Diethyltoluamide + TX, Diflubenzuron + TX, Diglyphus isaea isaea)+TX, dimatif+TX, dimethoate+TX, dimethylcalvert+TX, dimethyl phthalate+TX, dipropylidaz+TX, dinactin+TX, dinocap+TX, dinotefuran+TX, dioxabenzophos+TX, dipirithione+TX, disparle+TX, D-limonene+TX, dodeca-8-en-1-ylacetate+TX, dodeca-9-en-1-ylacetate+TX, dodeca-8,10-dien-1-ylacetate+TX, dodicine+TX, dominicalua+TX, doramectin+TX, emamectin+TX,Emamectin benzoate + TX, empenthrin + TX, Encarsia formosa + TX, Endal + TX, Endrin + TX, eprinomectin + TX, epsilon-momufluorothrin + TX, epsilon-metofluthrin + TX, Eretmocerus eremicus + TX, efenvalerate + TX, ethione + TX, ethiprole + TX, etoprophos + TX, ethyl 4-methyloctanoate + TX, ethylhexanediol + TX, ethylenedibromide + TX, etofenprox + TX, etoxazole + TX, etopyrafen + TX, eugenol + TX, seaweed extract and fermentation products derived from Melase + TX, seaweed extract and fermentation products derived from Melase containing urea + TX, seaweed extract and fermentation plant products + TX Seaweed extract and fermented plant products containing plant hormones, vitamins, EDTA-chelated copper, zinc, and iron +TX, Fanfur +TX, Phenaminosulf +TX, Phenamiphos +TX, Phenazaquin +TX, Fenfluthrin +TX, Fenitrothion +TX, Fenmezodithiaz +TX, Phenobucarb +TX, Phenothiocarb +TX, Phenoxycarb +TX, Fenpropathrin +TX, Fenpyrad +TX, Fenpyroximate +TX, Fensulfothion +TX, fenthione+TX, fentin+TX, fentin acetate+TX, fenvalerate+TX, ferric phosphate+TX, fipronil+TX, flomethoquin+TX, flonicamide+TX, fluacrypyrim+TX, fluazindolidine+TX, fluazurone+TX, flubendiamide+TX, flubendimine+TX, fluclodiniliprole+TX, flucitrinate+TX, flucycloxurone+TX, flucitrinate+TX, fluensulfone[3 18290-98-1]+TX, Fluensulfone+TX, Fluphenelim+TX, Flufenprox+TX, Flufiprole+TX, Fluhexaphon+TX, Flumethrin+TX, Fluopyram+TX, Flupyradiflon+TX, Flupyrimin+TX, Flupyroxystrobin+TX, Flularaner+TX, Fluvalinate+TX, Fluxamethamide+TX, Formaldehyde+TX, Fostiazate+TX, Phostiethane+TX, Frontalin+TX,Furfural+TX, Gamma-cyhalotrin+TX, Gossyplure(registered trademark) (1:1 mixture of (Z,E) and (Z,Z) isomers of hexadeca-7,11dien-1-yl acetate)+TX, Grandlua+TX, Grandlua I+TX, Grandlua II+TX, Grandlua III+TX, Grandlua IV+TX, Granulovirus+TX, Guadipyr+TX, GY-81+TX, Halfenprox+TX, Halofenozide+TX, Harpin+TX, Helicoverpa armigera nucleopolysludge virus+TX, Helicoverpa zea NPV+TX, Helicoverpa zea nucleopolysludge virus+TX, Heliothis punctatum punctigera nucleopolysludge virus + TX, Heliothis virescens nucleopolysludge virus + TX, Hemel + TX, Hempa + TX, Heptafluthrin + TX, Heterophos + TX, Heterorhabditis bacteriophora and H. megidis + TX, Hexarua + TX, Hexamide + TX, Hexithiazox + TX, Hippodamia convergence (Condens) + TX, Hydramethylnon + TX, Hydralgafen + TX, Hydrated lime + TX, Imisiaphos + TX, Imidacloprid + TX, Imiprothrin + TX, Indazapiroxamet + TX, Indoxacarb + TX, Iodomethane + TX, Iprodione + TX, Ipsdienol + TX, Ipsenol + TX, Isamidophos + TX, Isazofos + TX, Isocycloserum + TX, Isoflu Alanam (CAS number: 2892524-05-7) + TX, Isothioate + TX, Ivermectin TX +, Japonilua + TX, Kappabifenthrin + TX, Kappatefluthrin + TX, Kasugamycin + TX, Kasugamycin hydrochloride hydrate + TX, Kinetin + TX, Lambda-cyhalothrin + TX, Redoprona + TX, Lepimectin + TX, Leptomastix dactylopii + TX,Lineatin + TX, Littlea + TX, Lupula + TX, Rotilaner + TX, Lufenuron + TX, Macrolophus caliginosus + TX, Mamestra brassicae NPV + TX, Mecarfon + TX, Medrua + TX, Megaatomic acid + TX, Metaflumizone + TX, Metaaldehyde + TX, Metam + TX, Metam + TX, Metam-potassium + TX, Metam-sodium + TX, Metaphycus helvolus + TX, Metarhizium anisopliae var. acridum + TX, Metarhizium anisopliae var. anisopliae + TX, Metarhizium spp.)+TX, Metepa+TX, Methiocarb+TX, Methiotepa+TX, Methomyl+TX, Methoquine butyl+TX, Methoxyphenozide+TX, Methyl afoate+TX, Methyl bromide+TX, Methyl eugenol+TX, Methyl isothiocyanate+TX, Methylneodecanamide+TX, Metofluthrin+TX, Metolcarb+TX, Mexacalbate+TX, Milbemectin+TX, Milbemycin oxime+TX, Momfluorothrin+TX, Morzide+TX, Moxidectin+TX, Muscaria+TX, Muscodor albus 620 (NRRL accession number 30547)+TX, Muscodor roseusu A3-5 (NRRL accession number 30548)+TX, Myrothecium vercaria Verrucaria composition + TX, Nabam + TX, NC-184 + TX, Neem tree base product + TX, Neodiprion sertifer NPV and N. lecontei NPV + TX, Nickel bis(dimethyldithiocarbamate) + TX, Niclosamide + TX, Niclosamide-olamine + TX, Nicofluoroprole + TX, Nitenpyram + TX, Nichiazine + TX, Nitraprine + TX, Octadeca-2,13-diene-1-yl acetate + TX,Octadeca-3,13-diene-1-ylacetate + TX, Octylinone + TX, Omethoate + TX, Orflurua + TX, Orius spp. + TX, Orictalua + TX, Ostramon + TX, Oxamate + TX, Oxamyl + TX, Oxolinic acid + TX, Oxtetracycline + TX, Paecilomyces fumosoroseus + TX, Paecilomyces lilacinus + TX, parathion-ethyl + TX, Pasteuria nishizawae + TX, Pasteuria penetrans + TX, Pasteuria ramosa + TX, Pasteuria thornei + TX, Pasteuria usgae + TX, P-cymene + TX, penflurone + TX, pentachlorophenol + TX, permethrin + TX, phenothrin + TX, phorate + TX, phosphamidone + TX, phosphocarb + TX, Phytoseiulus persimilis persimilis)TX, picaridin+TX, picaridin+TX, picoxaniliprole+TX, piperazine+TX, piperonylbutoxide+TX, pyrimicarb+TX, pyrimiphosethyl+TX, pyrimiphos-methyl+TX, Plutella xylostella granulosis virus+TX, Plutella xylostella (Plutella Xylostella nucleopolyhedovirus + TX, Polyhedrosis virus + TX, potassium and molybdenum and EDTA-chelated manganese + TX, potassium ethylxanthate + TX, potassium hydroxyquinoline sulfate + TX, prallethrin + TX, probenazole + TX, profenofos + TX, profluthrin + TX, propargit + TX, propethamphos + TX, propoxa + TX, prothiofos + TX, protrefenebuta + TX, piflubmid + TX, pymetrozine + TX, pyraclofos + TX, pyrafluprole + cTX, pyretrim + TX, pyridaben + TX, pyridaryl + TX, pyridine-4-amine + TX, pyrifluquinazone + TX, pyrimidifen + TX, pyriminostrobin + TX, pyriprole [394730-71-3] + TX, pyriprole + TX, pyriproxyfen + TX, QRD 420 (Terpenoid Blend) + TX, QRD 452 (Terpenoid Blend) + TX, QRD460 (terpenoid blend) + TX, Quillaya saponaria + TX, Quinoclamine + TX, Quinonamide + TX, Resmethrin + TX, Rhodocuccus globerulus AQ719 (NRRL accession number B-21663) + TX, Saloraner + TX, S-Biorethrin + TX, Cebuphos + TX, Selamectin + TX, Siglua + TX, Cilafluorophene + TX, Simazine + TX, Sodium pentachlorophenoxide + TX, Solzidine + TX, Spidoxamato + TX, Spinetoram + TX, Spinosad + TX, Spirobudiphen + TX, Spirodiclofen + TX, Spiromesifen + TX, Spiropidione + TX, Spirotetramato + TX, Spodoptera exigua exigua) multicapsid nucleopolyhederovirus + TX, Spodoptera frugiperda nucleopolyhedrovirus + TX, Steinernema bibionis + TX, Steinernema carpocapsae + TX, Steinernema feltiae + TX, Steinernema glaseri + TX, Steinernema riobrave + TX, Steinernema riobravis + TX, Steinernema scapterisci + TX, Steinernema genus spp.)+TX, Streptomyces galbus (NRRL accession number 30232)+TX, Streptomyces genussp.) (NRRL accession number B-30145) + TX, streptomycin + TX, streptomycin sesquisulfate + TX, strychnine + TX, sulcatol + TX, sulfiflumin (CAS number: 2377084-09-6) + TX, sulfoxaflor + TX, tadinecarb + TX, tebufenozide + TX, tebufenpyrad + TX, tebupirimiphos + TX, tecrophthalam + TX, tefluthrin + TX, temephos + TX, tepa + TX, terbam + TX, terbuphos + TX, Terpenoid Blend + TX, Tetrachlorantraniliprole + TX, Tetrachlorothiophene + TX, Tetradeca-11-en-1-yl acetate + TX, Tetraphosphone + TX, Tetramethrin + TX, Tetramethylfluthrin + TX, Tetranactin + TX, Tetraniliprole + TX, Teta-cypermethrin + TX, Thiacloprid + TX, Thiafenox + TX, Thiamethoxam + TX, Thiocyclam + TX, Thiodicarb + TX, Thiofanox + TX, Thiohempa + TX, Thiomersal+TX, Thiometon+TX, Thionadin+TX, Thiophanate+TX, Thiosultap+TX, Thiotepa+TX, Tigolaner+TX, Thiolantraniliprole+TX, Thioxafen+TX, Tolfenpyrad+TX, Toxafen+TX, Tralometrin+TX, Transfluthrin+TX, Tretamine+TX, Triazamate+TX, Triazophos+TX, Triazurone+TX, Tributyltin oxide+TX, Trichlorfon+TX, Trichloronate+TX, Tri Chlorfon + TX, Tricogramma + TX, Triphenmorph + TX, Trifluenfronate + TX, Triflumezopyrim + TX, Trimedua + TX, Trimedua A + TX, Trimedua B1 + TX, Trimedua B2 + TX, Trimedua C + TX, Trimetacarb + TX, Triphenyltin acetate + TX, Triphenyltin hydroxide + TX, Tranquol + TX, Tyropyrazoflor + TX, Typhlomus occidentalis + TX, Uredepa + TX, Verticillium lecanii + TX, Verticillium(spp.) + TX, xylenol + TX, YI-5302 + TX, zeatin + TX, zeta-cypermethrin + TX; N-[(1R)-1-benzyl-3-chloro-1-methylbuta-3-enyl]-8-fluoroquinoline-3-carboxamide+TX, N-[(1S)-1-benzyl-3-chloro-1-methylbuta-3-enyl]-8-fluoroquinoline-3-carboxamide+TX, N-ethyl-N'-[5-methoxy-2-methyl-4-[(2-trifluoromethyl)tetrahydrofuran-2-yl]phenyl]-N-methyl-formamidine (these (These compounds can be prepared from the method described in International Publication No. 2019 / 110427) + TX, (3',4',5'-trifluorobiphenyl-2-yl)-amide + TX, (3-methylisoxazole-5-yl)-[4-[5-(trifluoromethyl)-1,2,4-oxadiazole-3-yl]phenyl]methanone (These compounds can be prepared from the method described in International Publication No. 2017 / 220485) + TX, (4-phenoxyphenyl)methyl 2-amino-6-methylpyridine-3-carboxylate (this compound can be prepared by the method described in International Publication No. 2014 / 006945) + TX, (5-methyl-2-pyridyl)-[4-[5-(trifluoromethyl)-1,2,4-oxadiazole-3-yl]phenyl]methanone + TX, (7E,9Z)-dodeca-7,9-diene-1-ylacetate + TX, (9Z,11E)-tetradeca-9,11-diene-1-ylacetate + TX, (9Z,12E)-tetradeca- 9,12-dien-1-yl acetate + TX, (E)-6-methylhepta-2-en-4-ol + TX, (E)-deca-5-en-1-yl acetate and (E)-deca-5-en-1-ol + TX, (E)-trideca-4-en-1-yl acetate + TX, (E,Z)-tetradeca-4,10-dien-1-yl acetate + TX, (R)-3-(difluoromethyl)-1-methyl-N-[1,1,3-trimethylindan-4-yl]pyrazole-4-carboxamide + TX, (Z)-Dodeca-7-en-1-ylacetate+TX, (Z)-Hexadeca-11-en-1-ylacetate+TX, (Z)-Hexadeca-11-enal+TX, (Z)-Hexadeca-13-en-11-in-1-ylacetate+TX, (Z)-Icosa-13-en-10-one+TX, (Z)-Tetradeca-7-en-1-al+TX, (Z)-Tetradeca-9-en-1-ol+TX, (Z)-Tetradeca-9-en-1-ylacetate+TX, (Z,2E)-5-[1-(2,4-dichlorophenyl)pyrazole-3-yl]oxy C-2-methoxyimino-N,3-dimethyl-penta-3-enamide (this compound can be prepared by the method described in International Publication No. 2018 / 153707) + TX, (Z,2E)-5-[1-(4-chlorophenyl)pyrazole-3-yl]oxy-2-methoxyimino-N,3-dimethyl-penta-3-enamide + TX, [2-[3-[2-[1-[2-[3,5-bis(difluoromethyl)pyrazole-1-yl]acetyl]-4-piperidyl]thiazole-4-yl]-4,5-dihydroisoxazole-5-yl]-3-chlorophenyl]methane Sulfonate + TX, 1-(4,5-dimethylbenzimidazole-1-yl)-4,4,5-trifluoro-3,3-dimethylisoquinoline + TX, 1-(4,5-dimethylbenzimidazole-1-yl)-4,4-difluoro-3,3-dimethylisoquinoline + TX, 1-(6,7-dimethylpyrazolo[1,5-a]pyridine-3-yl)-4,4,5-trifluoro-3,3-dimethylisoquinoline + TX, 1-(6,7-dimethylpyrazolo[1,5-a]pyridine-3-yl)-4,4,6-trifluoro-3,3-dimethyliso Quinoline + TX, 1-(6-chloro-7-methyl-pyrazolo[1,5-a]pyridine-3-yl)-4,4-difluoro-3,3-dimethylisoquinoline (these compounds can be prepared from the method described in International Publication No. 2017 / 025510) + TX, 1,1-bis(4-chlorophenyl)-2-ethoxyethanol + TX, 1,1-dichloro-2,2-bis(4-ethylphenyl)ethane + TX, 1,2-dibromo-3-chloropropane + TX, 1,2-dichloropropane and 1,3-dichloropropene + TX, 1,3-Dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazole-3-yl]phenyl]methyl]urea + TX, 1-[2-[[1-(4-chlorophenyl)pyrazole-3-yl]oxymethyl]-3-methylphenyl]-4-methyltetrazole-5-one + TX, 10-diene-1-yl acetate + TX, 14-methyloctadeca-1-ene + TX, 1-bromo-2-chloroethane + TX, 1-dichloro-1-nitroethane + TX, 1-hydroxy-1H-pyridine-2-thione + TX, 1-methoxy-3-methyl Tyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazole-3-yl]phenyl]methyl]urea + TX, 1-methyl-4-[3-methyl-2-[[2-methyl-4-(3,4,5-trimethylpyrazole-1-yl)phenoxy]methyl]phenyl]tetrazol-5-one + TX, 2-(difluoromethyl)-N-((3R)-1,1,3-trimethylindan-4-yl)pyridine-3-carboxamide + TX, 2-(difluoromethyl)-N-((3R)-1,1,3-trimethylindan-4-yl)pyridine-3- Carboxamide + TX, 2-(1,3-dithiolan-2-yl)phenyldimethylcarbamate + TX, 2-(2-butoxyethoxy)ethylpiperonylate + TX, 2-(2-butoxyethoxy)ethylthiocyanate + TX, 2-(4,5-dimethyl-1,3-dioxolan-2-yl)phenylmethylcarbamate + TX, 2-(4-chloro-3,5-xylyloxy)ethanol + TX, 2-(difluoromethyl)-N-(3-ethyl-1,1-dimethylindan-4-yl)pyridine-3-carboxamide + TX, 2-(difluoromethyl) -N-[(3R)-3-ethyl-1,1-dimethylindan-4-yl]pyridine-3-carboxamide + TX, 2-(difluoromethyl)-N-[(3S)-3-ethyl-1,1-dimethylindan-4-yl]pyridine-3-carboxamide (this compound can be prepared from the method described in International Publication No. 2014 / 095675) + TX, 2-(difluoromethyl)-N-[3-ethyl-1,1-dimethylindan-4-yl]pyridine-3-carboxamide + TX, 2-(octylthio)ethanol + TX, 2,2,2-trichloro-1-(3,4-Dichlorophenyl)ethyl acetate + TX, 2,2-Dichlorovinyl 2-ethylsulfinylethyl methyl phosphate + TX, 2,2-Difluoro-N-methyl-2-[4-[5-(trifluoromethyl)-1,2,4-oxadizaol-3-yl]phenyl]acetamide + TX, 2,4-Dichlorophenyl benzosulfonate + TX, 2,6-dimethyl-1H,5H-[1,4]dithiino[2,3-c:5,6-c']dipyrrole-1,3,5,7(2H,6H)-tetron (this compound can be prepared by the method described in International Publication No. 2011 / 138281) + TX, 2-[2-fluoro-6-[(8-fluoro-2-methyl-3-quinolyl)oxy]phenyl]propan-2-ol + TX, 2-[6-(4-bromophenoxy)-2- (trifluoromethyl)-3-pyridyl]-1-(1,2,4-triazole-1-yl)propan-2-ol (this compound can be prepared from the method described in International Publication No. 2017 / 029179) + TX, 2-[6-(4-chlorophenoxy)-2-(trifluoromethyl)-3-pyridyl]-1-(1,2,4-triazole-1-yl)propan-2-ol (this compound can be prepared from the method described in International Publication No. 2017 / 029179) (Preparable) + TX, 2-chlorovinyldiethyl phosphate + TX, 2-fluoro-N-methyl-N-1-naphthylacetamide + TX, 2-imidazolidone + TX, 2-isovalerylindan-1,3-dione + TX, 2-methyl(propa-2-inyl)aminophenylmethylcarbamate + TX, 2-oxo-N-propyl-2-[4-[5-(trifluoromethyl)-1,2,4-oxadiazole-3-yl]phenyl] Cetoamide (this compound can be prepared by the method described in International Publication No. 2018 / 065414) + TX, 2-thiocyanatoethyl laurate + TX, 3-(4,4-difluoro-3,3-dimethyl-1-isoquinolyl)-7,8-dihydro-6H-cyclopenta[e]benzimidazole (these compounds can be prepared by the method described in International Publication No. 2016 / 156085) + TX, 3-(4,4-difluoro-3,4-dihydro-3,3-Dimethylisoquinoline-1-yl)quinolone + TX, 3-(4-chlorophenyl)-5-methylrhodanine + TX, 3-(difluoromethyl)-1-methyl-N-[1,1,3-trimethylindan-4-yl]pyrazole-4-carboxamide + TX, 3,4-dichlorotetrahydrothiophene 1,1-dioxide + TX, 3-[2-(1-chlorocyclopropyl)-3-(2-fluorophenyl)-2-hydroxypropyl]imidazole-4-carbonitrile (This compound is derived from the method described in International Publication No. 2016 / 156290) (Preparable) + TX, 3-[2-(1-chlorocyclopropyl)-3-(3-chloro-2-fluorophenyl)-2-hydroxypropyl]imidazole-4-carbonitride (this compound can be prepared from the method described in International Publication No. 2016 / 156290) + TX, 3-bromo-1-chloropropa-1-ene + TX, 3-chloro-6-methyl-5-phenyl-4-(2,4,6-trifluorophenyl)pyridazine + TX, 3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxylic acid + TX, 3-ethyl-1-methoxy-1- [[4-[5-(trifluoromethyl)-1,2,4-oxadiazole-3-yl]phenyl]methyl]urea + TX, 3-methyl-1-phenylpyrazole-5-yldimethylcarbamate + TX, 4-(2-bromo-4-fluorophenyl)-N-(2-chloro-6-fluorophenyl)-1,3-dimethyl-1H-pyrazole-5-amine + TX, 4-(2,6-difluorophenyl)-6-methyl-5-phenylpyridazine-3-carbonitrile + TX, 4-(2-bromo-4-fluorophenyl)-N-(2-chloro-6- Luorophenyl)-2,5-dimethylpyrazole-3-amine + TX, 4-(quinoxaline-2-ylamino)benzenesulfonamide + TX, 4,4-difluoro-1-(5-fluoro-4-methylbenzimidazole-1-yl)-3,3-dimethylisoquinoline + TX, 4,4-difluoro-3,3-dimethyl-1-(6-methylpyrazolo[1,5-a]pyridine-3-yl)isoquinoline + TX, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridine-3-yl)isoquinoline + TX, 4,4-dimethyl-2-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazole-3-yl]phenyl]methyl]isoxazolidine-3-one + TX, 4-[[6-[2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(1,2,4-triazole-1-yl)propyl]-3-pyridyl]oxy]benzonitrile + TX, 4-[[6-[2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(5-sulfani [-1,2,4-triazole-1-yl)propyl]-3-pyridyl]oxy]benzonitrile + TX, 4-[[6-[2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(5-thioxo-4H-1,2,4-triazole-1-yl)propyl]-3-pyridyl]oxy]benzonitrile + TX, 4-chloro-2-(2-chloro-2-methyl-propyl)-5-[(6-iodo-3-pyridyl)methoxy]pyridazine-3-one + TX, 4-chlorophenyl Phenyl sulfone + TX, 4-methyl(propane-2-inyl)amino-3,5-xylylmethylcarbamate + TX, 4-methylnonan-5-ol and 4-methylnonan-5-one + TX, 5-(1,3-benzodioxol-5-yl)-3-hexylcyclohexa-2-enone + TX, 5,5-dimethyl-2-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazole-3-yl]phenyl]methyl]isoxazolidine-3-one + TX, 5,5-dimethyl-3-oxocycline Rohexa-1-enyldimethylcarbamate + TX, 5-amino-1,3,4-thiadiazole-2-thiol zinc salt (2:1) + TX, 5-methyl-6-thioxo-1,3,5-thiadiazinan-3-ylacetic acid + TX, 6-chloro-3-(3-cyclopropyl-2-fluorophenoxy)-N-[2-(2,4-dimethylphenyl)-2,2-difluoroethyl]-5-methylpyridazine-4-carboxamide (preparable from the method described in International Publication No. 2020 / 109391) + TX,6-Chloro-3-(3-cyclopropyl-2-fluorophenoxy)-N-[2-(3,4-dimethylphenyl)-2,2-difluoro-ethyl]-5-methylpyridazine-4-carboxamide (preparable by the method described in International Publication No. 2020 / 109391) + TX, 6-Chloro-4,4-difluoro-3,3-dimethyl-1-(4-methylbenzimidazole-1-yl)isoquinoline + TX, 6-Chloro-N-[2-(2-chloro-4-methylphenyl)-2,2-difluoro-ethyl]-3-(3-cyclopropyl-2-fluorophenoxy)-5-methylpyridazine-4-carboxamide (preparable by the method described in International Publication No. 2020 / 109391) + TX, 6-E Chil-5,7-dioxo-pyrrolo[4,5][1,4]dithiino[1,2-c]isothiazole-3-carbonitriel+TX, 6-isopentenylaminopurine+TX, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide+TX, 8-fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide+TX, 8-hydroxyquinoline sulfate+TX, acetylone+TX, acetoprol+TX, acibenzolar+TX, acibenzolar-S-methyl+TX, acrylonitrile+TX, Adoxophyes Orana orana) GV+TX, Agrobacterium radiobacter+TX, Aldoxicarb+TX, Aldrin+TX, Allosamidin+TX, Alixicarb+TX, Alpha-chlorohydrin+TX, Alpha-ecdysone+TX, Alpha-multistriatin+TX, Aluminum phosphide+TX, Amblyseius spp.+TX, Amectotractin+TX, Ametoctrazine+TX, Amidothione+TX, Amidothioate+TX, Aminocarb+TX, Aminopyriphen+TX, Amisulbrom+TX, Amiton+TX, Amiton oxalate+TX, Amitraz+TX, Anabacin+TX, Anagrapha falcifera NPV+TX,Anagrus atomus + TX, Ancimidor + TX, Anilazine + TX, Anisifuruprin + TX, Anthraquinone + TX, Antu + TX, Aphelinus abdominalis + TX, Aphidius colemani + TX, Aphidoletes aphidimyza + TX, Aphorate + TX, Aramite + TX, Arsenous acid + TX, Atidathion + TX, Autographa californica NPV + TX, Azaconazole + TX, Azamethiphos + TX, Azobenzene + TX, Azothoate + TX, Azoxystrobin + TX, Bacillus sphaericus Neide + TX, Bacillus thuringiensis (Bacillus (thuringiensis) Delta Endotoxin + TX, Barium Carbonate + TX, Barium Hexafluoridosalic Acid + TX, Polybarium Sulfide + TX, Bartholin + TX, Bayer 22 / 190 + TX, Bayer 22408 + TX, Beauveria brongniartii + TX, Benalaxyl + TX, Bencrotiaz + TX, Benomyl + TX, Benoxaphos + TX, Bentiavaricarb + TX, Benzothiostrobin + TX, Benzovindiflupir + TX, Benzyl Benzoate + TX, Beta-Cyfluthrin + TX, Beta-Cypermethrin + TX, Bethoxazine + TX, Bioethanomethrin + TX, Biopermethrin + TX, Bis(2-chloroethyl) ether + TX, Bis(tributyltin) oxide + TX, Bisazil + TX, Bisthioce Mi+TX, Vitertanol+TX, Bixafen+TX, Blastisidine-S+TX, Borax+TX, Bordeaux mixture+TX, Boscalid+TX, Brevicomin+TX, Brodifacom+TX, Brofenvalerate+TX, Bromadiolon+TX, Bromethalin+TX, Bromofenbinphos+TX, Bromoacetamide+TX, Bromocyclene+TX, Bromo-DDT+TX, Bromophos+TX, Bromopropylate+TX, Bromuconazole+TX, Bronopol+TX, Bufencarb+TX,Bupirimate + TX, Buprofezin + TX, Busulfan + TX, Buta-3-inyl N-[6-[[(Z)-[(1-methyltetrazole-5-yl)-phenyl-methylene]amino]oxymethyl]-2-pyridyl]carbamate+TX, Butacarb+TX, Butathiophos+TX, Butocarboxim+TX, Butonate+TX, Butopyronoxyl+TX, Butoxy(polypropylene glycol)+TX, Butoxycarboxim+TX, Butylpyridaben+TX, Calcium arsenate+TX, Calcium cyanide+TX, Calcium polysulfide+TX, Canfechlor+TX, Captafo+TX, Captan+TX, Carbanolate+TX, Carbendazim+TX, Carbon disulfide+TX, Carbon tetrachloride+TX, Carbophenothion+TX, Carboxine+TX, Cartabhydrochloride+TX, CAS No.: 2132414-04-9+TX, CAS No.: 2344 721-61-3+TX, Sebadin+TX, Tinomethionate+TX, Chloralose+TX, Chlorbenside+TX, Chlorbicyclene+TX, Chlordan+TX, Chlordecone+TX, Chlordimeform+TX, Chlordimeform hydrochloride+TX, Chlorphenetol+TX, Chlorfensone+TX, Chlorfensulfide+TX, Chlorobenzylate+TX, Chloroform+TX, Chloroinconazide+TX, Chloromebform+TX, Chloromethion+TX, Chloroneb+TX, Chlorophacinone+TX, Chloropicrin+TX, Chloropropylate+TX, Chlorthalonil+TX, Chlorophoxime+TX, Chlorprazophos+TX, Chlorthiophos+TX, Clozolinate+TX, Cholecalciferol+TX, Chrysoperla carnea carnea)+TX, Synerin I+TX, Synerin II+TX, Synerin+TX, Sysmethrin+TX, Cis-resmethrin+TX, Crocitrin+TX, Closantel+TX, Chodrelua+TX, Chodremon+TX, Copper arsenide acetate+TX, Copper arsenate+TX, Copper dioctanoate+TX, Copper hydroxide+TX, Copper naphthenate+TX, Copper oleate+TX, Copper oxide+TX, Copper oxychloride+TX, Copper sulfate+TX, Coumarol+TX, Coumafuryl+TX, Coumaphos+TX, Coumatetralyl+TX, Coomethoxystrobin (Diashangjunji)+TX,Cumithoate + TX, spideroxystrobin + TX, cresol + TX, crimidine + TX, crotamiton + TX, clotoxyphos + TX, clufomate + TX, cryolite + TX, Cryptolaemus montrouzieri + TX, CS 708 + TX, Cuela + TX, Cuflaneb + ​​TX, cyanophenphos + TX, cyanophos + TX, cyanthoate + TX, cyazofamide + TX, sibutrin + TX, cycloetrin + TX, cyclobutriflurum + TX, Cydia pomonella GV + TX, cyflufenaamide + TX, simiazole + TX, cymoxanil + TX, cyproconazole + TX, cyprodinil + TX, cythioate + TX, cytokinin + TX, Dacnusa sibirica sibirica)+TX, DAEP+TX, dazomet+TX, DCIP+TX, DCPM+TX, DDT+TX, debacarb+TX, decarbofuran+TX, demefion+TX, demefion-O+TX, demefion-S+TX, demeton-methyl+TX, demeton-O+TX, demeton-O-methyl+TX, demeton-S+TX, demeton-S-methyl+TX, demeton-S-methylsulfone+TX, diamidaphos+TX, dibutyladipate+TX, dibutylphthalate TX, Dibutyl succinate + TX, Dicapton + TX, Diclobentiazox + TX, Diclofenthion + TX, Diclofluanide + TX, Diclon + TX, Dichlorofen + TX, Dichlorvos + TX, Diclozoline + TX, Dicliphos + TX, Diclocimeth + TX, Diclomazine + TX, Dichloran + TX, Dicresyl + TX, Dicyclanil + TX, Dicyclopentadiene + TX, Dierdrin + TX, Dienochlor + TX, Dietofencarb + TX, Diethyl 5-methylpyrazole-3-yl phosphate + TX, Diethyltoluamide + TX, Difenacam + TX, Difenoconazole + TX, Difethiaron + TX, Diflovidazine + TX, Diglyphus isaea + TX, Dirol + TX, Dimatif + TX, Dimefluthrin + TX, Dimefox + TX, Dimethanone + TX, Dimethilimol + TX, Dimethomorph + TX, Dimethrin + TX, Dimethylcarbate + TX, Dimethylphthalate + TX, Dimethylvinphos + TX, Dimethilan + TX, Dimoxystrobin + TX, Dynex + TX, Dynex-Dikrexin + TX, Diniconasol + TX, Dinocap-4 + TX, Dinocap-6 + TX, Dinoctone + TX, Di Nopenton + TX, Dinoprop + TX, Dinosam + TX, Dinosev + TX, Dinosulfone + TX, Dinotervon + TX, Geophenolan + TX, Dioxabenzophos + TX, Dioxathion + TX, Difacinone + TX, Diphenylsulfone + TX, Dipimethitron + TX, Dipirithione + TX, Dispalur + TX, Disulfiram + TX, Dithianone + TX, Diticlophos + TX, DNOC + TX, Dodeca-8-en-1-yl acetate + TX, Dodeca-9-en-1-yl Acetate + TX, Dodeca-8 + TX, Dodemorph + TX, Dodicin + TX, Dodin + TX, Dofenapine + TX, Dominicarul + TX, Doramectin + TX, DSP + TX, d-Tetramethrin + TX, Ecdysterone + TX, Edifenphos + TX, EI 1642 + TX, EMPC + TX, Encarsia formosa + TX, Endotar + TX, Endothion + TX, Enestrobrin + TX, Enoxastrobin + TX, EPBP + TX, Epoxyconazole + TX, Eprinomectin + TX, Eretmocerus eremicus + TX, Ergocalciferol + TX, Etaphos + TX, Etaboxam + TX, Ethiofencarb + TX, Ethyrimol + TX, Ethoate-methyl + TX, Ethyl 1-[[4-[(Z)-2-ethoxy-3,3,3-trifluoropropa-1-enoxy]phenyl]methyl]pyrazole-3-carboxylate (can be prepared by the method described in International Publication No. 2020 / 056090) + TX,Ethyl 1-[[4-[[2-(trifluoromethyl)-1,3-dioxolan-2-yl]methoxy]phenyl]methyl]pyrazole-3-carboxylate (preparable by the method described in International Publication No. 2020 / 056090) + TX, Ethyl 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazole-3-yl]phenyl]methyl]pyrazole-4-carboxylate + TX, Ethyl 1-[[5-[5-(trifluoromethyl)-1,2,4-oxadiazole-3-yl]-2-thienyl]methyl]pyrazole-4-carboxylate (this compound can be prepared by the method described in International Publication No. 2018 / 158365) + TX, Ethyl 4-methyl octanoate + TX, Ethyl formate + TX, Ethyl hexanediol + TX, Ethylene dibromide + TX, Ethylene dichloride + TX, Ethylene oxide + TX, Etridiazole + TX Etrimphos + TX, Ougenol + TX, EXD + TX, Famoxadone + TX, Farnesol + TX, Nerolidol-containing Farnesol + TX, Phenamidon + TX, Phenaminosulf + TX, Phenaminestrobin + TX, Phenarimol + TX, Phenazaflor + TX, Fenbuconazole + TX, Fenbutatine oxide + TX, Fenchlorphos + TX, Phenesacarb + TX, Fenflam + TX, Fenhexamide + TX, F Phenonitrothion + TX, phenothiocarb + TX, phenoxacrim + TX, phenoxanil + TX, fenpiclonil + TX, fenpicosamide + TX, fenpyritrin + TX, fenpropidine + TX, fenpropimorph + TX, fenpyrad + TX, fenpyrazamine + TX, fenpyroximate + TX, fenson + TX, fensulfothion + TX, fenthion + TX, fenthion-ethyl + TX, fentin + TX, fentin Rifanil + TX, Farbam + TX, Felimzone + TX, Ferric phosphate + TX, Furocumafen + TX, Floryl picoxamide + TX, Fluazinam + TX, Fluveneteram + TX, Flubendimine + TX, Flucoflon + TX, Flucycloxone + TX, Fludioxonil + TX, Flunetyl + TX, Fluphenoxadiazam + TX, Fluphenoxystrobin + TX, Fluindapyr + TX, Flumethylsulfolim + TX, Flumorph + TX,Fluopicolide + TX, Fluopimomid + TX, Fluopyram + TX, Fluolbenzide + TX, Fluoroacetamide + TX, Fluoroimide + TX, Fluoxapiproline + TX, Fluoxastrobin + TX, Fluoxythioconazole + TX, Flupropazine + TX, Flupropazine hydrochloride + TX, Fluquinconazole + TX, Flusilazole + TX, Flusulfamide + TX, Fluthianil + TX, Flutolanil + TX, Flutriafoll + TX, Fluxapiroxad + TX, FMC 1137+TX, Forpet+TX, Formaldehyde+TX, Formetanate+TX, Formetanate Hydrochloride+TX, Formparanate+TX, Fosetylaluminum+TX, Fosmethilan+TX, Fosspire+TX, Fosthietan+TX, Frontalin+TX, Fuberidazole+TX, Flalaxil+TX, Flamethopyr+TX, Flathiocarb+TX, Fretolin+TX, Furufural+TX, Gamma-HCH+TX, Gliodin+TX, Grandluer+TX, Grandluer I+TX, Grandluer II+TX, Grandluer III+TX, Grandluer IV+TX, Guazatine+TX, Guazatine Acetate+TX, Hafenprox+TX, HCH+TX, Hemel+TX, Hempa+TX, HEOD+TX, Heptachlor+TX, Heterorhabditis+TX, Heterorhabditis bacteriophora H. megidis + TX, hexaconazole + TX, hexadecylcyclopropane carboxylate + TX, hexalua + TX, hexamide + TX, HHDN + TX, Hippodamia convergence (concentrates) + TX, hydralgafen + TX, slaked lime + TX, hydrogen cyanide + TX, himexazole + TX, hikincarb + TX, imanin + TX, imazalil + TX, imibenconazole + TX, iminoctadine + TX, impulfraxum + TX, ipconazole + TX, ipfentrifluconazole + TX, ipflufenoquin + TX, iprobenphos + TX, iprodione + TX, iprovalicarb + TX, ipsdienol + TX, ipsenol + TX, IPSP + TX, isamidophos + TX, iazophos + TX, isobenzan + TX,Isocarbofos+TX, Isodrine+TX, Isofenphos+TX, Isofetamide+TX, Isoflucipram+TX, Isolane+TX, Isoprothiolane+TX, Isopyrazam+TX, Isotianil+TX, Isoxathion+TX, Japonila+TX, Jasmolin I+TX, Jasmolin II+TX, Iodophenphos+TX, Juvenile Hormone I+TX, Juvenile Hormone II+TX, Juvenile Hormone III+TX, Cadetrin+TX, Kasugamycin+TX, Kasugamycin Hydrochloride Hydrate+TX, Kereban+TX, Kinetin+TX, Quinoprene+TX, Kresoxim-Methyl+TX, Lead Arsenate+TX, Leptomastix Dactylopii Dactylopii) + TX, Leptophos + TX, Lindane + TX, Lineatin + TX, Lilimphos + TX, Lithor + TX, Lupulua + TX, Ribembenmixianan + TX, Lithidathione + TX, Macrolophus caliginosus + TX, Magnesium phosphide + TX, Malonoben + TX, Mamestra brassicae NPV + TX, Mancopper + TX, Mancozeb + TX, Mandestrobin + TX, Mandipropamide + TX, Maneb + ​​TX, Magidox + TX, m-Cumenil Methylcarbamate + TX, Mecarbam + TX, Mecarphon + TX, Medrua + TX, Mefentrifluconazole + TX, Megatomoidic acid + TX, Menazone + TX, Mepanipyrim + TX, Meperfluthrin + TX, Mephosphorane + TX, Mepronil + TX, Mercury oxide + TX, Mercury chloride + TX, Mesulfen + TX, Mesulfenphos + TX, Metalaxyl + TX, Metam + TX, Metam-potassium + TX, Metam-sodium + TX, Metaphycus helvolus + TX, Metarhizium anisopliae var. acridum + TX, Metarhizium anisopliae var. anisopriae + TX, Metallyl picosamide + TX, Metconazole + TX, Metepa + TX, Methacryphos + TX, Methanesulfonyl fluoride + TX, Metasulfocarb + TX, Methiotepa + TX, Metoclotophos + TX, Methoprene + TX, Methquin-butyl + TX, Methotrin + TX, Methoxychlor + TX, Methyl(Z)-2-(5-cyclohexyl-2-methylphenoxy)-3-methoxypropa-2-enoate + TX, Methyl(Z)-2-(5-cyclopentyl-2-methylphenoxy)-3-methoxypropa-2-enoate (These compounds can be prepared from the methods described in International Publication No. 2020 / 193387) + TX, Methyl(Z)-2-[5-(3-isopropylpyrazole-1-yl)-2-methylphenoxy]-3-methoxypropa-2- Enoate + TX, Methyl(Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazole-1-yl)phenoxy]propa-2-enoate + TX, Methyl(Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazole-2-yl)phenoxy]propa-2-enoate + TX, Methyl(Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazole-1-yl]phenoxy]propa-2-enoate (These compounds can be prepared from the method described in International Publication No. 2020 / 079111) + TX, Methyl(Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazole-2-yl]phenoxy]propa-2-enoate + TX, Methyl Aphorate + TX, Methyl bromide + TX, Methyl eugenol + TX, Methyl isothiocyanate + TX, Methyl N-[[4-[1-(2,6-difluoro-4-isopropylphenyl)pyrazole-4-yl]-2-methylphenyl]methyl]carbamate (preparable from the method described in International Publication No. 2020 / 097012) + TX, Methyl N-[[4-[1-(4-cyclopropyl-2,6-difluorophenyl)pyrazole-4-yl]-2-methylphenyl]methyl]carbamate (preparable from the method described in International Publication No. 2020 / 097012) + TX, Methyl N-[[5-[4-(2,4-dimethylphenyl)triazole-2-yl]-2-methylphenyl]methyl]carbamate + TX, methylchloroform + TX, methylene chloride + TX, methylneodecanamide + TX, methylam + TX, methylcarb + TX, metminostrobin + TX, methoxadiazone + TX, metraphenone + TX, methyltetraprole + TX, MGK 264 + TX, milbemycin oxime + TX, mipafox + TX, mirex + TX, monoclotophos + TX, morphothion + TX, molzide + TX, moxidectin + TX, muscarua + TX, mycrobutanil + TX, microzoline + TX, Myrothecium bercaria verrucaria) composition + TX, N-((1R)-1-benzyl-3-chloro-1-methylbuta-3-enyl)-8-fluoroquinoline-3-carboxamide (these compounds can be prepared from the method described in International Publication No. 2017 / 153380) + TX, N-((1S)-1-benzyl-3-chloro-1-methylbuta-3-enyl)-8-fluoroquinoline-3-carboxamide (these compounds can be prepared from the method described in International Publication No. 2017 / 153380) + TX, N'-(2,5-dimethyl-4-phenoxyphenyl)-N-ethyl-N-methyl-formamidine + TX, N'-(2-chloro-5-methyl-4-phenoxyphenyl)-N-ethyl-N-methyl-formamidine + TX, N,2-dimethoxy-N-[[4-[5-(trifluoro Methyl)-1,2,4-oxadiazole-3-yl]phenyl]methyl]propanamide + TX, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazole-3-yl]phenyl]methyl]-1,2,4-triazole-3-amine (These compounds are listed in International Publication No. 2017 / 055473, International Publication No. 2017 / 055469, International Publication No. 2 (Preparable from the method described in International Publication No. 017 / 093348 and International Publication No. 2017 / 118689) + TX, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoroquinoline-3-carboxamide + TX, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoroquinoline-3-carboxamide + TX, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoroquinoline-3-carboxamide+TX,N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoroquinoline-3-carboxamide+TX,N-[(1S)-1-benzyl-1,3-dimethylbutyl]-8-fluoroquinoline-3-carboxamide+TX,N-[(1S)-1-benzyl- 3,3,3-trifluoro-1-methyl-propyl]-8-fluoroquinoline-3-carboxamide + TX, N-[(E)-methoxyiminomethyl]-4-[5-(trifluoromethyl)-1,2,4-oxadiazole-3-yl]benzamide + TX, N-[(Z)-methoxyiminomethyl]-4-[5-(trifluoromethyl)-1,2,4-oxadiazole-3-yl ]benzamide + TX, N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazole-3-yl]phenyl]methyl]propanamide + TX, N-[2-[2,4-dichloro-phenoxy]phenyl]-3-(difluoromethyl)-1-methylpyrazole-4-carboxamide + TX, N-[2-[2-chloro-4-(trifluoromethyl)phenoxy]phenyl]-3-(difluoromethyl)-1-methylpyrazole-4-carboxamide + TX, N'-[2-chloro-4-(2-fluorophenoxy)-5-methyl-phenyl]-N-ethyl-N-methyl-formamidine (this compound can be prepared by the method described in International Publication No. 2016 / 202742) + TX, N'-[4-(4,5-dichlorothiazole-2-yl)oxy-2,5-dimethylphenyl]-N-ethyl-N-methyl-formamidine + TX, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxyethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine + TX, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxyethoxy)-3-pyridyl]-N-isopropyl-N-methyl-formamidine (These compounds were prepared by the method described in International Publication No. 2015 / 155075) (Possible) + TX, N'-[5-bromo-2-methyl-6-(2-propoxypropoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine (This compound can be prepared from the method described in IPCOM000249876D) + TX, N'-[5-bromo-2-methyl-6-[(1R)-1-methyl-2-propoxyethoxy]-3-pyridyl]-N-ethyl-N-methyl-formamidine + TX, N'-[5-bromo-2-methyl-6-[(1S)-1-methyl- [2-propoxyethoxy]-3-pyridyl]-N-ethyl-N-methyl-formamidine + TX, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxyethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine + TX, N-[N-methoxy-C-methyl-carbonimidoyl]-4-[5-(trifluoromethyl)-1,2,4-oxadiazole-3-yl]benzamide (These compounds are described in International Publication No. 2018 / 202428) (Preparable from the method described) + TX, N'-[4-(1-cyclopropyl-2,2,2-trifluoro-1-hydroxy-ethyl)-5-methoxy-2-methyl-phenyl]-N-isopropyl-N-methyl-formamidine (These compounds can be prepared from the method described in International Publication No. 2018 / 228896) + TX, Nabam + TX, Naphthalophos + TX, Nared + TX, Naphthalene + TX, NC-170 + TX, Neodiprion sertifer NPV and N. lecontei NPV + TX, Nerolidol + TX, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-Oxadiazole-3-yl]phenyl]methyl]propanamide + TX, N-ethyl-N'-[5-methoxy-2-methyl-4-[(2-trifluoromethyl)oxetane-2-yl]phenyl]-N-methyl-formamidine + TX, Nickel bis(dimethyldithiocarbamate) + TX, Niclosamide-olamine + TX, Nicotin + TX, Nicotin sulfate + TX, Niflulidide + TX, Nikcomycin + TX, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methyl-formamidine + TX, Nichiazine + TX, Nitrapyrine + TX, Nitrilacarb + TX, Nitrilacarb 1:1 Zinc chloride complex + TX, nitrotal-isopropyl + TX, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazole-3-yl]phenyl]methyl]cyclopropanecarboxamide + TX, N-methyl-4-[5-(trifluoromethyl)-1,2,4-oxadiazole-3-yl]benzamide + TX, N-methyl-4-[5-(trifluoromethyl)-1,2,4-oxadiazole-3-yl]benzenecarbothioamide + TX, norbolmid + TX, Nualimol + TX, O,O,O',O'-tetrapropyldithiopyrophosphate + TX, Octadeca-2,13-diene-1-ylacetate + TX, Octadeca-3,13-diene-1-ylacetate + TX, Octylinone + TX, Oflace + TX, Oleic acid + TX, Omethoate + TX, Orflurua + TX, Orius spp. + TX, Orictalua + TX, Orysastrobin + TX, Ostramon + TX, Oxadixyl + TX, Oxamate + TX, Oxatiapiproline + TX, Oxine-copper + TX, Oxolinic acid + TX, Oxocarboxyne + TX, Oxideprophos + TX, Oxydisulfon + TX, Oxytetracycline + TX, Paclobutrazol + TX, Paecilomyces fumosoroseus Phytoseiulus persimilis (Phytoseiulus persimilis) + TX, para-dichlorobenzene + TX, parathion + TX, parathion-methyl + TX, pefurazoate + TX, penconazole + TX, pencyclon + TX, penflufen + TX, penflulon + TX, pentachlorophenol + TX, pentachlorophenyl laurate + TX, penthiopyrad + TX, permethrin + TX, PH 60-38 + TX, phenamacryl + TX, fencapton + TX, fosacetim + TX, phosalon + TX, phosudiphen + TX, phosphorane + TX, phosglycine + TX, fosniclor + TX, phosphamidone + TX, phosphine + TX, phosphorus + TX, phoxim-methyl + TX, phthalide + TX, Phytoseiulus persimilispersimilis)+TX, picarbtrazox+TX, picaridin+TX, picoxystrobin+TX, pindone+TX, piperazine+TX, piperonyl butoxide+TX, piprotal+TX, pyrimetaphos+TX, polychlorodicyclopentadiene isomer+TX, polychloroterpene+TX, polynactin+TX, polyoxin+TX, potassium arsenite+TX, potassium ethylxanthinate+TX, potassium hydroxyquinoline sulfate+TX, potassium thiocyanate+TX, pp'-DDT+TX, Precosen I+TX, Precosen II+TX, Precosen III+TX, Primidophos+TX, Probenazole+TX, Prochloraz+TX, Proclonol+TX, Procymidone+TX, Profluthrin+TX, Promacil+TX, Promecarb+TX, Propamocarb+TX, Propiconazole+TX, Propineb+TX, Propoxul+TX, Propropyl isomer+TX, Proquinazide+TX, Protidathion+TX, Prothioconazole+TX, Proti Ofos+TX, Protoate+TX, Pidiflumetofen+TX, Pyraclostrobin+TX, Pyramethrostrobin+TX, Pyraoxystrobin+TX, Pyrapropoin+TX, Pyraziflumid+TX, Pyrazofos+TX, Pyrethmetrin+TX, Pyrethrin I+TX, Pyrethrin II+TX, Pyrethrin+TX, Pyribencarb+TX, Pyridaclomethyl+TX, Pyridafenthion+TX, Pyridine-4-amine+TX, Pyriphenox+TX, Pyrimethanil+TX, Pyri Mitate + TX, Pyrimorph + TX, Pyrinulone + TX, Pyriophenone + TX, Pyrisoxazole + TX, Pyrroquilon + TX, Quasia + TX, Quinalphos + TX, Quinalphos-methyl + TX, Quinoclamine + TX, Quinofumeline + TX, Quinonamide + TX, Quinotion + TX, Quinoxyfen + TX, Quinchiophos + TX, Quintzene + TX, R-1492 + TX, Lafoxanide + TX, Resmethrin + TX, Reynoutria saccharinensisSachalinensis extract + TX, Ribavirin + TX, Lametalaxyl + TX, Rotenone + TX, Lianya + TX, Lianodine + TX, S421 + TX, Sabadilla + TX, Shuradan + TX, Siriloside + TX, Seboctilamine + TX, Cebuphos + TX, Sedaxane + TX, Selamectin + TX, Sesamex + TX, Sesamolin + TX, SI-0009 + TX, Siglua + TX, Simazine + TX, Simeconazole + T X, Sodium arsenite + TX, Sodium cyanide + TX, Sodium fluoride + TX, Sodium fluoroacetate + TX, Sodium hexafluorosilicate + TX, Sodium pentachloride + TX, Sodium selenite + TX, Sodium tetrathiocarbonate + TX, Sodium thiocyanate + TX, Sofamide + TX, Soldidine + TX, Spiroxamine + TX, SSI-121 + TX, Steinernema viviones Steinernema bibionis)+TX, Steinernema carpocapsae+TX, Steinernema feltiae+TX, Steinernema glaseri+TX, Steinernema riobrave+TX, Steinernema riobravis+TX, Steinernema scapterisci+TX, Steinernema genus (Steinernema) (spp.)+TX, Streptomycin+TX, Streptomycin sesquisulfate+TX, Strychnine+TX, Sulcatol+TX, Sulcoflon+TX, Sulcoflon-sodium+TX, Sulfiram+TX, Sulfuramide+TX, Sulfotep+TX, Sulfoxide+TX, Sulfur+TX, Sulfur fluoride+TX, Sulprophos+TX, Tar oil+TX, Tau-fluvalinate+TX, Tadimucarb+TX, TDE+TX, Tebuconazole+TX, Tebufloquine+TX, Tebupyrimphos+TX, Tecrophthalam+TX, Temephos+TX, Tepa+TX, TEPP+TX, Terarethrin+TX, Terbam+TX, Tert-butylN-[6-[[[(1-methyltetrazole-5-yl)-phenyl-methylene]amino]oxymethyl]-2-pyridyl]carbamate+TX, tetrachloroethane+TX, tetrachlorothiophene+TX, tetraconazole+TX, tetradeca-11-en-1-yl acetate+TX, tetradiphon+TX, tetramethylfluthrin+TX, tetrasul+TX, thallium sulfate+TX, thiabendazole+TX, thiaphenox+TX, thiapronil+TX, cyclophos+TX, tifluzamide+TX, thiocarboxyme+TX, thiocyclam+TX, thiocyclam hydrogen oxalate+TX, thiodiazole copper+TX, thiophanox+TX, thiohenpa+TX, thiomelsar+TX, thiometon+TX, thi Onazine + TX, Thiophanate + TX, Thiophanate-methyl + TX, Thioquinox + TX, Thiosultap + TX, Thiosultap-sodium + TX, Thiotepa + TX, Thyramine + TX, Thuringensin + TX, Thiazinyl + TX, Tolcrophos-methyl + TX, Tolprocarb + TX, Tolylfuranide + TX, Tralomethrin + TX, Transpermethrin + TX, Tretamine + TX, Triadimephone + TX, Triadimenol + TX, Triamiphos + TX, Triatene + TX, Triazamate + TX, Triazophos + TX, Triazoxide + TX, Triazurone + TX, Tributyltin oxide + TX, Trichlormetaphos-3 + TX, Trichloronat + TX, Tricogramma spp.)+TX, Triclopyricarb+TX, Tricyclazole+TX, Tridemorph+TX, Triphenmorph+TX, Triphenophos+TX, Trifloxystrobin+TX, Triflumizole+TX, Triforin+TX, Trimedrua+TX, Trimedrua A+TX, Trimedrua B1+TX, Trimedrua B2+TX, Trimedrua C+TX, Trimetacarb+TX, Triactin+TX, Trinexapac+TX, Triphenyltin acetate+TX, Triphenyltin hydroxide+TX, Triplen+TX, Triticonazole+TX, Tranquol+TX, Typhlodromus occidentalisOccidentalis + TX, Uredepa + TX, Validamycin + TX, Valifenarate + TX, Bamidhione + TX, Vaniliprole + TX, Veratridine + TX, Veratrin + TX, Berbutin + TX, Verticillium lecanii + TX, Vinclozoline + TX, Warfarin + TX, XMC + TX, Xylenol + TX, Zeatin + TX, Zetamethrine + TX, Jonsemycin + TX, Zinc naphthenate + TX, Zinc phosphate + TX, Thiazole zinc + TX, Zineb + ​​TX, Ziram + TX, Zolaprofos + TX; Acinetobacter lwoffii + TX, Acremonium alternatum + TX, Acremonium cephalosporium + TX, Acremonium diospyri + TX, Acremonium obclavatum + TX, Adoxophyes orana granulovirus (AdoxGV) (Capex®) + TX, Agrobacterium radiobacter K84 strain (Galltrol-A®) + TX, Alternaria alternate + TX, Alternaria cassia + TX, Alternaria destoluene (Alternaria destruens)(Smolder(registered trademark))+TX, Ampelomyces quisqualis(AQ10(registered trademark))+TX, Aspergillus flavus AF36(AF36(registered trademark))+TX, Aspergillus flavus NRRL 21882(Aflaguard(registered trademark))+TX, Aspergillus genus (Aspergillus spp.) + TX, Aureobasidium pullulans + TX, Azospirillum (MicroAZ®, TAZO B®) + TX, Azotobacter + TX, Azotobacter chroocuccum (Azotomeal®) + TX, Azotobacter cysts (Bionatural Blooming Blossoms®) + TX, Bacillus amyloliquefaciens + TX, Bacillus cereus + TX, Bacillus chitinosporus AQ746 strain + TX, Bacillus chitinosporus (Bacillus Bacillus chitinosporus) CM-1 strain + TX, Bacillus circulans + TX, Bacillus firmus (BioSafe®, BioNem-WP®), especially CNMC 1-1582 strain (e.g., BASF SE's VOTIVO®) + TX, Bacillus licheniformis 3086 strain (EcoGuard®, Green Releaf®) + TX, Bacillus licheniformis HB-2 strain (Biostart®, formerly Rhizoboost®) + TX, Bacillus macerans + TX, Bacillus marismortui + TX, Bacillus megatherium (Bacillus megaterium) + TX, Bacillus mycoides AQ726 strain + TX, Bacillus papillae (Milky Spore Powder®) + TX, Bacillus pumilus spp.)+TX, Bacillus pumilus AQ717 strain +TX, Bacillus pumilus GB34 strain (Yield Shield®) +TX, Bacillus pumilus QST 2808 strain (Sonata®, Ballad Plus®) +TX, Bacillus sphaericus (VectoLex®) +TX, Bacillus spp. +TX, Bacillus spp. AQ175 strain +TX, Bacillus spp. AQ177 strain +TX, Bacillus spp. AQ178 strain +TX, Bacillus subtilis (Bacillus Bacillus subtilis) AQ153 strain + TX, Bacillus subtilis AQ743 strain + TX, Bacillus subtilis QST 713 strain (CEASE (registered trademark), Serenade (registered trademark), Rhapsody (registered trademark)) + TX, Bacillus subtilis QST714 strain (JAZZ (registered trademark)) + TX, Bacillus subtilis QST3002 strain + TX, Bacillus subtilis QST3004 strain + TX, Bacillus subtilis var.Amyloliquefaciens FZB24 strain (Taegro®, Rhizopro®) + TX, Bacillus thuringiensis aizawai GC 91 (Agree®) + TX, Bacillus thuringiensis Cry 2Ae + TX, Bacillus thuringiensis Cry1Ab + TX, Bacillus thuringiensis israelensis (BMP123®, Aquabac®, VectoBac®) + TX, Bacillus thuringiensis krustaki Bacillus thuringiensis kurstaki (Javelin®, Deliver®, CryMax®, Bondide®, Scutella WP®), Turilav WP®, Astuto®, Dipel WP®, Biobit®, Foray®) + TX, Bacillus thuringiensis kurstaki BMP 123 (Baritone®) + TX, Bacillus thuringiensis kurstaki HD-1 (Bioprotec-CAF / 3P®) + TX, Bacillus thuringiensis AQ52 strain + TX, Bacillus thuringiensis Bacillus thuringiensis)BD#32 strain + TX, Bacillus thuringiensis tenebrionis (Novodor®, BtBooster) + TX, Bacillus thuringiensis var. aizawai (XenTari®, DiPel®) + TX, Bacteria spp.)(GROWMEND(registered trademark), GROWSWEET(registered trademark), Shootup(registered trademark))+TX, Clavipacter michiganensis bacteriophage (AgriPhage(registered trademark), Bakflor(registered trademark))+TX, Beauveria bassiana (Beaugenic(registered trademark), Brocaril WP(registered trademark))+TX, Beauveria bassiana GHA (Mycotrol ES(registered trademark), Mycotrol O(registered trademark), BotaniGuard(registered trademark))+TX, Beauveria brongniartii (Engerlingspilz(registered trademark), Schweizer Beauveria(registered trademark), Melocont(registered trademark))+TX, Beauveria genus (Beauveria spp)+TX, Botrytis cineria cineria)+TX, Bradyrhizobium japonicum (TerraMax®)+TX, Brevibacillus brevis+TX, Burkholderia cepacia (Deny®, Intercept®, Blue Circle®)+TX, Burkholderia gladii+TX, Burkholderia gladioli+TX, Burkholderia spp.+TX, Canadian Bioherbicide® (CBH)+TX, Candida butyri+TX, Candida famata+TX, . Candida fructus + TX, Candida glabrata + TX, Candida guilliermondii + TX, Candida melibiosica + TX, Candida oleophila strain O + TX, Candida parapsilosis + TX, Candida pelliculosa + TX, Candida pulcherrima + TX, Candida reukaufii + TX, Candida saitoana (Bio-Coat®, Biocure®) + TX, Candida salmon (Candida sake)+TX, Candida spp.+TX, Candida tenius+TX, Cedecea davisae+TX, Cellulomonas flavigena+TX, Chaetomium cochliodes (Nova-Cide®)+TX, Chaetomium globosum (Nova-Cide®)+TX, Chromobacterium subtsugae PRAA4-1T strain (Grandevo®)+TX, Cladosporium chlorocephalum+TX, Cladosporium cladospolioides (Cladosporium Cladosporioides) + TX, Cladosporium oxysporum + TX, Cladosporium genus (Cladosporium spp.)+TX, Cladosporium tenuissimum+TX, Clonostachys rosea (EndoFine®)+TX, Colletotrichum acutatum+TX, Coniothyrium minitans (Cotans WG®)+TX, Coniothyrium spp.)+TX, Cryptococcus albidus (YIELDPLUS®)+TX, Cryptococcus humicola+TX, Cryptococcus infirmo-miniatus+TX, Cryptococcus laurentii+TX, Cryptophlebia leucotreta granulovirus (Cryptex®)+TX, Cupriavidus campinensis+TX, Cydia pomonella granulovirus (CYD-X®, Madex®, Madex® Plus, Madex Max, Carpovirusine® + TX, Cylindrobasidium laeve (Stumpout®) + TX, Cylindrocladium + TX, Debaryomyces hansenii + TX, Drecslera hawaiinensis + TX, Enterobacter cloacae + TX, Enterobacteriaceae + TX, Entomophtora virulenta (Vektor®) + TX, Epicoccum nigrum + TX, Epicoccum purpurascens + TX, Epicoccum spp.)+TX, Filobasidium floriforme+TX, Fusarium acuminatum+TX, Fusarium chlamydosporum+TX, Fusarium oxysporum (Fusaclean®, Biofox C®)+TX, Fusarium proliferatum+TX, Fusarium spp.+TX, Galactomyces geotrichum+TX, Gliocladium catenulatum (Primastop®, Prestop®)+TX, Gliocladium roseum roseum)+TX, Gliocladium spp. (SoilGard®)+TX, Gliocladium virens (Soilgard®)+TX, Granulovirus (Granupom®)+TX, Halobacillus halophilus+TX, Halobacillus litoralis+TX, Halobacillus trueperi+TX, Halomonas spp.)+TX, Halomonas subglaciescola+TX, Halovibrio variabilis+TX, Hanseniaspora uvarum+TX, Helicoverpa armigera nucleopolyhedrositis virus (Helicovex®)+TX, Helicoverpa zea nucleopolyhedrositis virus (Gemstar®)+TX, Isaria fumosorosea (Paecilomyces fumosoroseu strain, also known as PFR-97®, PreFeRal®)+TX, Isoflavone formononetin formononetin)(Myconate(registered trademark))+TX, Kloeckera apiculata+TX, Kloeckera spp.) + TX, Lagenidium giganteum (Laginex®) + TX, Lecanicillium lecanii (formerly known as Verticillium lecanii (Mycotal®)) conidia of strain KV01 (e.g., Vertalec® of Koppert / Arysta) + TX, Lecanicillium longisporum (Vertiblast®) + TX, Lecanicillium muscarium (Vertikil®) + TX, Lymantria Dispar nucleopolyhedrositis virus (Disparvirus®) + TX, Marinococcus halophyllus halophilus)+TX, Meira geulakonigii+TX, Metarhizium anisopliae (Destruxin WP(registered trademark))+TX, Metarhizium anisopliae (Met52(registered trademark))+TX, Metschnikowia fruticola (Shemer(registered trademark))+TX, Metschnikowia pulcherrima+TX, Microdochium dimerum (Antibot(registered trademark))+TX, Micromonospora coerulea+TX, Microsphaeropsis ochracea+TX, Muscodor albus albus)620(Muscudor(registered trademark))+TX, Muscodor roseus, especially strain A3-5 (accession number NRRL 30548)+TX, Mycorrhizae spp.)(AMykor(registered trademark), Root Maximizer(registered trademark))+TX, . Myrothecium verrucaria AARC-0255 strain (DiTera®, BROS PLUS®) + TX, Ophiostoma piliferum D97 strain (Sylvanex®) + TX, Paecilomyces farinosus + TX, Paecilomyces lilacinus 251 strain (MeloCon WG®) + TX, Paecilomyces linacinus (Biostat WP®) + TX, Paenibacillus polymyxa + TX, Pantoea agglomerans (BlightBan C9-1(registered trademark))+TX, Pantoea spp.+TX, Pasteuria nishizawae, especially Pn1 strain (CLARIVA of Syngenta / ChemChina);+TX, Pasteuria spp. (Econem(registered trademark))+TX, Penicillium aurantiogriseum+TX, Penicillium billai (Jumpstart(registered trademark), TagTeam(registered trademark))+TX, Penicillium brevicompactum+TX, Penicillium frequentans+TX, Penicillium griseofulum (Penicillium Penicillium griseofulvum)+TX, Penicillium purpurogenum+TX, Penicillium spp.)+TX, Penicillium viridicatum+TX, Phlebiopsis gigantean (Rotstop®)+TX, Phosphate-soluble bacteria (Phosphomeal®)+TX, Phytophthora cryptogea+TX, Phytophthora palmivora (Devine®)+TX, Pichia anomala+TX, Pichia guilliermondii+TX, Pichia membranaefaciens+TX, Pichia onychis+TX, Pichia stipites (Pichia Pseudomonas stipites) + TX, Pseudomonas aeruginosa + TX, Pseudomonas aureofasciens (Spot-Less Biofungicide®) + TX, Pseudomonas cepacia + TX, Pseudomonas chlororaphis (AtEze®) + TX, Pseudomonas corrugate + TX, Pseudomonas fluorescens (Zequanox®) + TX, Pseudomonas fluorescens strain A506 (BlightBan A506®) + TX, Pseudomonas putida (Pseudomonas putida)+TX, Pseudomonas reactans+TX, Pseudomonas spp.) + TX, Pseudomonas syringae (Bio-Save®) + TX, Pseudomonas viridiflava + TX, Pseudozyma flocculosa PF-A22 UL strain (Sporodex L®) + TX, Puccinia canaliculata + TX, Puccinia thlaspeos (Wood Warrior®) + TX, Pythium paroecandrum + TX, Pythium oligandrum (Polygandron®, Polyversum®) + TX, Pythium periplocum + TX, Ranella aquatilis (Rhanella aquatilis)+TX, Rhanella spp.+TX, Rhizobia (Dormal®, Vault®)+TX, Rhizoctonia+TX, Rhodococcus globerulus AQ719 strain+TX, Rhodosporidium diobovatum+TX, Rhodosporidium toruloides+TX, Rhodotorula glutinis+TX, Rhodotorula graminis+TX, Rhodotorula mucilagnosa+TX, Rhodotorula rubra+TX, Rhodotorula genus spp.)+TX, Saccharomyces cerevisiae+TX, Salinococcus roseus+TX, Sclerotinia minor (SARRITOR®)+TX, Sclerotinia minor+TX, Scytalidium spp.+TX, Scytalidium uredinicola+TX, Serratia marcescens+TX, Serratia plymuthica+TX, Serratia spp.)+TX, Sordaria fimicola+TX, Spodoptera exigua nuclear polyhedosis virus (Spod-X®, Spexit®)+TX, Spodoptera littoralis nuclear polyhedosis virus (Littovir®)+TX, Sporobolomyces roseus+TX, Stenotrophomonas maltophilia+TX, Streptomyces albaduncus+TX, Streptomyces exfoliates+TX, Streptomyces garbus (Streptomyces galbus)+TX, Streptomyces griseoplanus+TX, Streptomyces griseoviridis (Mycostop®)+TX, Streptomyces hygroscopicus+TX, Streptomyces lydicus (Actinovate®)+TX, Streptomyces lydicus WYEC-108 (ActinoGrow®)+TX, Streptomyces violaceus+TX, Tilletiopsis minor+TX, Tilletiopsis spp.)+TX, Trichoderma asperellum (T34 Biocontrol®)+TX, Trichoderma atroviride (Plantmate®)+TX, Trichoderma gamsii (Tenet®)+TX, Trichoderma hamatum TH 382+TX, Trichoderma harzianum rifai (Mycostar®)+TX, Trichoderma harzianum T-22 (Trianum-P®, PlantShield HC®, RootShield®, Trianum-G®)+TX, Trichoderma harzianum (Trichoderma harzianum)T-39(Trichodex(registered trademark))+TX,. Trichoderma inhamatum + TX, Trichoderma koningii + TX, Trichoderma lignorum + TX, Trichoderma longibrachiatum + TX, Trichoderma polysporum (Binab T®) + TX, Trichoderma spp. LC 52 (Sentinel®) + TX, Trichoderma taxi + TX, Trichoderma virens (formerly known as Gliocladium virens GL-21) (SoilGuard®) + TX, Trichoderma virens (Trichoderma Trichoderma viride +TX, Trichoderma viride ICC 080 strain (Remedier®) +TX, Trichosporon pullulans +TX, Trichosporon spp. +TX, Trichothecium roseum +TX, Trichothecium spp.)+TX, Typhula phacorrhiza strain 94670+TX, Typhula phacorrhiza strain 94671+TX, Ulocladium atrum+TX, Ulocladium oudemansii (Botry-Zen®)+TX, Ustilago maydis+TX, various bacteria and auxiliary micronutrients (Natural II®)+TX, various fungi (Millennium Microbes®)+TX, Verticillium chlamydosporium+TX, Vip3Aa20 (VIPtera®)+TX, Virgibaclillus marisumaltui marismortui)+TX, Xanthomonas campestris pv. pv. poai (Camperico®)+TX, Xenorhabdus bovienii+TX, Xenorhabdus nematophilus+TX;. AGNIQUE® MMF + TX, Azadirachtin (Plasma Neem Oil®, AzaGuard®, MeemAzal®, Molt-X®, e.g., Certis, US AZATIN XL) + TX, Botanical IGR (Neemazad®, Neemix®) + TX, BugOil® + TX, Canola Oil (Lilly Miller Vegol®) + TX, Chenopodium ambrosioides near ambrosioides (Requiem®) + TX, Chrysanthemum Extract (Crisant®) + TX, Lamiaceae Essential Oil (Botania®) + TX, Neem Oil Extract (Trilogy®) + TX, Blackberry Rosemary Peppermint and Thyme Oil Extract (Garden Insect) Killer® + TX, Garlic + TX, Glycine Betaine (Greenstim®) + TX, Kaolin (Screen®) + TX, Lemongrass Oil (GreenMatch®) + TX, Melaleuca alternifolia Extract (also known as Tea Tree Oil) (Timorex Gold®) + TX, Clove Peppermint Garlic Oil and Mint Mixture (Soil Shot®) + TX, Clove Rosemary and Peppermint Extract Mixture (EF 400®) + TX, Rosemary Sesame Peppermint Thyme and Cinnamon Extract Mixture (EF 300®) + TX, Neem Oil + TX, Nepeta cataria (Catnip Oil) + TX, Nepeta Catalina (Nepeta catarina) + TX, nicotine + TX, oregano oil (MossBuster®) + TX, pedaliaceae oil (Nematon®) + TX, pine oil (Retenol®) + TX, pyrethrium + TX, Quillaja saponaria (QuillajaSaponaria (NemaQ®) + TX, Reynoutria sachalinensis (Regalia®, Sakalia®) + TX, Rotenone (Eco Roten®) + TX, Rutaceae plant extract (Soleo®) + TX, Soybean oil (Ortho ecosense®) + TX, Brown algae storage glucum (Laminarin®) + TX, Thyme oil + TX; (E,Z)-7,9-Dodecadiene-1-yl acetate + TX, (E,Z,Z)-3,8,11-Tetradecatrienylate + TX, (Z,Z,E)-7,11,13-Hexadecatrienal + TX, 2-Methyl-1-butanol + TX, Biolure® + TX, Blackheaded Fireworm Pheromone (3M Sprayable Blackheaded Fireworm Pheromone®) + TX, Calcium Acetate + TX, Check-Mate® + TX, Codling Moth Pheromone (Paramount dispenser-(CM) / Isomate C-Plus®) + TX, Entostat Powder (Exosex CM®) (Exosex extract from palm trees) + TX, Grape Berry Moth Pheromone (3M MEC-GBM Sprayable Pheromone(registered trademark) + TX, Lavanzuryl senecioate + TX, Leafroller pheromone (3M MEC-LR Sprayable Pheromone(registered trademark)) + TX, Muscamone (Snip7 Fly Bait(registered trademark)) + TX, Oriental Fruit Moth pheromone (3M oriental fruit moth sprayable pheromone(registered trademark)) + TX, Peachtree Borer pheromone (Isomate-P(registered trademark)) + TX, Scenturion(registered trademark) + TX, Starbar Premium Fly Bait(registered trademark) + TX, Tomato pinworm pheromone (3M Sprayable pheromone(registered trademark)) + TX; Acerophagus papaya + TX, Adalia bipunctata (Adalia-System®) + TX, Adalia bipunctata (Adaline®) + TX, Adalia bipunctata (Aphidalia®) + TX, Ageniaspis citricola + TX, Ageniaspis fuscicollis + TX, Amblyseius andersoni (Anderline®, Andersoni-System®) + TX, Amblyseius californicus (Amblyline®, Spical®) + TX, Amblyseius cucumeris cucumeris) (Thripex®, Bugline cucumeris®) + TX, Amblyseius fallacis (Fallacis®) + TX, Amblyseius swirskii (Bugline swirskii®, Swirskii-Mite®) + TX, Amblyseius womersleyi (WomerMite®) + TX, Amitus hesperidum + TX, Anagrus atomus + TX, Anagyrus fusciventris + TX, Anagyrus kamali + TX, Anagyrus roeckii (Anagyrus loecki)+TX, Anagyrus pseudococci (Citripar(registered trademark))+TX, Anicetus benefices+TX, Anisopteromalus calandraecalandrae)+TX, Anthocoris nemoralis (Anthocoris-System(registered trademark))+TX, Aphelinus abdominalis (Apheline(registered trademark), Aphiline(registered trademark))+TX, Aphelinus asychis+TX, Aphidius colemani (Aphipar(registered trademark))+TX, Aphidius ervi (Aphelinus-System(registered trademark))+TX, Aphidius ervi (Ervipar(registered trademark))+TX, Aphidius gifuensis+TX, Aphidius matricariae (Aphidius matricariae)(Aphipar-M(registered trademark))+TX, Aphidoletes aphidimiza(Aphidend(registered trademark), Aphidoline(registered trademark))+TX, Aphytis lingnanensis+TX, Aphytis melinus+TX, Aprostocetus hagenowii+TX, Atheta coriaria(Staphyline(registered trademark))+TX, Bombus spp.+TX, Bombus terrestris(Beeline(registered trademark), Tripol(registered trademark))+TX, Bombus terrestris(Natupol Beehive (registered trademark) + TX, Cephalonomia stephanoderis + TX, Chilocorus nigritus + TX, Chrysoperla carnea (Chryssoline (registered trademark), Chrysopa (registered trademark)) + TX, Chrysoperla rufirabris (Chrysoperlarufilabris)+TX, Cirrospilus ingenuus+TX, Cirrospilus quadristriatus+TX, Citrostichus phyllocnistoides+TX, Closterocerus chamaeleon+TX, Closterocerus spp+TX, Coccidoxenoides perminutus (Planopar(registered trademark))+TX, Coccophagus cowperi+TX, Coccophagus lycimnia+TX, Cotesia flavipes+TX, Cotesia plutellae (Cotesia plutellae)+TX, Cryptolaemus montrozieri (Cryptobug®, Cryptoline®)+TX, Cibocephalus nipponicus+TX, Dacnusa sibirica (Minusa®, DacDigline®, Minex®)+TX, Delphastus catalinae (Delphastus®)+TX, Delphastus pusillus+TX, Diachasmimorpha krausii+TX, Diachasorpha longicaudata+TX, Diaparsis jucunda jucunda)+TX, Diaporencyrtus aligarhensis+TX, Diglyphus isaeaeisaea) (Andersin®, Andersoni-System®) + TX, Diversinervus spp. + TX, Encarsia citrina + TX, Encarsia formosa (Amblyline®, Spical®) + TX, Encarsia guadeloupae + TX, Encarsia haitiensis + TX, Episyrphus balteatus (Syrphidend®) + TX, Eretmoceris siphonini + TX, Eretmocerus californicus + TX, Eretmocerus erus ericus) (Thripex®, Bugline cucumeris®) + TX, Eretmocerus hayati + TX, Eretmocerus mundus (Bugline swirskii®, Swirskii-Mite®) + TX, Eretmocerus siphonini + TX, Exochomus quadripustulatus + TX, Feltiella acarisuga (Feltirine®) + TX, Feltiella acarisuga (Spidend®) + TX, Foparisanus + TX, Phopius cerativorus (Fopius ceratitivorus) + TX, formononetin (Wirless Beehome®) + TX, Franklinothrips vespiformis (Vespop®) + TX, Galendromus occidentalisoccidentalis)+TX, Goniozus legneri+TX, Habrobacon hebetor+TX, Harmonia axyridis (HarmoBeetle®)+TX, Heterorhabditis bacteriophora (NemaShield HB®, Nemaseek®, Terranem-Nam®, Terranem®, Larvanem®, B-Green®, NemAttack®, Nematop®)+TX, Heterorhabditis megidis (Nemasys H®, BioNem H®, Exhibitline) hm(registered trademark), Larvanem-M(registered trademark))+TX, Heterorhabditis spp. (Lawn Patrol(registered trademark))+TX, Hippodamia convergens+TX, Hypoaspis aculeifer (Aculeifer-System(registered trademark), Entomite-A(registered trademark))+TX, Hypoaspis miles (Hypoline m(registered trademark), Entomite-M(registered trademark))+TX, Lbalia leucospoides+TX, Lecanoideus floccissimus+TX, Lemophagus errabundus+TX, Leptomastidea abnormis+TX, Leptomastix dactylopii (Leptopar(registered trademark))+TX, Leptomastix epona+TX, Lindorus lophanthae+TX, Lipolexis oregmae+TX, Golden Fly (Lucilia caesar) (Natufly®) + TX, Lysiphlebus testaceipes + TX, Macrolophus caliginosus (Mirical-N®, Macroline c®, Mirical®) + TX, Mesoseiulus longipes + TX, Metaphycus flavus + TX, Metaphycus lounsburyi + TX, Micromus angulatus (Milacewing®) + TX, Microterys flavus + TX, Muscidifurax raptorellus and Spalangia cameloni cameroni) (Biopar(registered trademark)) + TX, Neodryinus typhlocybae + TX, Neoseiulus californicus + TX, Neoseiulus cucumeris (THRYPEX(registered trademark)) + TX, Neoseiulus farasis (Neoseiulusfallacis)+TX, Nesideocoris tenuis (NesidioBug(registered trademark)+TX, Nesibug(registered trademark))+TX, Ophyra aenescens (Biofly(registered trademark))+TX, Orius insidiosus (Thripor-I(registered trademark)+TX, Oriline i(registered trademark))+TX, Orius laevigatus (Thripor-L(registered trademark), Oriline l(registered trademark))+TX, Orius majusculus (Oriline m(registered trademark))+TX, Orius strigicollis (Thripor-S(registered trademark))+TX, Pauesia juniperorum Juniperorum) + TX, Pediobius foveolatus + TX, Phasmarhabditis hermaphrodita (Nemaslug®) + TX, Phymastichus coffea + TX, Phytoseiulus macropilus + TX, Phytoseiulus persimilis (Spidex®, Phytoline p®) + TX, Podisus maculiventris (Podisus®) + TX, Pseudacteon curvatus + TX, Pseudacteon obtusus + TX, Pseudacteon tricasspis (Pseudacteon tricuspis) + TX, Pseudaphycus maculipennis + TX, Pseudleptomastix mexicana + TX, Psyllaephagus pilosuspilosus)+TX, Psyttalia concolor (complex)+TX, Quadrastichus spp.+TX, Rhyzobius lophanthae+TX, Rodolia cardinalis+TX, Rumina decollate+TX, Semielacher petiolatus+TX, Sitobion avenae (Ervibank®)+TX, Steinernema carpocapsae (Nematac C®, Millennium®, BioNem C (registered trademark), NemAttack (registered trademark), Nemastar (registered trademark), Capsanem (registered trademark)) + TX, Steinernema feltiae (NemaShield (registered trademark), Nemasys F (registered trademark), BioNem F (registered trademark), Steinernema-System (registered trademark), NemAttack (registered trademark), Nemaplus (registered trademark), Exhibitline sf (registered trademark), Scia-rid (registered trademark), Entonem (registered trademark)) + TX, Steinernema kraussei (Nemasys L (registered trademark), BioNem L (registered trademark), Exhibitline srb (registered trademark)) + TX, Steinernema riobrave (BioVector (registered trademark), BioVektor (registered trademark)) + TX, Steinernema skapteriski (Steinernema Steinernema spp. (Nematac S®) + TX, Steinernema spp. (Steinernema spp.) + TX, Steinernematid spp. (Guardian Nematodes®) + TX, Stethorus punctulumpunctillum)(Stethorus(registered trademark))+TX, Tamarixia radiate+TX, Tetrastichus setifer+TX, Thripobius semiluteus+TX, Torymus sinensis+TX, Tricogramma brassicae(Tricholine b(registered trademark))+TX, Tricogramma brassicae(Tricho-Strip(registered trademark))+TX, Tricogramma evanescens+TX, Tricogramma minutum+TX, Tricogramma ostriniae+TX, Tricogramma platneri(Trichogramma platneri)+TX, Trichogramma pretiosum+TX, Xanthopimpla stemmator+TX; Abscisic acid + TX, Aminomite® + TX, BioGain® + TX, bioSea® + TX, CAS number: 2643947-26-4 + TX, Chondrostereum purpureum (Chontrol Paste®) + TX, Colletotrichum gloeosporioides (Collego®) + TX, Copper octanoate (Cueva®) + TX, Delta Trap (Trapline d®) + TX, Erwinia amylovora (Harpin) (ProAct®), Ni-HIBIT Gold CST(registered trademark))+TX, fatty acids derived from natural by-products of extra virgin olive oil (FLIPPER(registered trademark))+TX, ferric phosphate (Ferramol(registered trademark))+TX, funnel trap (Trapline y(registered trademark))+TX, Gallex(registered trademark)+TX, Grower's Secret(registered trademark)+TX, homo-brassonolide+TX, iron phosphate (Lilly Miller Worry Free Ferramol Slug & Snail Bait(registered trademark))+TX, MCP hail trap (Trapline f(registered trademark))+TX, Microctonus hyperodae+TX, Mycoleptodiscus terrestris (Des-X(registered trademark))+TX, Nosema locustae (Semaspore Organic Grasshopper) Control (registered trademark) + TX, pheromone trap (Thripline ams (registered trademark)) + TX, potassium bicarbonate (MilStop (registered trademark)) + TX, potassium iodide + potassium thiocyanate (Enzicur (registered trademark)) + TX, potassium salt of fatty acid (Sanova (registered trademark)) + TX, potassium silicate solution (Sil-Matrix (registered trademark)) + TX, spider venom + TX, sticky trap (TraplineYF(registered trademark), Rebell Amarillo(registered trademark))+TX, SuffOil-X(registered trademark)+TX, Trap(Takitrapline y+b(registered trademark))+TX; Bacillus mojavensis strain R3B (accession number NCAIM(P)B001389) (International Publication No. 2013 / 034938) + TX from Certis USA LLC, Bacillus pumilus, in particular strain BU F-33 with NRRL accession number 50185 (BASF's CARTISSA®, EPA registration number 71840-19) + TX from Certis USA LLC, Bacillus subtilis CX-9060 from Certis USA LLC, Bacillus sp., in particular strain D747 with accession number FERM BP-8234, U.S. Patent No. 7,094,592 (DOUBLE from Kumiai Chemical Industry Co., Ltd.) Bacillus subtilis BU1814 strain (available as NICKEL®, VELONDIS® FLEX, and VELONDIS® EXTRA from BASF SE) + TX, Bacillus subtilis var. amyloliquefaciens FZB24 strain (available from Novozymes as TAEGRO® or TAEGRO® ECO (EPA registration number 70127-5)) + TX, Bacillus subtilis, particularly strain QST713 / AQ713 (with NRRL accession number B-21661, listed in U.S. Patent No. 6,060,051, Bayer CropScience) Available from LP, US as SERENADE® OPTI or SERENADE® ASO) + TX, Paenibacillus polymyxa, especially strain AC-1 (e.g., Green Biotech Company Ltd.)TOPSEED® (registered trademark) + TX; strains of the genus Paenibacillus (with accession number NRRL B-50972 or accession number NRRL B-67129, International Publication No. 2016 / 154297) + TX; Pantoea agglomerans, in particular strain E325 (accession number NRRL B-21856) (available from Northwest Agri Products as BLOOMTIME BIOLOGICAL® FD BIOPESTICIDE) + TX; Pseudomonas proradix (e.g., PRORADIX® of Sourcon Padena) + TX; : Aureobasidium pullulans, especially spores of strain DSM14940, spores of strain DSM14941, or mixtures of spores of strains DSM14940 and DSM14941 (e.g., BOTECTOR® and BLOSSOM PROTECT® from bio-ferm, CH) +TX; Pseudozyma aphidis (disclosed in International Publication No. 2011 / 151819 by Yissum Research Development Company of the Hebrew University of Jerusalem) +TX; Saccharomyces cerevisiae from Lesaffre et Compagnie, FR cerevisiae), particularly strains CNCM No. 1-3936, CNCM No. 1-3937, CNCM No. 1-3938 or CNCM No. 1-3939 (International Publication No. 2010 / 086790) + TX; Agrobacterium radiobacter strain K84 (e.g., GALLTROL-A® from AgBioChem, CA) + TX, Bacillus amyloliquefaciens isolate B246 (e.g., AVOGREEN® from University of Pretoria) + TX, Bacillus amyloliquefaciens strain F727 (also known as MBI110) (NRRL accession number B-50768, International Publication No. 2014 / 028521) (STARGUS® from Marrone Bio Innovations) + TX, Bacillus amyloliquefaciens strain FZB42, accession number DSM 23117 (available from ABiTEP, DE as RhizOVITAL®) + TX, Bacillus amyloliquefaciens, particularly strain D747 (available from Kumiai Chemical Industry Co., Ltd. as Double Nickel®, with accession number FERM BP-8234, U.S. 7,094,592) + TX, Bacillus licheniformis FMCH001 and Bacillus subtilis FMCH002 (QUARTZO® (WG) and PRESENCE® (WP) from FMC Corporation) + TX, Bacillus licheniformis, in particular strain SB3086 (with accession number ATCC 55406, International Publication No. 2003 / 000051) (available from Novozymes as ECOGUARD® Biofungicide and GREEN RELEAF®) + TX, Bacillus methylotrophicus strain BAC-9912 (Chinese Academy of Sciences' Institute of Applied (from Ecology) +TX, Bacillus mycoides isolate with accession number B-30890 (available from Certis USA LLC as BMJ TGAI® or WG and LifeGard®) +TX, Bacillus pumilus, in particular strain GB34 (available from Bayer AG, DE as Yeld Shield®) +TX, Bacillus pumilus, in particular strain QST2808 (available from Bayer CropScience LP, US as SONATA®, with accession number NRRL B-30087, U.S. 6,245,(as described in Specification No. 551) +TX, Bacillus subtilis CX-9060 +TX from Certis USA LLC, Bacillus subtilis IAB / BS03 (AVIV (trademark) from STK Bio-Ag Technologies, PORTENTO (registered trademark) from Idai Nature) +TX, Bacillus subtilis KTSB strain (FOLIACTIVE (registered trademark) from Donaghys) +TX, Bacillus subtilis BU1814 strain (available from BASF SE as VELONDIS (registered trademark) PLUS, VELONDIS (registered trademark) FLEX and VELONDIS (registered trademark) EXTRA) +TX, Bacillus subtilis GB03 strain (available from Bayer AG, DE as Kodiak (registered trademark)) +TX, Accession number NRRL Bacillus subtilis MBI 600 strain (available from BASF SE as SUBTILEX) + TX, U.S. Patent No. 5,061,495, with B-50595; Bacillus subtilis Y1336 strain (available from Bion-Tech, Taiwan as BIOBAC®, registered in Taiwan as a biological fungicide with registration numbers 4764, 5454, 5096 and 5277) + TX; Bacillus subtilis var. amyloliquefaciens FZB24 strain (available from Novozymes as TAEGRO® or TAEGRO (or) ECO) + TX, with accession number DSM 10271; Bacillus subtilis (subtilis)Y1336 (Available from Bion-Tech, Taiwan as BIOBAC (registered trademark), registered in Taiwan as a biological fungicide with registration numbers 4764, 5454)Paenibacillus epiphyticus (International Publication No. 2016 / 020371) from BASF SE (registered in 5096 and 5277) +TX, Paenibacillus polymyxa ssp. plantarum from BASF SE +TX, strain of Paenibacillus sp. with accession number NRRL B-50972 or accession number NRRL B-67129 (International Publication No. 2016 / 154297) +TX, strain of Pseudomonas chlororaphis AFS009 (International Publication No. 2017 / 019448 (e.g. AgBiome) with accession number NRRL B-50897) HOWLER (trademark) and ZIO (registered trademark) from Innovations, US + TX, Pseudomonas chlororaphis, especially strain MA342 (e.g., CEDOMON (registered trademark), CERALL (registered trademark), and CEDRESS (registered trademark) by Bioagri and Koppert) + TX, Pseudomonas fluorescens A506 strain (e.g., BLIGHTBAN (registered trademark) A506 by NuFarm) + TX, Pseudomonas proradix (e.g., PRORADIX (registered trademark) from Sourcon Padena) + TX, Streptomyces griseoviridis K61 strain (also known as Streptomyces galbus K61) (Accession number DSM) 7206) (Verdera's MYCOSTOP (registered trademark), BioWorks' PREFENCE (registered trademark), Crop Protection 2006, 25,(See 468-475) +TX, Streptomyces lydicus WYEC108 strain (also known as Streptomyces lydicus WYCD108US strain) (Acti-Iron® and Actinovate® from Novozymes) +TX; Trichoderma atroviride strain T11 (IMI352941 / CECT20498) + TX, Ampelomyces quisqualis AQ10 (e.g., AQ 10® from IntrachemBio Italia) + TX with accession number CNCM 1-807, Ampelomyces quisqualis, especially strain AQ10 (e.g., AQ 10® from IntrachemBio Italia) + TX, Aspergillus flavus NRRL 21882 strain (product known as AFLA-GUARD® from Syngenta / ChemChina) + TX, Aureobasidium pullulans, especially DSM 14941 strain blast cell pore + TX, Aureobasidium pullulans, especially DSM14940 strain blast cell pore + TX, Aureobasidium pullulans, especially DSM14940 strain and DSM 14941 strain (e.g., bio-ferm,Mixture of blast pores of Botector® by CH + TX, Chaetomium cupreum (accession no. CABI 353812) (e.g., BIOKUPRUM® by AgriLife) + TX, Chaetomium globosum (available as RIVADIOM® by Rivale) + TX, Cladosporium cladosporioides H39 strain with accession no. CBS122244 (US Patent Application Publication No. 2010 / 0291039) (by Stichting Dienst Landbowkundig Onderzoek) + TX, Coniothyrium minitans, in particular CON / M / 91-8 strain (accession no. DSM9660, e.g., Bayer CropScience Biologics) From GmbH, Contans(registered trademark)) + TX, Cryptococcus flavescens, strain 3C (NRRL Y-50378) + TX, Dactylaria candida, Dilophosphora alopecuri (available as TWIST FUNGUS(registered trademark)), Fusarium oxysporum, strain Fo47 (available as FUSACLEAN(registered trademark) by Natural Plant Protection) + TX, Gliocladium catenulatum (synonym: Clonostachys rosea f. catenulate) strain J1446 (e.g., Prestop(registered trademark) by Lallemand) + TX, Gliocladium roseum roseum) (also known as Clonostachys rosea f rosea) IK726 strain (Jensen DF,(et al. Development of a biocontrol agent for plant disease control with special emphasis on the near commercial fungal antagonist Clonostachys rosea strain 'IK726', Australasian Plant Pathol. 2007, 36(2):95-101) + TX, Gliocladium roseum (also known as Clonostachys rosea f rosea), especially strain 321U from Adjuvants Plus, strain ACM941 + TX as disclosed in Xue AG (Efficacy of Clonostachys rosea strain ACM941 and fungicide seed treatments for controlling the root tot complex of field pea, Can Jour Plant Sci 2003, 83(3):519-524), Metschnikowia fructicola, especially NRRL Y-30752 strain + TX, Microsphaeropsis ochracea, Penicillium steckii (DSM 27859, International Publication No. 2015 / 067800) + TX from BASF SE, Trichoderma asperellum ICC 012 strain (also known as Trichoderma harzianum ICC 012) with accession number CABI CC IMI 392716, and Trichoderma gamsii (formerly known as T. viride) ICC 080 strain + TX (e.g., BIO-TAM (trademark) or Agrobiosol de from Isagro USA, Inc.) Mexico,Mixture with BIODERMA® by SAde CV + TX, Penicillium vermiculatum + TX, Phlebiosis gigantea VRA 1992 strain (ROTSTOP® C from Danstar Ferment) + TX, Pseudozyma flocculosa, PF-A22 UL strain (available as SPORODEX® L from Plant Products Co., CA) + TX, Saccharomyces cerevisiae LAS117 cell wall (CEREVISANE® from Lesaffre, ROMEO® from BASF SE) + TX, Saccharomyces cerevisiae from Lesaffre et Compagnie, FR Saccharomyces cerevisiae) CNCM No. 1-3936, CNCM No. 1-3937, CNCM No. 1-3938, CNCM No. 1-3939 (International Publication No. 2010 / 086790) + TX, Saccharomyces cerevisiae, especially LASO2 strain (from Agro-Levures et Derives) + TX, Simplicillium lanosoniveum + TX, T34 strain (e.g., T34 Biocontrol by Biocontrol Technologies SL,ES) or ICC 012 strain from Isagro + TX, WRL-076 strain (NRRL Y-30842) (US No. 7,579,183) + TX, Talaromyces flavus, strain V117b + TX, Trichoderma asperelloides JM41R (accession number NRRL B-50759) (TRICHO PLUS® from BASF SE) + TX, Trichoderma asperellum, in particular strain SKT-1 with accession number FERM P-16510 (e.g., ECO-HOPE® from Kumiai Chemical Industry) + TX, Trichoderma asperellum, in particular kd strain (e.g., T-Gro from Andermatt Biocontrol) + TX, Trichoderma atroviride strain 77B (Andermatt Biocontrol T77) + TX, Trichoderma atroviride ATCC 20476 strain (IMI 206040) + TX, Trichoderma atroviride LC52 strain (e.g., Tenet by Agrimm Technologies Limited) + TX, Trichoderma atroviride LU132 strain (e.g., Sentinel from Agrimm Technologies Limited) + TX, Trichoderma atroviride NMI number V 08 / 002388 strain + TX, Trichoderma atroviride NMI number V 08 / 002389 strain + TX, Trichoderma atroviride NMI number V 08 / 002390 strain + TX, Trichoderma atroviride number V 08 / 002387 strain + TX, Trichoderma atroviride SKT-1 strain (FERM P-16510) (JP-A-11-253151) + TX, Trichoderma atroviride SKT-2 strain (FERM P-16511) (JP-A-11-253151) + TX, Trichoderma atroviride SKT-3 strain (FERM P-17021) (JP-A-11-253151), Trichoderma atroviride, especially SC1 strain (Accession No. CBS 122089, International Publication No. 2009 / 116106 and U.S. Patent No. 8,431,120 (Bi-PA)) + TX, Trichoderma atroviride, CNCM 1-1237 strains (e.g., Agrauxine, Esquive® WP from FR) + TX, Trichoderma fertile (TrichoPlus product from BASF) + TX, Trichoderma gamsii (formerly known as T. viride) + TX, Trichoderma gamsii (formerly known as T. viride) ICC080 strain (IMI CC 392151 CABI) (AGROBIOSOL DE MEXICO,(Available as BIODERMA® by SADE CV) +TX, Trichoderma ...

Claims

1. A fungicidal composition comprising components (A) and (B) as active ingredients, wherein component (A) is of formula (I): 【Chemistry 1】 (In the formula, Z is O; R 1 is C 1-6 alkyl, C 1-6 alkoxy-C 1-6 alkyl, C 3-6 cycloalkyl, C 1-6 alkylsulfonyl-C 1-6 alkyl, and C 3-6 cycloalkyl-C 1-4 alkyl selected from, wherein said C 1-6 alkyl, C 1-6 alkoxy-C 1-6 alkyl, C 3-6 cycloalkyl, C 1-6 alkylsulfonyl-C 1-6 alkyl, and C 3-6 cycloalkyl-C 1-4 each of the alkyl groups may be optionally substituted with CN; R 2a H, C 1-6 Alkyl, C 3-6 Cycloalkyl, and C 1-6 Alkoxy-C 1-6 Selected from alkyl groups; R 2b H, CN, C 1-6 Alkyl, C 3-6 Cycloalkyl, C 1-6 Alkoxy-C 1-6 Alkyl, amino, and -NHC(O)C 1-6 Selected from alkyl groups; R 2c is H; J is N or CR 4 And; G is CR 5 And; R 3 is H; R 4 is a halogen or CN; R 5 H, C 1-6 Alkyl, C 1-6 Selected from alkoxy and halogen; A is CH or N; and R 6 C 1-6 Alkyl, C 1-6 Alkoxy, C 3-6 Cycloalkyl, C 1-6 Alkylamino, C 1-6 Alkoxyaminos and C 1-6 Alkyl C 1-6 (Selected from alkoxyaminos); It is a compound of or a salt or N-oxide thereof; and Ingredient (B) is acetamiprid, acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, Bacillus amyloliquefaciens, benzovindiflupir, broflanilide, chlorothalonil, clothianidin, chlorantraniliprole, cis-jasmon, cyantraniliprole, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, etaboxam, fenpicoxamide, florylpicoxamide, fluazinam, fludioxonil, fluindapir, fluopicolide, fluopyram, fluoxapiproline, fluoxythioconazole, fluxamethoxamide, fluxapyroxad, flu Pet, imidacloprid, impulfluxam, ipconazole, ipflufenokine, isocycloseram, isoflucipram, isothianil, mandipropamide, mefentrifluconazole, metalaxyl, metalaxyl-M (mefenoxam), methyltetraprole, oxatiapiproline, penflufen, phosphite (phosphonate), picarbutrazox, prothioconazole, pidflumetofen, pyraclostrobin, quinofumerine, sedaxane, silthiofame, Streptomyces crestomycetics (chrestomyceticus), tebuconazole, tetraniliprol, thiabendazole, thiamethoxam, tolprocarb, triticonazole, zoxamide, N-[(1R)-1-benzyl-3-chloro-1-methylbuta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methylbuta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1R) -1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoroquinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoroquinoline-3-carboxamide A fungicidal composition comprising a compound selected from the group consisting of N-[(1S)-1-benzyl-1,3-dimethylbutyl]-8-fluoroquinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methylbuta-3-enyl)-8-fluoroquinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methylbuta-3-enyl)-8-fluoroquinoline-3-carboxamide.

2. -R 1 However, CH 3 ,CH 2 -CH 3 ,CH 2 -O-CH 3 ,CH 2 -SO 2 -CH 3 , and CH 2 Selected from CN; -R 2a H and CH 3 Selected from; -R 2b However, H, CH 3 ien-CH 2 OCH 3 NH 2 , and -NHC(O)CH 3 Selected from; -R 2c H is; - J is N or CR 4 And; -G is CR 5 And; -R 3 H is; -R 4 However, it is chloro, fluoro, or CN; -R 5 However, H, CH 3 , -OCH 3 Selected from , and fluoro; -A is CH or N; and -R 6 However, cyclopropyl, -OCH 3 and -NH-O-CH 3 Selected from, The fungicidal composition according to claim 1.

3. The aforementioned component (A) is: Methyl N-[5-[6-[(4-fluoro-3-methoxyphenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate Methyl N-[5-[6-[(4-fluoro-3-methoxyphenyl)-methyl-carbamoyl]-8-methyl-imidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate, Methyl N-[5-[6-[(4-fluoro-3-methoxyphenyl)-(methoxymethyl)carbamoyl]-8-methyl-imidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate, Methyl N-[5-[6-[(4-fluoro-3-methoxyphenyl)-(methoxymethyl)carbamoyl]imidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate Methyl N-[4-[6-[(4-fluoro-3-methoxyphenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridine-3-yl]phenyl]carbamate 3-[6-(cyclopropanecarbonylamino)-3-pyridyl]-N-(4-fluoro-3-methoxyphenyl)-N-methylimidazo[1,2-a]pyridine-6-carboxamide Methyl N-[4-[6-[(4-fluorophenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridine-3-yl]phenyl]carbamate, Methyl N-[4-[6-[(4-chlorophenyl)-methyl-carbamoyl]-8-methyl-imidazo[1,2-a]pyridine-3-yl]phenyl]carbamate, Methyl N-[5-[6-[(4-fluoro-3-methyl-phenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate, Methyl N-[5-[6-[(4-cyano-3-methoxyphenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate, Methyl N-[5-[6-[(4-chloro-3-methoxyphenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate, Methyl N-[5-[6-[(4-fluorophenyl)-methyl-carbamoyl]-8-methylimidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate, Methyl N-[5-[6-[(4-fluorophenyl)-methyl-carbamoyl]-7-methylimidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate, Methyl N-[5-[6-[cyanomethyl-(4-fluoro-3-methoxyphenyl)carbamoyl]imidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate, Methyl N-[5-[6-[(4-chloro-3-methoxyphenyl)-(cyanomethyl)carbamoyl]imidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate, Methyl N-[5-[6-[(4-fluoro-3-methoxyphenyl)-(methylsulfonylmethyl)carbamoyl]imidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate, N-(4-fluoro-3-methoxyphenyl)-3-[6-(methoxycarbamoylamino)-3-pyridyl]-N-methylimidazo[1,2-a]pyridine-6-carboxamide, Methyl N-[5-[8-acetamido-6-[(4-fluorophenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate, Methyl N-[5-[6-[ethyl-(4-fluorophenyl)carbamoyl]imidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate, Methyl N-[5-[8-acetamido-6-[(4-fluoro-3-methoxyphenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate, Methyl {N}-[5-[6-[(4-fluoro-3-methoxyphenyl)-methyl-carbamoyl]-8-(methoxymethyl)imidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate, Methyl N-[5-[6-[(2-methoxy-4-pyridyl)-methyl-carbamoyl]-8-methyl-imidazo[1,2-a]pyridin-3-yl]-2-pyridyl]carbamate, and Methyl N-[5-[6-[(4-cyano-3-methoxyphenyl)-methyl-carbamoyl]-8-methyl-imidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate A compound selected from, or its salt or N-oxide, The fungicidal composition according to claim 1 or 2.

4. The aforementioned component (A) is: Methyl N-[5-[6-[(4-fluoro-3-methoxyphenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate, or Methyl N-[5-[6-[(4-fluoro-3-methoxyphenyl)-methyl-carbamoyl]-8-methyl-imidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate, or Methyl N-[5-[6-[(4-fluoro-3-methoxyphenyl)-(methoxymethyl)carbamoyl]-8-methyl-imidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate, or Methyl N-[5-[6-[(4-fluoro-3-methoxyphenyl)-(methoxymethyl)carbamoyl]imidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate, or Methyl N-[4-[6-[(4-fluoro-3-methoxyphenyl)-methyl-carbamoyl]imidazo[1,2-a]pyridine-3-yl]phenyl]carbamate, or 3-[6-(cyclopropanecarbonylamino)-3-pyridyl]-N-(4-fluoro-3-methoxyphenyl)-N-methylimidazo[1,2-a]pyridine-6-carboxamide, or Methyl{N}-[5-[6-[(4-fluoro-3-methoxyphenyl)-methyl-carbamoyl]-8-(methoxymethyl)imidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate, or Methyl N-[5-[6-[(2-methoxy-4-pyridyl)-methyl-carbamoyl]-8-methyl-imidazo[1,2-a]pyridin-3-yl]-2-pyridyl]carbamate, or Methyl N-[5-[6-[(4-cyano-3-methoxyphenyl)-methyl-carbamoyl]-8-methyl-imidazo[1,2-a]pyridine-3-yl]-2-pyridyl]carbamate; or its salt or N-oxide, The fungicidal composition according to any one of claims 1 to 3.

5. The aforementioned component (B) is acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, chlorothalonil, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, florylpicoxamide, fluazinam, fludioxonil, fluopicolide, fluoxapipproline, forpet, mandipropamide, mefentrifluconazole, metalaxyl-M, oxathiapipproline, picarbutrazox, pidflumetofen, sedaxane, Streptomyces crestomycetics The fungicidal composition according to any one of claims 1 to 4, wherein the compound is selected from *Chrestomyceticus*, zoxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoroquinoline-3-carboxamide and N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoroquinoline-3-carboxamide.

6. The fungicidal composition according to any one of claims 1 to 5, wherein the weight ratio of component (A) to component (B) is 100:1 to 1:

100.

7. The fungicidal composition according to any one of claims 1 to 6, wherein the weight ratio of component (A) to component (B) is 20:1 to 1:

40.

8. The fungicidal composition according to any one of claims 1 to 7, wherein the weight ratio of component (A) to component (B) is 12:1 to 1:

25.

9. The fungicidal composition according to any one of claims 1 to 8, wherein the weight ratio of component (A) to component (B) is 5:1 to 1:

15.

10. The fungicidal composition according to any one of claims 1 to 9, wherein the weight ratio of component (A) to component (B) is 2:1 to 1:

5.

11. Unlike ingredient (B), acetamiprid, acibenzolar-S-methyl, ametoctrazine, amisulbrom, azoxystrobin, Bacillus amyloliquefaciens, benzovindiflupir, broflanilide, chlorothalonil, clothianidin, chlorantraniliprole, cis-jasmon, cyantraniliprole, cyazofamide, cyclobutrifluram, cymoxanil, difenoconazole, phosphonate disodium, etaboxam, fenpicoxamide, florylpicoxamide, fluazinam, fludioxonil, fluindapir, fluopicolide, fluopyram, fluoxapiproline, fluoxythioconazole, fluxamethoxamide, fluxapyroxad, flu Pet, imidacloprid, impulfluxam, ipconazole, ipflufenokine, isocycloseram, isoflucipram, isothianil, mandipropamide, mefentrifluconazole, metalaxyl, metalaxyl-M (mefenoxam), methyltetraprole, oxatiapiproline, penflufen, phosphite (phosphonate), picarbutrazox, prothioconazole, pidflumetofen, pyraclostrobin, quinofumerine, sedaxane, silthiofame, Streptomyces crestomycetics (chrestomyceticus), tebuconazole, tetraniliprol, thiabendazole, thiamethoxam, tolprocarb, triticonazole, zoxamide, N-[(1R)-1-benzyl-3-chloro-1-methylbuta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methylbuta-3-enyl]-8-fluoroquinoline-3-carboxamide, N-[(1R) -1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoroquinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoroquinoline-3-carboxamide, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoroquinoline-3-carboxamide, N-[(1S)-1-benzyl- The fungicidal composition according to any one of claims 1 to 10, further comprising a further active ingredient component (C) selected from the group consisting of 1,3-dimethylbutyl]-8-fluoroquinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methylbuta-3-enyl)-8-fluoroquinoline-3-carboxamide, and N-((1S)-1-benzyl-3-chloro-1-methylbuta-3-enyl)-8-fluoroquinoline-3-carboxamide.

12. The fungicidal composition according to any one of claims 1 to 11, wherein the composition further comprises an agriculturally acceptable carrier and optionally a surfactant and / or a formulation aid.

13. A method for controlling or preventing plant pathogenic diseases, particularly plant pathogenic fungi, of useful plants or their reproductive materials, comprising applying a fungicidal composition according to any one of claims 1 to 12 to the useful plants, their habitat or their reproductive materials.

14. The method according to claim 13, wherein components (A) and (B) are applied sequentially.

15. Formula (XXI) 【Chemistry 2】 (wherein A is CH or N; R 2a H, C 1-6 Alkyl, C 3-6 Cycloalkyl, and C 1-6 Alkoxy-C 1-6 Selected from alkyl groups; R 2b H, CN, C 1-6 Alkyl, C 3-6 Cycloalkyl, C 1-6 Alkoxy-C 1-6 Alkyl, amino, and -NHC(O)C 1-6 Selected from alkyl groups; R 2c is H; R 6 is selected from C 1-6 alkyl, C 1-6 alkoxy, C 3-6 cycloalkyl, C 1-6 alkylamino, C 1-6 alkoxyamino and C 1-6 alkyl C 1-6 alkoxyamino; and X is chloro(Cl), bromo(Br), or iodine(I). Compounds of the same; or salts or N-oxides thereof.

Images